Source Class, Target Class, Score
Country,B cell receptor complex,0.55
Country,COVID-19 disease incidence proportion,0.5409090909090909
Country,COVID-19 mortality rate,0.5833333333333334
Country,three-dimensional spatial region,0.5525641025641026
Country,communicability start temporal region,0.5863636363636363
Country,incubation end temporal region,0.5851351351351352
Country,infection incidence rate,0.5790322580645162
Country,PR_000003622,0.5026315789473684
Country,infectious disease mortality rate,0.575
Country,one-dimensional spatial region,0.5581081081081081
Country,GEO_000000371,0.5
Country,latency end process boundary,0.6214285714285714
Country,infection incidence proportion profile,0.5611111111111111
Country,establishment of a clinically abnormal colony,0.5269230769230769
Country,temporal region,0.5409090909090909
Country,geospatial region,0.575
Country,incubation end process boundary,0.6078947368421053
Country,latency end temporal region,0.5676470588235294
Country,Country,0.95
Country,infection end temporal region,0.5888888888888889
Country,two-dimensional spatial region,0.5581081081081081
Country,zero-dimensional spatial region,0.5552631578947369
Country,SARS-CoV-2 incidence rate,0.575
Country,communicability end process boundary,0.6127906976744186
Country,cell space,0.5088235294117647
Country,SARS-CoV-2 incidence proportion,0.5552631578947369
Country,infection start temporal region,0.581578947368421
Country,infection incidence proportion,0.5581081081081081
Country,pathogen birth temporal region,0.5581081081081081
Country,communicability end temporal region,0.5928571428571429
Country,infectious disease incidence proportion,0.558695652173913
Country,T cell receptor complex,0.55
Country,GEO_000000370,0.5
Country,CL_0000000,0.5088235294117647
Country,pathogen death temporal region,0.5581081081081081
Country,zero-dimensional temporal region,0.5525641025641026
Country,country,0.95
Country,infection incidence rate profile,0.5782051282051281
Country,COVID-19 incidence rate,0.5833333333333334
Country,infectious disease incidence rate,0.575
Country,geographical region,0.5653846153846154
Country,GEO_000000372,0.5
Country,anatomical space,0.5369565217391304
Country,spatial region,0.5452380952380953
Country,simple infection,0.5804347826086956
Country,one-dimensional temporal region,0.5552631578947369
Country,spatiotemporal region,0.5571428571428572
Patient,B cell receptor complex,0.55
Patient,COVID-19 mortality rate,0.55
Patient,ERO_0000347,0.5055555555555555
Patient,incubation end temporal region,0.6121621621621621
Patient,infection incidence rate,0.6112903225806451
Patient,PR_000003622,0.5026315789473684
Patient,infectious disease mortality rate,0.55
Patient,passive immunity to infectious agent,0.6127906976744186
Patient,ERO_0000008,0.5055555555555555
Patient,generically dependent continuant,0.5782051282051281
Patient,latency end process boundary,0.5642857142857143
Patient,passive immunization against infectious agent,0.5846153846153846
Patient,lower respiratory tract disease,0.581578947368421
Patient,establishment of a clinically abnormal colony,0.5461538461538461
Patient,ribonucleic acid,0.5369565217391304
Patient,ERO_0001362,0.5055555555555555
Patient,incubation end process boundary,0.581578947368421
Patient,latency end temporal region,0.5970588235294118
Patient,infection end temporal region,0.5888888888888889
Patient,nucleic acid,0.5552631578947369
Patient,specifically dependent continuant,0.6
Patient,ERO_0000671,0.5055555555555555
Patient,SARS-CoV-2 incidence rate,0.60625
Patient,communicability end process boundary,0.5430232558139535
Patient,ERO_0000006,0.5055555555555555
Patient,communicability end temporal region,0.569047619047619
Patient,case isolation control strategy,0.581578947368421
Patient,T cell receptor complex,0.55
Patient,ERO_0000337,0.5055555555555555
Patient,infection incidence rate profile,0.5782051282051281
Patient,deoxyribonucleic acid,0.5214285714285714
Patient,COVID-19 incidence rate,0.5833333333333334
Patient,infectious disease incidence rate,0.575
PM_Swanidhi,establishment of a clinically abnormal colony,0.5392857142857143
PM_Swanidhi,T cell receptor complex,0.5088235294117647
Doubtfull,B cell receptor complex,0.54375
Doubtfull,T cell receptor complex,0.54375
Cooperative_Banks,B cell receptor complex,0.575
Cooperative_Banks,COVID-19 mortality rate,0.65
Cooperative_Banks,ERO_0000347,0.5571428571428572
Cooperative_Banks,object aggregate,0.6318181818181818
Cooperative_Banks,coronavirus aggregate,0.6342105263157894
Cooperative_Banks,incubation end temporal region,0.6202127659574468
Cooperative_Banks,infection incidence rate,0.6207317073170732
Cooperative_Banks,PR_000003622,0.553448275862069
Cooperative_Banks,infectious structure aggregate,0.598936170212766
Cooperative_Banks,infectious disease mortality rate,0.61
Cooperative_Banks,virus aggregate,0.575
Cooperative_Banks,ERO_0000008,0.5571428571428572
Cooperative_Banks,generically dependent continuant,0.5928571428571429
Cooperative_Banks,latency end process boundary,0.6055555555555556
Cooperative_Banks,SARS-CoV-2 aggregate,0.6121621621621621
Cooperative_Banks,acellular structure aggregate,0.6021739130434782
Cooperative_Banks,establishment of a clinically abnormal colony,0.5790322580645162
Cooperative_Banks,reservoir of pathogen role,0.6127906976744186
Cooperative_Banks,ERO_0001362,0.5571428571428572
Cooperative_Banks,incubation end process boundary,0.6166666666666667
Cooperative_Banks,collective resistance disposition,0.67
Cooperative_Banks,latency end temporal region,0.5863636363636363
Cooperative_Banks,infection end temporal region,0.6021739130434782
Cooperative_Banks,specifically dependent continuant,0.59
Cooperative_Banks,ERO_0000671,0.5571428571428572
Cooperative_Banks,SARS-CoV-2 incidence rate,0.6166666666666667
Cooperative_Banks,active immunization against infectious agent,0.5975409836065574
Cooperative_Banks,communicability end process boundary,0.6009433962264151
Cooperative_Banks,viroid aggregate,0.6015151515151516
Cooperative_Banks,ERO_0000006,0.5571428571428572
Cooperative_Banks,communicability end temporal region,0.6038461538461539
Cooperative_Banks,T cell receptor complex,0.575
Cooperative_Banks,CL_0000000,0.524074074074074
Cooperative_Banks,ERO_0000337,0.5571428571428572
Cooperative_Banks,infection incidence rate profile,0.6132653061224489
Cooperative_Banks,infectious agent reservoir,0.6127906976744186
Cooperative_Banks,COVID-19 incidence rate,0.625
Cooperative_Banks,infectious disease incidence rate,0.61
Cooperative_Banks,collective disposition,0.6807692307692308
Cooperative_Banks,symbiotic process,0.5970588235294118
Cooperative_Banks,prion aggregate,0.60625
Cooperative_Banks,collective pathogenic disposition,0.67
BankingRelationShip,B cell receptor complex,0.5928571428571429
BankingRelationShip,establishment of a clinically abnormal colony,0.590625
BankingRelationShip,T cell receptor complex,0.569047619047619
RBd3rcWt9QqVoT4OMScWPmr,B cell receptor complex,0.6239130434782608
RBd3rcWt9QqVoT4OMScWPmr,T cell receptor complex,0.6021739130434782
InfectedBrother,B cell receptor complex,0.6078947368421053
InfectedBrother,infected population,0.7441176470588234
InfectedBrother,T cell receptor complex,0.6078947368421053
ExposureViaCongregation,establishment of a clinically abnormal colony,0.5970588235294118
ExposureViaCongregation,T cell receptor complex,0.6021739130434782
RdAsLc5UxSB5GO0siRrhu6,B cell receptor complex,0.5388888888888889
RdAsLc5UxSB5GO0siRrhu6,GO_0019814,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0051093,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0019061,0.575
RdAsLc5UxSB5GO0siRrhu6,GO_0048525,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0019081,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0008150,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0019083,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0050777,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0065007,0.575
RdAsLc5UxSB5GO0siRrhu6,establishment of a clinically abnormal colony,0.5544776119402985
RdAsLc5UxSB5GO0siRrhu6,GO_0006959,0.575
RdAsLc5UxSB5GO0siRrhu6,GO_0006955,0.575
RdAsLc5UxSB5GO0siRrhu6,GO_0044409,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0002443,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0032502,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0019062,0.575
RdAsLc5UxSB5GO0siRrhu6,GO_0032991,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0045087,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_19076,0.5833333333333334
RdAsLc5UxSB5GO0siRrhu6,GO_0019028,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0046718,0.575
RdAsLc5UxSB5GO0siRrhu6,GO_0019031,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0048519,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0046727,0.575
RdAsLc5UxSB5GO0siRrhu6,GO_0044403,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0051234,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0002250,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0019068,0.575
RdAsLc5UxSB5GO0siRrhu6,GO_0042101,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0044411,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0019815,0.54375
RdAsLc5UxSB5GO0siRrhu6,GO_0044406,0.575
Cluster,B cell receptor complex,0.5833333333333334
Cluster,exotoxin disposition,0.524074074074074
Cluster,object aggregate,0.5804347826086956
Cluster,coronavirus aggregate,0.6285714285714286
Cluster,invasive disposition,0.524074074074074
Cluster,zoonotic disposition,0.5611111111111111
Cluster,establishment of localization in human host,0.55
Cluster,infectious structure aggregate,0.6121621621621621
Cluster,virus aggregate,0.6318181818181818
Cluster,host,0.6318181818181818
Cluster,virostatic disposition,0.553448275862069
Cluster,fungicidal disposition,0.5879310344827586
Cluster,viral load,0.5088235294117647
Cluster,adhesion disposition,0.524074074074074
Cluster,parasiticidal disposition,0.575
Cluster,neurotoxin disposition,0.553448275862069
Cluster,SARS-CoV-2 aggregate,0.5611111111111111
Cluster,definitive host,0.5409090909090909
Cluster,enterotoxin disposition,0.55
Cluster,primary infectious disposition,0.5581081081081081
Cluster,acellular structure aggregate,0.6444444444444444
Cluster,static agent disposition,0.5467741935483871
Cluster,pathogenic disposition,0.553448275862069
Cluster,dead-end host,0.55
Cluster,action specification,0.5611111111111111
Cluster,virulence factor disposition,0.5357142857142857
Cluster,establishment of a clinically abnormal colony,0.5269230769230769
Cluster,disposition,0.5611111111111111
Cluster,colonized host,0.6404761904761905
Cluster,pathogen host,0.55
Cluster,cidal agent disposition,0.5833333333333334
Cluster,invasion disposition,0.524074074074074
Cluster,endotoxin disposition,0.5214285714285714
Cluster,collective resistance disposition,0.575
Cluster,virus host,0.6264705882352941
Cluster,viral adhesion disposition,0.5409090909090909
Cluster,transmissibility disposition,0.5357142857142857
Cluster,dead-end host role,0.57
Cluster,intermediate host role,0.553448275862069
Cluster,viricidal disposition,0.5928571428571429
Cluster,infectious structure host role,0.6121621621621621
Cluster,entry into host through host barriers,0.5636363636363636
Cluster,infectious structure host,0.60625
Cluster,opportunistic infectious disposition,0.5430232558139535
Cluster,infectious agent host role,0.6015151515151516
Cluster,parasitostatic disposition,0.5409090909090909
Cluster,fungistatic disposition,0.55
Cluster,viroid aggregate,0.5369565217391304
Cluster,infectious agent host,0.5928571428571429
Cluster,symbiont host role,0.57
Cluster,cytotoxin disposition,0.5571428571428572
Cluster,establishment of localization in host,0.5409090909090909
Cluster,host role,0.6375
Cluster,establishment of localization in virus host,0.55
Cluster,reverse zoonotic disposition,0.5357142857142857
Cluster,colonization of host,0.5981481481481481
Cluster,T cell receptor complex,0.5833333333333334
Cluster,CL_0000000,0.5676470588235294
Cluster,intermediate host,0.575
Cluster,definitive host role,0.5611111111111111
Cluster,collective disposition,0.5879310344827586
Cluster,toxin disposition,0.5333333333333333
Cluster,adhesion of symbiont to host,0.5071428571428571
Cluster,prion aggregate,0.5409090909090909
Cluster,bactericidal disposition,0.5790322580645162
Cluster,bacteriostatic disposition,0.5712121212121213
Cluster,infectious disposition,0.5879310344827586
Cluster,pathogen host role,0.57
Cluster,collective pathogenic disposition,0.55
Cluster,immunosuppressive disposition,0.5333333333333333
Cluster,entry into host,0.5409090909090909
Cluster,SARS-COV-2 adhesion disposition,0.5289473684210526
AtmNirbhor,B cell receptor complex,0.5409090909090909
AtmNirbhor,establishment of a clinically abnormal colony,0.5772727272727273
AtmNirbhor,T cell receptor complex,0.5712121212121213
Covid Care Centre (CCC),B cell receptor complex,0.6673913043478261
Covid Care Centre (CCC),positive-sense single-stranded RNA virus,0.5928571428571429
Covid Care Centre (CCC),GO_0019814,0.5106060606060606
Covid Care Centre (CCC),GO_0051093,0.5106060606060606
Covid Care Centre (CCC),GO_0019061,0.5106060606060606
Covid Care Centre (CCC),incubation end temporal region,0.619811320754717
Covid Care Centre (CCC),PR_000003622,0.5071428571428571
Covid Care Centre (CCC),GO_0048525,0.5106060606060606
Covid Care Centre (CCC),GO_0019081,0.5106060606060606
Covid Care Centre (CCC),GO_0008150,0.5106060606060606
Covid Care Centre (CCC),viral load,0.5712121212121213
Covid Care Centre (CCC),GO_0019083,0.5106060606060606
Covid Care Centre (CCC),GO_0050777,0.5106060606060606
Covid Care Centre (CCC),latency end process boundary,0.6068627450980393
Covid Care Centre (CCC),GO_0065007,0.5106060606060606
Covid Care Centre (CCC),infectious disease control strategy,0.6396551724137931
Covid Care Centre (CCC),action specification,0.5895348837209302
Covid Care Centre (CCC),establishment of a clinically abnormal colony,0.5823529411764706
Covid Care Centre (CCC),GO_0006959,0.5106060606060606
Covid Care Centre (CCC),GO_0006955,0.5106060606060606
Covid Care Centre (CCC),incubation end process boundary,0.6166666666666667
Covid Care Centre (CCC),GO_0044409,0.5106060606060606
Covid Care Centre (CCC),GO_0002443,0.5106060606060606
Covid Care Centre (CCC),GO_0032502,0.5106060606060606
Covid Care Centre (CCC),pathogen portal of exit,0.5804347826086956
Covid Care Centre (CCC),GO_0019062,0.5106060606060606
Covid Care Centre (CCC),pathogen portal of exit site,0.5872549019607843
Covid Care Centre (CCC),GO_0032991,0.5106060606060606
Covid Care Centre (CCC),latency end temporal region,0.61
Covid Care Centre (CCC),GO_0045087,0.5106060606060606
Covid Care Centre (CCC),infection end temporal region,0.6038461538461539
Covid Care Centre (CCC),GO_19076,0.5145161290322581
Covid Care Centre (CCC),quarantine control strategy,0.63
Covid Care Centre (CCC),double-stranded RNA virus,0.575
Covid Care Centre (CCC),SARS-CoV-2 attachment stage,0.65
Covid Care Centre (CCC),GO_0019028,0.5106060606060606
Covid Care Centre (CCC),GO_0046718,0.5106060606060606
Covid Care Centre (CCC),GO_0019031,0.5106060606060606
Covid Care Centre (CCC),GO_0048519,0.5106060606060606
Covid Care Centre (CCC),GO_0046727,0.5106060606060606
Covid Care Centre (CCC),place closure control strategy,0.6575471698113208
Covid Care Centre (CCC),GO_0044403,0.5106060606060606
Covid Care Centre (CCC),GO_0051234,0.5106060606060606
Covid Care Centre (CCC),communicability end process boundary,0.6364406779661017
Covid Care Centre (CCC),vector control strategy,0.6456521739130434
Covid Care Centre (CCC),single-stranded RNA retrovirus,0.6009433962264151
Covid Care Centre (CCC),GO_0002250,0.5106060606060606
Covid Care Centre (CCC),communicability end temporal region,0.6396551724137931
Covid Care Centre (CCC),case isolation control strategy,0.6351851851851852
Covid Care Centre (CCC),negative-sense single-stranded RNA virus,0.5769841269841269
Covid Care Centre (CCC),T cell receptor complex,0.6673913043478261
Covid Care Centre (CCC),CL_0000000,0.5106060606060606
Covid Care Centre (CCC),pathogen portal of exit role,0.6068627450980393
Covid Care Centre (CCC),infectious disease control objective specification,0.6417808219178082
Covid Care Centre (CCC),GO_0019068,0.5106060606060606
Covid Care Centre (CCC),herd immunity to infectious organism,0.5516949152542373
Covid Care Centre (CCC),GO_0042101,0.5106060606060606
Covid Care Centre (CCC),acute respiratory distress syndrome,0.6051724137931035
Covid Care Centre (CCC),GO_0044411,0.5106060606060606
Covid Care Centre (CCC),virus attachment stage,0.65
Covid Care Centre (CCC),GO_0019815,0.5106060606060606
Covid Care Centre (CCC),GO_0044406,0.5106060606060606
Foreign_Banks,B cell receptor complex,0.5333333333333333
Foreign_Banks,COVID-19 mortality rate,0.5888888888888889
Foreign_Banks,ERO_0000347,0.5333333333333333
Foreign_Banks,positive-sense single-stranded RNA virus,0.6009433962264151
Foreign_Banks,incubation end temporal region,0.5895348837209302
Foreign_Banks,epitope site,0.61
Foreign_Banks,virus adhesion susceptible cell,0.5863636363636363
Foreign_Banks,normal resident microbiota population,0.63
Foreign_Banks,infection incidence rate,0.6121621621621621
Foreign_Banks,PR_000003622,0.53
Foreign_Banks,infectious disease mortality rate,0.5804347826086956
Foreign_Banks,pathogen portal of entry site,0.6166666666666667
Foreign_Banks,ERO_0000008,0.5333333333333333
Foreign_Banks,generically dependent continuant,0.5833333333333334
Foreign_Banks,processed material,0.5790322580645162
Foreign_Banks,latency end process boundary,0.5719512195121951
Foreign_Banks,source of infection site,0.6391891891891892
Foreign_Banks,local infection,0.5928571428571429
Foreign_Banks,TRANS_0000008,0.6038461538461539
Foreign_Banks,site,0.5088235294117647
Foreign_Banks,acellular structure aggregate,0.5452380952380953
Foreign_Banks,acellular structure,0.54375
Foreign_Banks,establishment of a clinically abnormal colony,0.5706896551724138
Foreign_Banks,cell,0.5088235294117647
Foreign_Banks,reservoir of pathogen role,0.6038461538461539
Foreign_Banks,ERO_0001362,0.5333333333333333
Foreign_Banks,incubation end process boundary,0.5863636363636363
Foreign_Banks,immaterial entity,0.5833333333333334
Foreign_Banks,material entity,0.5928571428571429
Foreign_Banks,pathogen portal of exit site,0.5963414634146341
Foreign_Banks,latency end temporal region,0.575
Foreign_Banks,TRANS_0000002,0.6038461538461539
Foreign_Banks,infection end temporal region,0.6166666666666667
Foreign_Banks,material processing,0.575
Foreign_Banks,double-stranded RNA virus,0.6078947368421053
Foreign_Banks,specifically dependent continuant,0.5804347826086956
Foreign_Banks,ERO_0000671,0.5333333333333333
Foreign_Banks,SARS-CoV-2 incidence rate,0.581578947368421
Foreign_Banks,communicability end process boundary,0.5724489795918367
Foreign_Banks,cell space,0.5804347826086956
Foreign_Banks,site of infection,0.5833333333333334
Foreign_Banks,single-stranded RNA retrovirus,0.5895348837209302
Foreign_Banks,extracellular infection,0.5888888888888889
Foreign_Banks,ERO_0000006,0.5333333333333333
Foreign_Banks,communicability end temporal region,0.575
Foreign_Banks,TRANS_0000000,0.6038461538461539
Foreign_Banks,negative-sense single-stranded RNA virus,0.5820754716981132
Foreign_Banks,TRANS_0000007,0.6038461538461539
Foreign_Banks,T cell receptor complex,0.5333333333333333
Foreign_Banks,ERO_0000337,0.5333333333333333
Foreign_Banks,infection incidence rate profile,0.5833333333333334
Foreign_Banks,infectious agent reservoir,0.6294871794871795
Foreign_Banks,COVID-19 incidence rate,0.5888888888888889
Foreign_Banks,independent continuant,0.5928571428571429
Foreign_Banks,infectious disease incidence rate,0.6021739130434782
Foreign_Banks,SARS-COV-2 adhesion susceptible cell,0.5724489795918367
ContactWithInfactedBankingStaff,B cell receptor complex,0.5425925925925926
ContactWithInfactedBankingStaff,contact pathogen transmission process,0.6852941176470588
ContactWithInfactedBankingStaff,establishment of a clinically abnormal colony,0.6078947368421053
ContactWithInfactedBankingStaff,T cell receptor complex,0.5425925925925926
ContactWithInfactedBankingStaff,contact tracing,0.7326086956521739
R9l0YWN0aTqPn16MAR8ttyA,establishment of a clinically abnormal colony,0.5529411764705883
R9l0YWN0aTqPn16MAR8ttyA,T cell receptor complex,0.5152173913043478
InfectedFamilyMember,B cell receptor complex,0.5895348837209302
InfectedFamilyMember,establishment of a clinically abnormal colony,0.6038461538461539
InfectedFamilyMember,infected population,0.7064102564102563
InfectedFamilyMember,T cell receptor complex,0.5895348837209302
NormalSavingAccount,normal resident microbiota population,0.6821428571428573
NormalSavingAccount,establishment of a clinically abnormal colony,0.60625
NormalSavingAccount,T cell receptor complex,0.5452380952380953
Deposit,B cell receptor complex,0.55
Deposit,PR_000003622,0.5026315789473684
Deposit,TRANS_0000008,0.5
Deposit,establishment of a clinically abnormal colony,0.5269230769230769
Deposit,TRANS_0000002,0.5
Deposit,plan specification,0.61
Deposit,place closure control strategy,0.5581081081081081
Deposit,TRANS_0000000,0.5
Deposit,TRANS_0000007,0.5
Deposit,T cell receptor complex,0.55
Dedicated Covid Health Centre,B cell receptor complex,0.6423076923076922
Dedicated Covid Health Centre,COVID-19 mortality rate,0.6807692307692308
Dedicated Covid Health Centre,GO_0019814,0.5012820512820513
Dedicated Covid Health Centre,object aggregate,0.6277777777777778
Dedicated Covid Health Centre,GO_0051093,0.5012820512820513
Dedicated Covid Health Centre,GO_0019061,0.5012820512820513
Dedicated Covid Health Centre,incubation end temporal region,0.6703389830508475
Dedicated Covid Health Centre,immunoglobulin complex,0.5676470588235294
Dedicated Covid Health Centre,infection incidence rate,0.6764150943396227
Dedicated Covid Health Centre,infectious disease mortality rate,0.6596774193548387
Dedicated Covid Health Centre,GO_0048525,0.5012820512820513
Dedicated Covid Health Centre,GO_0019081,0.5012820512820513
Dedicated Covid Health Centre,GO_0008150,0.5012820512820513
Dedicated Covid Health Centre,GO_0019083,0.5012820512820513
Dedicated Covid Health Centre,GO_0050777,0.5012820512820513
Dedicated Covid Health Centre,latency end process boundary,0.6429824561403508
Dedicated Covid Health Centre,GO_0065007,0.5012820512820513
Dedicated Covid Health Centre,TRANS_0000008,0.5214285714285714
Dedicated Covid Health Centre,establishment of a clinically abnormal colony,0.6121621621621621
Dedicated Covid Health Centre,GO_0006959,0.5012820512820513
Dedicated Covid Health Centre,GO_0006955,0.5012820512820513
Dedicated Covid Health Centre,incubation end process boundary,0.65
Dedicated Covid Health Centre,GO_0044409,0.5012820512820513
Dedicated Covid Health Centre,GO_0002443,0.5012820512820513
Dedicated Covid Health Centre,GO_0032502,0.5012820512820513
Dedicated Covid Health Centre,GO_0019062,0.5012820512820513
Dedicated Covid Health Centre,GO_0032991,0.5012820512820513
Dedicated Covid Health Centre,latency end temporal region,0.6642857142857143
Dedicated Covid Health Centre,TRANS_0000002,0.5214285714285714
Dedicated Covid Health Centre,GO_0045087,0.5012820512820513
Dedicated Covid Health Centre,infection end temporal region,0.656896551724138
Dedicated Covid Health Centre,GO_19076,0.504054054054054
Dedicated Covid Health Centre,GO_0019028,0.5012820512820513
Dedicated Covid Health Centre,GO_0046718,0.5012820512820513
Dedicated Covid Health Centre,GO_0019031,0.5012820512820513
Dedicated Covid Health Centre,GO_0048519,0.5012820512820513
Dedicated Covid Health Centre,GO_0046727,0.5012820512820513
Dedicated Covid Health Centre,SARS-CoV-2 incidence rate,0.6537037037037037
Dedicated Covid Health Centre,GO_0044403,0.5012820512820513
Dedicated Covid Health Centre,active immunization against infectious agent,0.6280821917808219
Dedicated Covid Health Centre,GO_0051234,0.5012820512820513
Dedicated Covid Health Centre,communicability end process boundary,0.6346153846153847
Dedicated Covid Health Centre,GO_0002250,0.5012820512820513
Dedicated Covid Health Centre,communicability end temporal region,0.653125
Dedicated Covid Health Centre,TRANS_0000000,0.5214285714285714
Dedicated Covid Health Centre,TRANS_0000007,0.5214285714285714
Dedicated Covid Health Centre,T cell receptor complex,0.6615384615384616
Dedicated Covid Health Centre,CL_0000000,0.5269230769230769
Dedicated Covid Health Centre,appearance of disorder,0.6264705882352941
Dedicated Covid Health Centre,macromolecular complex,0.6068627450980393
Dedicated Covid Health Centre,GO_0019068,0.5012820512820513
Dedicated Covid Health Centre,infection incidence rate profile,0.6631147540983606
Dedicated Covid Health Centre,COVID-19 incidence rate,0.6615384615384616
Dedicated Covid Health Centre,complex infection,0.6021739130434782
Dedicated Covid Health Centre,GO_0042101,0.5012820512820513
Dedicated Covid Health Centre,infectious disease incidence rate,0.6758064516129032
Dedicated Covid Health Centre,object,0.5642857142857143
Dedicated Covid Health Centre,GO_0044411,0.5012820512820513
Dedicated Covid Health Centre,GO_0019815,0.5012820512820513
Dedicated Covid Health Centre,GO_0044406,0.5012820512820513
Scheduled_Banks,B cell receptor complex,0.581578947368421
Scheduled_Banks,incubation end temporal region,0.6055555555555556
Scheduled_Banks,infectious disease course,0.575
Scheduled_Banks,obligatory symbiont,0.5676470588235294
Scheduled_Banks,epitope site,0.5981481481481481
Scheduled_Banks,pathogen portal of entry site,0.5863636363636363
Scheduled_Banks,latency end process boundary,0.6127906976744186
Scheduled_Banks,source of infection site,0.6038461538461539
Scheduled_Banks,site,0.5552631578947369
Scheduled_Banks,establishment of a clinically abnormal colony,0.5833333333333334
Scheduled_Banks,coronavirus disease course,0.5719512195121951
Scheduled_Banks,chronic infectious disease course,0.5958333333333333
Scheduled_Banks,reservoir of pathogen role,0.5719512195121951
Scheduled_Banks,planned process,0.6166666666666667
Scheduled_Banks,acute infectious disease course,0.5804347826086956
Scheduled_Banks,incubation end process boundary,0.6021739130434782
Scheduled_Banks,pathogen portal of exit site,0.5895348837209302
Scheduled_Banks,disease course,0.6224137931034482
Scheduled_Banks,latency end temporal region,0.5928571428571429
Scheduled_Banks,plan specification,0.5712121212121213
Scheduled_Banks,infection end temporal region,0.5863636363636363
Scheduled_Banks,communicability end process boundary,0.6068627450980393
Scheduled_Banks,site of infection,0.575
Scheduled_Banks,viral disease course,0.5928571428571429
Scheduled_Banks,communicability end temporal region,0.61
Scheduled_Banks,T cell receptor complex,0.581578947368421
Scheduled_Banks,CL_0000000,0.57
Scheduled_Banks,infectious agent reservoir,0.5963414634146341
Scheduled_Banks,long-term non-progressing infectious disease course,0.5409090909090909
Scheduled_Banks,COVID-19 disease course,0.581578947368421
Rxyv0iCwqfDNhogth78U1s,T cell receptor complex,0.5166666666666666
Employee,B cell receptor complex,0.6112903225806451
Employee,source of infection role,0.575
Employee,static agent,0.5
Employee,innate immunity to infectious agent,0.5662790697674418
Employee,infectious agent,0.575
Employee,incubation end temporal region,0.581578947368421
Employee,asymptomatic carrier role,0.6015151515151516
Employee,susceptibility to infectious agent,0.5928571428571429
Employee,mutualist role,0.6318181818181818
Employee,pathogen portal of entry role,0.6121621621621621
Employee,PR_000003622,0.5
Employee,infectious agent population,0.5642857142857143
Employee,passive immunity to infectious agent,0.5636363636363636
Employee,pathogen transporter role,0.6015151515151516
Employee,drug susceptibility of infectious agent,0.5776595744680851
Employee,latency end process boundary,0.5611111111111111
Employee,passive immunization against infectious agent,0.5443396226415094
Employee,pathogen vector role,0.5928571428571429
Employee,secondary infection role,0.60625
Employee,lower respiratory tract disease,0.6038461538461539
Employee,static agent disposition,0.54375
Employee,immunization against infectious agent,0.5388888888888889
Employee,adhesion factor,0.5369565217391304
Employee,virulence factor disposition,0.5333333333333333
Employee,commensal role,0.6318181818181818
Employee,establishment of a clinically abnormal colony,0.5443396226415094
Employee,reservoir of pathogen role,0.5970588235294118
Employee,leukocyte-mediated immunity to infectious agent,0.5409090909090909
Employee,cidal agent disposition,0.5467741935483871
Employee,incubation end process boundary,0.5525641025641026
Employee,biological vector role,0.5833333333333334
Employee,primary infection role,0.5833333333333334
Employee,latency end temporal region,0.5928571428571429
Employee,symbiont role,0.5928571428571429
Employee,infectious agent generative stage,0.5475609756097561
Employee,infection end temporal region,0.5851351351351352
Employee,reagent role,0.6
Employee,dead-end host role,0.5653846153846154
Employee,intermediate host role,0.5833333333333334
Employee,epitope role,0.7
Employee,infectious structure host role,0.5552631578947369
Employee,parasite role,0.5928571428571429
Employee,symptomatic carrier role,0.60625
Employee,infectious agent host role,0.5676470588235294
Employee,active immunization against infectious agent,0.5461538461538461
Employee,communicability end process boundary,0.5636363636363636
Employee,vaccination against infectious agent,0.5181818181818182
Employee,antigen role,0.6
Employee,infectious agent host,0.553448275862069
Employee,role,0.6166666666666667
Employee,symbiont host role,0.5653846153846154
Employee,mechanical vector role,0.5833333333333334
Employee,pathogen vehicle role,0.5879310344827586
Employee,host role,0.5676470588235294
Employee,communicability end temporal region,0.5662790697674418
Employee,symptomatic infectious agent carrier,0.5636363636363636
Employee,virulence factor,0.575
Employee,asymptomatic infectious agent carrier,0.5611111111111111
Employee,T cell receptor complex,0.6112903225806451
Employee,CL_0000000,0.5055555555555555
Employee,pathogen portal of exit role,0.6166666666666667
Employee,definitive host role,0.5571428571428572
Employee,infectious agent reservoir,0.5676470588235294
Employee,sterilizing immunity to infectious agent,0.5541666666666667
Employee,biological role,0.5804347826086956
Employee,pathogen host role,0.6038461538461539
Employee,fomite role,0.6078947368421053
Employee,biological vehicle role,0.5790322580645162
Employee,cidal agent,0.5552631578947369
Employee,acquired immunity to infectious agent,0.5611111111111111
Employee,infectious agent colony,0.5790322580645162
Employee,humoral immunity to infectious agent,0.5636363636363636
Premises,B cell receptor complex,0.5790322580645162
Premises,COVID-19 mortality rate,0.5467741935483871
Premises,source of infection role,0.575
Premises,epitope site,0.65
Premises,source of infection,0.5981481481481481
Premises,establishment of localization in human host,0.5480392156862746
Premises,infection incidence rate,0.54375
Premises,disease surveillance objective specification,0.5461538461538461
Premises,PR_000003622,0.55
Premises,infectious disease mortality rate,0.5719512195121951
Premises,objective specification,0.5790322580645162
Premises,pathogen portal of entry site,0.5851351351351352
Premises,source of infection site,0.60625
Premises,site,0.6166666666666667
Premises,lower respiratory tract disease,0.6038461538461539
Premises,negative regulation of establishment of localization,0.5333333333333333
Premises,action specification,0.5571428571428572
Premises,establishment of a clinically abnormal colony,0.5254716981132076
Premises,pathogen portal of exit site,0.6166666666666667
Premises,Country,0.5166666666666666
Premises,plan specification,0.5653846153846154
Premises,place closure control strategy,0.581578947368421
Premises,SARS-CoV-2 incidence rate,0.5409090909090909
Premises,site of infection,0.57
Premises,organism substance,0.6038461538461539
Premises,establishment of localization in host,0.5611111111111111
Premises,establishment of localization,0.5581081081081081
Premises,establishment of localization in virus host,0.5480392156862746
Premises,T cell receptor complex,0.5790322580645162
Premises,infectious disease control objective specification,0.5362068965517242
Premises,country,0.5166666666666666
Premises,infection incidence rate profile,0.55
Premises,COVID-19 incidence rate,0.5145161290322581
Premises,infectious disease incidence rate,0.5719512195121951
Doctor,B cell receptor complex,0.5879310344827586
Doctor,COVID-19 mortality rate,0.5879310344827586
Doctor,incubation end temporal region,0.5611111111111111
Doctor,infection incidence rate,0.5833333333333334
Doctor,PR_000003622,0.5055555555555555
Doctor,infectious disease mortality rate,0.5525641025641026
Doctor,viral load,0.5125
Doctor,respiratory system disease,0.54375
Doctor,GEO_000000371,0.5026315789473684
Doctor,latency end process boundary,0.5970588235294118
Doctor,TRANS_0000008,0.5552631578947369
Doctor,establishment of a clinically abnormal colony,0.5284313725490196
Doctor,incubation end process boundary,0.5851351351351352
Doctor,latency end temporal region,0.5712121212121213
Doctor,TRANS_0000002,0.5552631578947369
Doctor,plan specification,0.575
Doctor,infection end temporal region,0.5642857142857143
Doctor,SARS-CoV-2 incidence rate,0.5467741935483871
Doctor,communicability end process boundary,0.569047619047619
Doctor,communicability end temporal region,0.5719512195121951
Doctor,TRANS_0000000,0.5552631578947369
Doctor,TRANS_0000007,0.5552631578947369
Doctor,T cell receptor complex,0.5879310344827586
Doctor,GEO_000000370,0.5026315789473684
Doctor,CL_0000000,0.5125
Doctor,infection incidence rate profile,0.5552631578947369
Doctor,COVID-19 incidence rate,0.553448275862069
Doctor,infectious disease incidence rate,0.5525641025641026
Doctor,GEO_000000372,0.5026315789473684
Doctor,SARS-CoV-2 spike glycoprotein,0.5642857142857143
InfectedViaJob,B cell receptor complex,0.5581081081081081
InfectedViaJob,establishment of a clinically abnormal colony,0.5686440677966101
InfectedViaJob,infected population,0.7530303030303032
InfectedViaJob,T cell receptor complex,0.5581081081081081
Retail,B cell receptor complex,0.5879310344827586
Retail,incubation end temporal region,0.5611111111111111
Retail,PR_000003622,0.5055555555555555
Retail,latency end process boundary,0.5382352941176471
Retail,establishment of a clinically abnormal colony,0.5480392156862746
Retail,incubation end process boundary,0.5310810810810811
Retail,latency end temporal region,0.5712121212121213
Retail,infection end temporal region,0.5642857142857143
Retail,communicability end process boundary,0.5214285714285714
Retail,communicability end temporal region,0.5475609756097561
Retail,T cell receptor complex,0.5879310344827586
Corporate_Lending,B cell receptor complex,0.65
Corporate_Lending,COVID-19 mortality rate,0.65
Corporate_Lending,object aggregate,0.6015151515151516
Corporate_Lending,coronavirus aggregate,0.6605263157894737
Corporate_Lending,incubation end temporal region,0.6627659574468084
Corporate_Lending,epitope site,0.6224137931034482
Corporate_Lending,infection incidence rate,0.5963414634146341
Corporate_Lending,PR_000003622,0.553448275862069
Corporate_Lending,infectious structure aggregate,0.6202127659574468
Corporate_Lending,infectious disease mortality rate,0.61
Corporate_Lending,virus aggregate,0.60625
Corporate_Lending,pathogen portal of entry site,0.6456521739130434
Corporate_Lending,latency end process boundary,0.6277777777777778
Corporate_Lending,SARS-CoV-2 aggregate,0.6121621621621621
Corporate_Lending,source of infection site,0.6207317073170732
Corporate_Lending,site,0.5452380952380953
Corporate_Lending,acellular structure aggregate,0.6239130434782608
Corporate_Lending,establishment of a clinically abnormal colony,0.5629032258064516
Corporate_Lending,incubation end process boundary,0.6166666666666667
Corporate_Lending,collective resistance disposition,0.65
Corporate_Lending,pathogen portal of exit site,0.6277777777777778
Corporate_Lending,latency end temporal region,0.6545454545454545
Corporate_Lending,infection end temporal region,0.6673913043478261
Corporate_Lending,SARS-CoV-2 incidence rate,0.5928571428571429
Corporate_Lending,communicability end process boundary,0.619811320754717
Corporate_Lending,viroid aggregate,0.6318181818181818
Corporate_Lending,site of infection,0.6264705882352941
Corporate_Lending,communicability end temporal region,0.6423076923076922
Corporate_Lending,T cell receptor complex,0.65
Corporate_Lending,infection incidence rate profile,0.6336734693877552
Corporate_Lending,COVID-19 incidence rate,0.6
Corporate_Lending,infectious disease incidence rate,0.61
Corporate_Lending,collective disposition,0.6551282051282051
Corporate_Lending,prion aggregate,0.6375
Corporate_Lending,collective pathogenic disposition,0.65
Health_Care_Professional,B cell receptor complex,0.6414893617021277
Health_Care_Professional,positive-sense single-stranded RNA virus,0.590625
Health_Care_Professional,object aggregate,0.625
Health_Care_Professional,incubation end temporal region,0.6537037037037037
Health_Care_Professional,establishment of localization in human host,0.6291044776119403
Health_Care_Professional,immunoglobulin complex,0.558695652173913
Health_Care_Professional,PR_000003622,0.5055555555555555
Health_Care_Professional,viral load,0.5970588235294118
Health_Care_Professional,latency end process boundary,0.7192307692307692
Health_Care_Professional,TRANS_0000008,0.5310810810810811
Health_Care_Professional,infectious disease control strategy,0.6194915254237288
Health_Care_Professional,negative regulation of establishment of localization,0.6473684210526315
Health_Care_Professional,action specification,0.6318181818181818
Health_Care_Professional,establishment of a clinically abnormal colony,0.6239130434782608
Health_Care_Professional,incubation end process boundary,0.7045454545454546
Health_Care_Professional,pathogen portal of exit,0.6840425531914894
Health_Care_Professional,pathogen portal of exit site,0.6807692307692308
Health_Care_Professional,latency end temporal region,0.6656862745098039
Health_Care_Professional,TRANS_0000002,0.5310810810810811
Health_Care_Professional,infection end temporal region,0.6575471698113208
Health_Care_Professional,quarantine control strategy,0.6068627450980393
Health_Care_Professional,double-stranded RNA virus,0.6132653061224489
Health_Care_Professional,SARS-CoV-2 attachment stage,0.5872549019607843
Health_Care_Professional,place closure control strategy,0.6351851851851852
Health_Care_Professional,communicability end process boundary,0.7
Health_Care_Professional,vector control strategy,0.6202127659574468
Health_Care_Professional,single-stranded RNA retrovirus,0.6166666666666667
Health_Care_Professional,establishment of localization in host,0.630327868852459
Health_Care_Professional,communicability end temporal region,0.6533898305084747
Health_Care_Professional,case isolation control strategy,0.6136363636363636
Health_Care_Professional,TRANS_0000000,0.5310810810810811
Health_Care_Professional,negative-sense single-stranded RNA virus,0.60625
Health_Care_Professional,establishment of localization,0.6575471698113208
Health_Care_Professional,establishment of localization in virus host,0.6141791044776119
Health_Care_Professional,TRANS_0000007,0.5310810810810811
Health_Care_Professional,T cell receptor complex,0.6414893617021277
Health_Care_Professional,CL_0000000,0.5088235294117647
Health_Care_Professional,appearance of disorder,0.6456521739130434
Health_Care_Professional,pathogen portal of exit role,0.7
Health_Care_Professional,infectious disease control objective specification,0.6256756756756756
Health_Care_Professional,macromolecular complex,0.6239130434782608
Health_Care_Professional,herd immunity to infectious organism,0.6166666666666667
Health_Care_Professional,complex infection,0.6451219512195122
Health_Care_Professional,object,0.5166666666666666
Health_Care_Professional,acute respiratory distress syndrome,0.6533898305084747
Health_Care_Professional,virus attachment stage,0.6021739130434782
Disease,B cell receptor complex,0.5166666666666666
Disease,COVID-19 disease incidence proportion,0.609090909090909
Disease,respiratory droplet virus fomite,0.5525641025641026
Disease,positive-sense single-stranded RNA virus,0.5563829787234043
Disease,exotoxin disposition,0.5981481481481481
Disease,source of infection role,0.5467741935483871
Disease,invasive disposition,0.5981481481481481
Disease,infectious disease endemicity,0.6444444444444444
Disease,incubation end temporal region,0.5581081081081081
Disease,infectious disease course,0.66875
Disease,zoonotic disposition,0.5981481481481481
Disease,metastatic infection,0.5981481481481481
Disease,virus adhesion susceptible cell,0.581578947368421
Disease,source of infection,0.5653846153846154
Disease,disordered virus,0.6673913043478261
Disease,infectious disease,0.73
Disease,process of establishing an infection,0.5662790697674418
Disease,disease,0.95
Disease,infection incidence rate,0.5790322580645162
Disease,subclinical virus infection,0.5676470588235294
Disease,disease surveillance objective specification,0.5872549019607843
Disease,infectious disease mortality rate,0.625
Disease,virus synthesis stage,0.6285714285714286
Disease,chronic infection,0.5333333333333333
Disease,virus aggregate,0.6772727272727272
Disease,infection prevalence,0.5981481481481481
Disease,virus uncoating stage,0.6285714285714286
Disease,virostatic disposition,0.5879310344827586
Disease,fungicidal disposition,0.5879310344827586
Disease,disorder,0.7166666666666667
Disease,virus penetration stage,0.65
Disease,virus translation stage,0.6166666666666667
Disease,adhesion disposition,0.5981481481481481
Disease,parasiticidal disposition,0.575
Disease,neurotoxin disposition,0.5879310344827586
Disease,virus,0.6166666666666667
Disease,intracellular infection,0.5833333333333334
Disease,disease transmission model,0.6621212121212122
Disease,respiratory system disease,0.6621212121212122
Disease,latency end process boundary,0.5357142857142857
Disease,infection incidence proportion profile,0.5166666666666666
Disease,infection incidence,0.5653846153846154
Disease,systematic infection,0.5981481481481481
Disease,infection incidence profile,0.5382352941176471
Disease,source of infection site,0.5790322580645162
Disease,local infection,0.5409090909090909
Disease,acute infection,0.5409090909090909
Disease,secondary infection role,0.5790322580645162
Disease,enterotoxin disposition,0.5833333333333334
Disease,coronavirus disease,0.7192307692307692
Disease,infectious disease control strategy,0.6166666666666667
Disease,infectious disease lifetime prevalence,0.6055555555555556
Disease,viral disease epidemic,0.6913793103448276
Disease,primary infectious disposition,0.5581081081081081
Disease,lower respiratory tract disease,0.6342105263157894
Disease,infectious disease prevalence,0.6444444444444444
Disease,subclinical SARS-CoV-2 infection,0.5782051282051281
Disease,static agent disposition,0.5790322580645162
Disease,pathogenic disposition,0.5879310344827586
Disease,single-stranded DNA virus,0.60625
Disease,virulence factor disposition,0.5642857142857143
Disease,establishment of a clinically abnormal colony,0.5269230769230769
Disease,coronavirus disease course,0.6621212121212122
Disease,disposition,0.6722222222222223
Disease,chronic infectious disease course,0.625
Disease,acute infectious disease course,0.6342105263157894
Disease,cidal agent disposition,0.5833333333333334
Disease,incubation end process boundary,0.5289473684210526
Disease,coronavirus disorder,0.5981481481481481
Disease,invasion disposition,0.5981481481481481
Disease,endotoxin disposition,0.5928571428571429
Disease,primary infection role,0.553448275862069
Disease,collective resistance disposition,0.55
Disease,disease course,0.7833333333333333
Disease,latency end temporal region,0.5676470588235294
Disease,virus host,0.6264705882352941
Disease,viral adhesion disposition,0.5712121212121213
Disease,transmissibility disposition,0.5642857142857143
Disease,infection end temporal region,0.5611111111111111
Disease,community-acquired infection,0.5357142857142857
Disease,secondary infection,0.6038461538461539
Disease,viricidal disposition,0.5928571428571429
Disease,infection,0.575
Disease,double-stranded RNA virus,0.60625
Disease,subclinical infection,0.5571428571428572
Disease,opportunistic infectious disposition,0.5430232558139535
Disease,SARS-CoV-2 disorder,0.6038461538461539
Disease,parasitostatic disposition,0.5712121212121213
Disease,fungistatic disposition,0.5833333333333334
Disease,communicability end process boundary,0.5197674418604651
Disease,site of infection,0.575
Disease,viral disease course,0.7092592592592593
Disease,infectious disease sporadicity,0.6391891891891892
Disease,virus transcription stage,0.60625
Disease,infection start temporal region,0.581578947368421
Disease,infection incidence proportion,0.5310810810810811
Disease,cytotoxin disposition,0.5928571428571429
Disease,infectious disease pandemic,0.6558823529411765
Disease,infectious disorder,0.6038461538461539
Disease,extracellular infection,0.55
Disease,communicability end temporal region,0.5452380952380953
Disease,infectious disease incidence proportion,0.6021739130434782
Disease,nursing-home acquired infection,0.5552631578947369
Disease,negative-sense single-stranded RNA virus,0.5563829787234043
Disease,infection start process boundary,0.5525641025641026
Disease,establishment of localization in virus host,0.55
Disease,reverse zoonotic disposition,0.5642857142857143
Disease,T cell receptor complex,0.5166666666666666
Disease,appearance of disorder,0.5879310344827586
Disease,subclinical coronavirus infection,0.55
Disease,infectious disease control objective specification,0.5728070175438597
Disease,infection incidence rate profile,0.5525641025641026
Disease,complex infection,0.5333333333333333
Disease,viral disease pandemic,0.6913793103448276
Disease,process of establishing viral infection,0.558695652173913
Disease,virus disorder,0.6404761904761905
Disease,infectious disease incidence rate,0.625
Disease,collective disposition,0.5879310344827586
Disease,toxin disposition,0.6166666666666667
Disease,long-term non-progressing infectious disease course,0.5706896551724138
Disease,bactericidal disposition,0.5790322580645162
Disease,COVID-19 epidemic,0.575
Disease,bacteriostatic disposition,0.5712121212121213
Disease,double-stranded DNA virus,0.60625
Disease,infectious disposition,0.5879310344827586
Disease,acute respiratory distress syndrome,0.5928571428571429
Disease,viral disease,0.8
Disease,infectious disease epidemic,0.6558823529411765
Disease,infectious disease incidence,0.65
Disease,virus attachment stage,0.6224137931034482
Disease,virus replication,0.6166666666666667
Disease,collective pathogenic disposition,0.55
Disease,hospital-acquired infection,0.5382352941176471
Disease,simple infection,0.5804347826086956
Disease,virus generative stage,0.656896551724138
Disease,immunosuppressive disposition,0.5888888888888889
Disease,primary infection,0.575
Disease,SARS-COV-2 adhesion disposition,0.5552631578947369
Disease,virus release stage,0.6807692307692308
Disease,COVID-19 disease course,0.6833333333333332
Impact,B cell receptor complex,0.5189655172413793
Impact,incubation end temporal region,0.5611111111111111
Impact,PR_000003622,0.5055555555555555
Impact,contact pathogen transmission process,0.5197674418604651
Impact,latency end process boundary,0.5088235294117647
Impact,process that results in death,0.5357142857142857
Impact,action specification,0.6038461538461539
Impact,establishment of a clinically abnormal colony,0.5284313725490196
Impact,incubation end process boundary,0.5310810810810811
Impact,latency end temporal region,0.5409090909090909
Impact,infection end temporal region,0.5642857142857143
Impact,polymerase chain reaction,0.5790322580645162
Impact,communicability end process boundary,0.5214285714285714
Impact,communicability end temporal region,0.5475609756097561
Impact,T cell receptor complex,0.5189655172413793
Impact,CL_0000000,0.5125
Impact,contact tracing,0.5928571428571429
Bankers,B cell receptor complex,0.55
Bankers,incubation end temporal region,0.5851351351351352
Bankers,PR_000003622,0.5026315789473684
Bankers,GEO_000000371,0.5
Bankers,latency end process boundary,0.5928571428571429
Bankers,establishment of a clinically abnormal colony,0.5269230769230769
Bankers,incubation end process boundary,0.6078947368421053
Bankers,latency end temporal region,0.5676470588235294
Bankers,infection end temporal region,0.5333333333333333
Bankers,communicability end process boundary,0.5430232558139535
Bankers,communicability end temporal region,0.5452380952380953
Bankers,T cell receptor complex,0.5166666666666666
Bankers,GEO_000000370,0.5
Bankers,GEO_000000372,0.5
InfectedCousin,infected population,0.8136363636363637
InfectedCousin,T cell receptor complex,0.5851351351351352
Business,droplet pathogen transmission process,0.5833333333333334
Business,B cell receptor complex,0.5145161290322581
Business,source of infection role,0.575
Business,pathogen death process boundary,0.5525641025641026
Business,incubation end temporal region,0.5552631578947369
Business,process profile,0.5804347826086956
Business,source of infection,0.5981481481481481
Business,latency start process boundary,0.5552631578947369
Business,establishment of localization in human host,0.5480392156862746
Business,process of establishing an infection,0.5636363636363636
Business,innate immune response,0.6166666666666667
Business,pathogen portal of entry role,0.504054054054054
Business,negative regulation of viral process,0.5863636363636363
Business,pathogen portal of entry site,0.5310810810810811
Business,contact pathogen transmission process,0.5833333333333334
Business,immune response,0.6673913043478261
Business,humoral immune response,0.6435483870967742
Business,generically dependent continuant,0.525
Business,surveillance process,0.6642857142857143
Business,negative regulation of biological process,0.5724489795918367
Business,latency end process boundary,0.5611111111111111
Business,negative regulation of life-sustaining process,0.5796296296296296
Business,process that results in death,0.5851351351351352
Business,source of infection site,0.60625
Business,TRANS_0000008,0.5452380952380953
Business,communicability start process boundary,0.558695652173913
Business,pathogen birth process boundary,0.5782051282051281
Business,negative regulation of developmental process,0.5653846153846154
Business,lower respiratory tract disease,0.5525641025641026
Business,negative regulation of establishment of localization,0.55
Business,action specification,0.5571428571428572
Business,adhesion factor,0.5804347826086956
Business,virulence factor disposition,0.5888888888888889
Business,establishment of a clinically abnormal colony,0.5254716981132076
Business,process boundary,0.575
Business,pathogen transmission process,0.6121621621621621
Business,planned process,0.6239130434782608
Business,incubation end process boundary,0.6038461538461539
Business,indirect pathogen transmission process,0.5804347826086956
Business,PCR product,0.5026315789473684
Business,biological process,0.6423076923076922
Business,latency end temporal region,0.5071428571428571
Business,TRANS_0000002,0.5452380952380953
Business,plan specification,0.5653846153846154
Business,infection end temporal region,0.5310810810810811
Business,incubation start process boundary,0.5963414634146341
Business,invasion factor,0.5804347826086956
Business,polymerase chain reaction,0.5712121212121213
Business,entry into host through host barriers,0.5611111111111111
Business,function,0.6375
Business,production,0.6166666666666667
Business,specifically dependent continuant,0.5475609756097561
Business,developmental process,0.5879310344827586
Business,communicability end process boundary,0.5863636363636363
Business,negative regulation of immune response,0.5804347826086956
Business,organism substance,0.6038461538461539
Business,pathogen portal of entry,0.5125
Business,horizontal pathogen transmission process,0.575
Business,establishment of localization in host,0.5611111111111111
Business,communicability end temporal region,0.5430232558139535
Business,virulence factor,0.575
Business,TRANS_0000000,0.5452380952380953
Business,establishment of localization,0.5581081081081081
Business,infection start process boundary,0.575
Business,establishment of localization in virus host,0.5676470588235294
Business,TRANS_0000007,0.5452380952380953
Business,adaptive immune response,0.60625
Business,process,0.65
Business,process of establishing viral infection,0.5563829787234043
Business,symbiotic process,0.65
Business,entry into host,0.5804347826086956
Business,negative regulation of production,0.523170731707317
RBiH0hZdSfPdUZyQMTyTYtq,B cell receptor complex,0.5152173913043478
RBiH0hZdSfPdUZyQMTyTYtq,T cell receptor complex,0.5152173913043478
Standard,B cell receptor complex,0.5145161290322581
Standard,COVID-19 mortality rate,0.5467741935483871
Standard,ERO_0000347,0.5026315789473684
Standard,object aggregate,0.575
Standard,source of infection role,0.575
Standard,biological regulation,0.5189655172413793
Standard,incubation end temporal region,0.581578947368421
Standard,asymptomatic carrier role,0.6015151515151516
Standard,normal resident microbiota population,0.5388888888888889
Standard,mutualist role,0.5863636363636363
Standard,pathogen portal of entry role,0.5581081081081081
Standard,infection incidence rate,0.575
Standard,disease surveillance objective specification,0.5269230769230769
Standard,PR_000003622,0.5
Standard,negative regulation of viral process,0.5636363636363636
Standard,infectious disease mortality rate,0.5475609756097561
Standard,objective specification,0.5467741935483871
Standard,pathogen transporter role,0.5712121212121213
Standard,ERO_0000008,0.5026315789473684
Standard,negative regulation of biological process,0.5520408163265306
Standard,disease transmission model,0.5970588235294118
Standard,latency end process boundary,0.5888888888888889
Standard,negative regulation of life-sustaining process,0.5425925925925926
Standard,definitive host,0.5369565217391304
Standard,pathogen vector role,0.5571428571428572
Standard,secondary infection role,0.60625
Standard,negative regulation of developmental process,0.5653846153846154
Standard,negative regulation of establishment of localization,0.5333333333333333
Standard,action specification,0.5571428571428572
Standard,adhesion factor,0.6239130434782608
Standard,virulence factor disposition,0.5611111111111111
Standard,commensal role,0.5863636363636363
Standard,establishment of a clinically abnormal colony,0.5632075471698114
Standard,reservoir of pathogen role,0.5676470588235294
Standard,ERO_0001362,0.5026315789473684
Standard,incubation end process boundary,0.5782051282051281
Standard,biological vector role,0.5166666666666666
Standard,primary infection role,0.55
Standard,latency end temporal region,0.5928571428571429
Standard,symbiont role,0.5928571428571429
Standard,plan specification,0.5653846153846154
Standard,infection end temporal region,0.5851351351351352
Standard,reagent role,0.6
Standard,dead-end host role,0.6038461538461539
Standard,invasion factor,0.6239130434782608
Standard,negative regulation of replication,0.5452380952380953
Standard,intermediate host role,0.5833333333333334
Standard,epitope role,0.55
Standard,infectious structure host role,0.5289473684210526
Standard,parasite role,0.5928571428571429
Standard,symptomatic carrier role,0.60625
Standard,infectious agent host role,0.5676470588235294
Standard,ERO_0000671,0.5026315789473684
Standard,SARS-CoV-2 incidence rate,0.6015151515151516
Standard,communicability end process boundary,0.5636363636363636
Standard,negative regulation of immune response,0.5369565217391304
Standard,antigen role,0.6
Standard,role,0.5333333333333333
Standard,symbiont host role,0.5653846153846154
Standard,mechanical vector role,0.5833333333333334
Standard,pathogen vehicle role,0.553448275862069
Standard,ERO_0000006,0.5026315789473684
Standard,host role,0.6264705882352941
Standard,communicability end temporal region,0.5662790697674418
Standard,virulence factor,0.575
Standard,T cell receptor complex,0.5145161290322581
Standard,pathogen portal of exit role,0.5611111111111111
Standard,ERO_0000337,0.5026315789473684
Standard,definitive host role,0.5571428571428572
Standard,infectious disease control objective specification,0.5189655172413793
Standard,infection incidence rate profile,0.575
Standard,COVID-19 incidence rate,0.5467741935483871
Standard,infectious disease incidence rate,0.5719512195121951
Standard,object,0.5214285714285714
Standard,biological role,0.5369565217391304
Standard,pathogen host role,0.5653846153846154
Standard,fomite role,0.5552631578947369
Standard,biological vehicle role,0.5145161290322581
Standard,negative regulation of production,0.5719512195121951
Women,NCBITaxon_2,0.575
Women,incubation end temporal region,0.5642857142857143
Women,latency end process boundary,0.5409090909090909
Women,establishment of a clinically abnormal colony,0.51
Women,incubation end process boundary,0.5333333333333333
Women,latency end temporal region,0.54375
Women,infection end temporal region,0.5676470588235294
Women,communicability end process boundary,0.5475609756097561
Women,communicability end temporal region,0.55
Women,T cell receptor complex,0.5571428571428572
Women,angiotensin-converting enzyme 2,0.5333333333333333
Market,B cell receptor complex,0.553448275862069
Market,incubation end temporal region,0.5611111111111111
Market,PR_000003622,0.5055555555555555
Market,latency end process boundary,0.5382352941176471
Market,TRANS_0000008,0.5026315789473684
Market,lower respiratory tract disease,0.5310810810810811
Market,action specification,0.5653846153846154
Market,establishment of a clinically abnormal colony,0.5088235294117647
Market,incubation end process boundary,0.5310810810810811
Market,PCR product,0.5676470588235294
Market,latency end temporal region,0.5712121212121213
Market,TRANS_0000002,0.5026315789473684
Market,infection end temporal region,0.5642857142857143
Market,production,0.575
Market,place closure control strategy,0.5611111111111111
Market,communicability end process boundary,0.5452380952380953
Market,communicability end temporal region,0.5475609756097561
Market,TRANS_0000000,0.5026315789473684
Market,TRANS_0000007,0.5026315789473684
Market,T cell receptor complex,0.553448275862069
Market,negative regulation of production,0.5525641025641026
InfectedDomesticHelp,infected population,0.732051282051282
InfectedDomesticHelp,T cell receptor complex,0.5895348837209302
Saving,GO_0019814,0.5125
Saving,GO_0051093,0.5125
Saving,GO_0019061,0.5125
Saving,GO_0048525,0.5125
Saving,GO_0019081,0.5125
Saving,GO_0008150,0.5125
Saving,GO_0019083,0.5125
Saving,respiratory system disease,0.54375
Saving,GEO_000000371,0.5026315789473684
Saving,GO_0050777,0.5125
Saving,GO_0065007,0.5125
Saving,systematic infection,0.6038461538461539
Saving,infectious disease control strategy,0.5475609756097561
Saving,lower respiratory tract disease,0.5310810810810811
Saving,establishment of a clinically abnormal colony,0.5284313725490196
Saving,GO_0006959,0.5125
Saving,GO_0006955,0.5125
Saving,GO_0044409,0.5125
Saving,GO_0002443,0.5125
Saving,GO_0032502,0.5125
Saving,GO_0019062,0.5125
Saving,GO_0032991,0.5125
Saving,GO_0045087,0.5125
Saving,GO_19076,0.5214285714285714
Saving,quarantine control strategy,0.5712121212121213
Saving,GO_0019028,0.5125
Saving,GO_0046718,0.5125
Saving,GO_0019031,0.5125
Saving,GO_0048519,0.5125
Saving,GO_0046727,0.5125
Saving,place closure control strategy,0.5333333333333333
Saving,GO_0044403,0.5125
Saving,active immunization against infectious agent,0.55
Saving,GO_0051234,0.5125
Saving,SARS-CoV-2 release stage,0.5833333333333334
Saving,vector control strategy,0.553448275862069
Saving,GO_0002250,0.5125
Saving,case isolation control strategy,0.5851351351351352
Saving,GEO_000000370,0.5026315789473684
Saving,infectious disease control objective specification,0.5392857142857143
Saving,GO_0019068,0.5125
Saving,GO_0042101,0.5125
Saving,GEO_000000372,0.5026315789473684
Saving,GO_0044411,0.5125
Saving,GO_0019815,0.5125
Saving,virus release stage,0.57
Saving,GO_0044406,0.5125
RBdVjT6X9mH1nSXd2YTRm0t,B cell receptor complex,0.5369565217391304
RBdVjT6X9mH1nSXd2YTRm0t,NCBITaxon_2,0.5970588235294118
RBdVjT6X9mH1nSXd2YTRm0t,T cell receptor complex,0.5369565217391304
RBdVjT6X9mH1nSXd2YTRm0t,angiotensin-converting enzyme 2,0.5425925925925926
BankingRetailCenters,B cell receptor complex,0.6127906976744186
BankingRetailCenters,establishment of a clinically abnormal colony,0.6038461538461539
BankingRetailCenters,T cell receptor complex,0.5895348837209302
CashCredit,establishment of a clinically abnormal colony,0.5409090909090909
CashCredit,T cell receptor complex,0.5712121212121213
Bank,incubation end temporal region,0.5382352941176471
Bank,latency end process boundary,0.5125
Bank,establishment of a clinically abnormal colony,0.5112244897959184
Bank,reservoir of pathogen role,0.5166666666666666
Bank,incubation end process boundary,0.5357142857142857
Bank,latency end temporal region,0.5145161290322581
Bank,infection end temporal region,0.5106060606060606
Bank,communicability end process boundary,0.5
Bank,communicability end temporal region,0.5269230769230769
Bank,infectious agent reservoir,0.5166666666666666
Current,B cell receptor complex,0.5833333333333334
Current,incubation end temporal region,0.6121621621621621
Current,infectious disease course,0.575
Current,normal resident microbiota population,0.5636363636363636
Current,PR_000003622,0.5026315789473684
Current,latency end process boundary,0.5642857142857143
Current,establishment of a clinically abnormal colony,0.5076923076923077
Current,coronavirus disease course,0.5712121212121213
Current,chronic infectious disease course,0.55
Current,acute infectious disease course,0.581578947368421
Current,incubation end process boundary,0.581578947368421
Current,disease course,0.6404761904761905
Current,latency end temporal region,0.5970588235294118
Current,infection end temporal region,0.5888888888888889
Current,communicability end process boundary,0.5662790697674418
Current,viral disease course,0.5981481481481481
Current,communicability end temporal region,0.5928571428571429
Current,T cell receptor complex,0.5833333333333334
Current,CL_0000000,0.5088235294117647
Current,long-term non-progressing infectious disease course,0.5362068965517242
Current,COVID-19 disease course,0.5833333333333334
InfectedNephew,infected population,0.7227272727272727
InfectedNephew,T cell receptor complex,0.5851351351351352
Limit,B cell receptor complex,0.5214285714285714
Limit,COVID-19 mortality rate,0.5928571428571429
Limit,incubation end temporal region,0.5357142857142857
Limit,latency start process boundary,0.5071428571428571
Limit,infection incidence rate,0.553448275862069
Limit,infectious disease mortality rate,0.5552631578947369
Limit,latency end process boundary,0.5106060606060606
Limit,communicability start process boundary,0.5197674418604651
Limit,pathogen birth process boundary,0.5055555555555555
Limit,lower respiratory tract disease,0.5333333333333333
Limit,establishment of a clinically abnormal colony,0.53
Limit,incubation end process boundary,0.5055555555555555
Limit,latency end temporal region,0.54375
Limit,infection end temporal region,0.5382352941176471
Limit,incubation start process boundary,0.5289473684210526
Limit,place closure control strategy,0.5071428571428571
Limit,SARS-CoV-2 incidence rate,0.55
Limit,communicability end process boundary,0.523170731707317
Limit,communicability end temporal region,0.55
Limit,infection start process boundary,0.5310810810810811
Limit,T cell receptor complex,0.5214285714285714
Limit,CL_0000000,0.5166666666666666
Limit,infection incidence rate profile,0.5310810810810811
Limit,COVID-19 incidence rate,0.5571428571428572
Limit,infectious disease incidence rate,0.5289473684210526
RiskLossFactors,adhesion factor,0.7166666666666667
RiskLossFactors,virulence factor disposition,0.6593023255813953
RiskLossFactors,establishment of a clinically abnormal colony,0.5833333333333334
RiskLossFactors,invasion factor,0.75
RiskLossFactors,virulence factor,0.7080645161290323
RiskLossFactors,T cell receptor complex,0.581578947368421
RBqIsgUuzTJdw7LkbNHKb9e,B cell receptor complex,0.5369565217391304
RBqIsgUuzTJdw7LkbNHKb9e,T cell receptor complex,0.5369565217391304
Person,B cell receptor complex,0.553448275862069
Person,information content entity,0.54375
Person,establishment of localization in human host,0.5316326530612244
Person,drug-based immunosuppressed organism,0.569047619047619
Person,descriptive information content entity,0.5636363636363636
Person,colonization of human,0.524074074074074
Person,division of geopolitical entity,0.5310810810810811
Person,extended organism,0.5804347826086956
Person,geopolitical entity,0.57
Person,susceptible organism,0.6038461538461539
Person,immunosuppressed organism,0.6112903225806451
Person,resistant entity,0.5863636363636363
Person,designative information content entity,0.5409090909090909
Person,lower respiratory tract disease,0.5581081081081081
Person,establishment of a clinically abnormal colony,0.5284313725490196
Person,immaterial entity,0.5804347826086956
Person,material entity,0.5928571428571429
Person,immunocompetent organism,0.5833333333333334
Person,organism,0.5928571428571429
Person,immunodeficient organism,0.55
Person,entity,0.6166666666666667
Person,realizable entity,0.5369565217391304
Person,organism substance,0.575
Person,anatomical entity,0.5369565217391304
Person,geographical entity,0.57
Person,pathologically immunosuppressed organism,0.558695652173913
Person,T cell receptor complex,0.553448275862069
Person,molecular entity,0.5863636363636363
Person,herd immunity to infectious organism,0.569047619047619
Person,organism population,0.61
Person,directive information content entity,0.5452380952380953
Person,infectious human pathogen,0.5790322580645162
InfectedCo-Customer,infected population,0.7657894736842106
InfectedCo-Customer,T cell receptor complex,0.6404761904761905
Former,B cell receptor complex,0.5879310344827586
Former,GO_0019814,0.5125
Former,GO_0051093,0.5125
Former,EFO_1000637,0.5676470588235294
Former,GO_0019061,0.5125
Former,incubation end temporal region,0.5333333333333333
Former,establishment of localization in human host,0.5112244897959184
Former,PR_000003622,0.5055555555555555
Former,GO_0048525,0.5125
Former,GO_0019081,0.5125
Former,host,0.55
Former,GO_0008150,0.5125
Former,GO_0019083,0.5125
Former,GO_0050777,0.5125
Former,latency end process boundary,0.5382352941176471
Former,GO_0065007,0.5125
Former,definitive host,0.5452380952380953
Former,dead-end host,0.5026315789473684
Former,establishment of a clinically abnormal colony,0.5284313725490196
Former,GO_0006959,0.5125
Former,colonized host,0.55
Former,pathogen host,0.5552631578947369
Former,EFO_0009433,0.5676470588235294
Former,GO_0006955,0.5125
Former,incubation end process boundary,0.5581081081081081
Former,GO_0044409,0.5125
Former,GO_0002443,0.5125
Former,GO_0032502,0.5125
Former,GO_0019062,0.5125
Former,GO_0032991,0.5125
Former,latency end temporal region,0.5409090909090909
Former,virus host,0.5125
Former,GO_0045087,0.5125
Former,infection end temporal region,0.5642857142857143
Former,dead-end host role,0.575
Former,GO_19076,0.5214285714285714
Former,intermediate host role,0.5928571428571429
Former,infectious structure host role,0.5888888888888889
Former,GO_0019028,0.5125
Former,GO_0046718,0.5125
Former,entry into host through host barriers,0.5430232558139535
Former,GO_0019031,0.5125
Former,infectious structure host,0.5790322580645162
Former,GO_0048519,0.5125
Former,GO_0046727,0.5125
Former,infectious agent host role,0.575
Former,GO_0044403,0.5125
Former,GO_0051234,0.5125
Former,communicability end process boundary,0.5452380952380953
Former,EFO_0000684,0.5676470588235294
Former,infectious agent host,0.5611111111111111
Former,symbiont host role,0.575
Former,host role,0.65
Former,GO_0002250,0.5125
Former,communicability end temporal region,0.5475609756097561
Former,establishment of localization in virus host,0.5112244897959184
Former,colonization of host,0.5269230769230769
Former,T cell receptor complex,0.5879310344827586
Former,intermediate host,0.5804347826086956
Former,definitive host role,0.6038461538461539
Former,GO_0019068,0.5125
Former,GO_0042101,0.5125
Former,adhesion of symbiont to host,0.5088235294117647
Former,pathogen host role,0.575
Former,GO_0044411,0.5125
Former,GO_0019815,0.5125
Former,entry into host,0.5452380952380953
Former,GO_0044406,0.5125
National,B cell receptor complex,0.5467741935483871
National,NCBITaxon_2,0.6605263157894737
National,positive-sense single-stranded RNA virus,0.5333333333333333
National,GO_0019814,0.5055555555555555
National,GO_0051093,0.5055555555555555
National,GO_0019061,0.5055555555555555
National,normal resident microbiota population,0.6055555555555556
National,GO_0048525,0.5055555555555555
National,GO_0019081,0.5055555555555555
National,GO_0008150,0.5055555555555555
National,GO_0019083,0.5055555555555555
National,GO_0050777,0.5055555555555555
National,GO_0065007,0.5055555555555555
National,local infection,0.6673913043478261
National,establishment of a clinically abnormal colony,0.5632075471698114
National,GO_0006959,0.5055555555555555
National,GO_0006955,0.5055555555555555
National,GO_0044409,0.5055555555555555
National,GO_0002443,0.5055555555555555
National,GO_0032502,0.5055555555555555
National,GO_0019062,0.5055555555555555
National,GO_0032991,0.5055555555555555
National,Country,0.5833333333333334
National,GO_0045087,0.5055555555555555
National,GO_19076,0.5125
National,double-stranded RNA virus,0.5409090909090909
National,GO_0019028,0.5055555555555555
National,GO_0046718,0.5055555555555555
National,GO_0019031,0.5055555555555555
National,GO_0048519,0.5055555555555555
National,GO_0046727,0.5055555555555555
National,GO_0044403,0.5055555555555555
National,GO_0051234,0.5055555555555555
National,single-stranded RNA retrovirus,0.5552631578947369
National,GO_0002250,0.5055555555555555
National,negative-sense single-stranded RNA virus,0.575
National,T cell receptor complex,0.5467741935483871
National,country,0.5833333333333334
National,GO_0019068,0.5055555555555555
National,GO_0042101,0.5055555555555555
National,angiotensin-converting enzyme 2,0.5782051282051281
National,GO_0044411,0.5055555555555555
National,GO_0019815,0.5055555555555555
National,GO_0044406,0.5055555555555555
Infectious_Disease,B cell receptor complex,0.5963414634146341
Infectious_Disease,COVID-19 disease incidence proportion,0.6318181818181818
Infectious_Disease,respiratory droplet virus fomite,0.63
Infectious_Disease,ERO_0000347,0.553448275862069
Infectious_Disease,positive-sense single-stranded RNA virus,0.6224137931034482
Infectious_Disease,exotoxin disposition,0.6605263157894737
Infectious_Disease,source of infection role,0.6880952380952381
Infectious_Disease,innate immunity to infectious agent,0.6952830188679244
Infectious_Disease,infectious agent,0.8323529411764706
Infectious_Disease,invasive disposition,0.6605263157894737
Infectious_Disease,infectious disease endemicity,0.8329787234042553
Infectious_Disease,incubation end temporal region,0.6791666666666666
Infectious_Disease,infectious disease course,0.8686046511627907
Infectious_Disease,zoonotic disposition,0.6605263157894737
Infectious_Disease,metastatic infection,0.6605263157894737
Infectious_Disease,COVID-19 pandemic,0.5928571428571429
Infectious_Disease,virus adhesion susceptible cell,0.6336734693877552
Infectious_Disease,source of infection,0.6662162162162162
Infectious_Disease,disordered virus,0.5970588235294118
Infectious_Disease,susceptibility to infectious agent,0.7
Infectious_Disease,infectious disease,0.95
Infectious_Disease,process of establishing an infection,0.5981481481481481
Infectious_Disease,disease,0.73
Infectious_Disease,infection incidence rate,0.7595238095238095
Infectious_Disease,diseased population,0.6391891891891892
Infectious_Disease,subclinical virus infection,0.65
Infectious_Disease,disease surveillance objective specification,0.6112903225806451
Infectious_Disease,infectious structure aggregate,0.7625
Infectious_Disease,infectious agent population,0.7388888888888888
Infectious_Disease,infectious disease mortality rate,0.8029411764705883
Infectious_Disease,virus synthesis stage,0.6807692307692308
Infectious_Disease,passive immunity to infectious agent,0.6907407407407408
Infectious_Disease,chronic infection,0.6785714285714286
Infectious_Disease,virus aggregate,0.6621212121212122
Infectious_Disease,infection prevalence,0.7657894736842106
Infectious_Disease,ERO_0000008,0.553448275862069
Infectious_Disease,virus uncoating stage,0.6807692307692308
Infectious_Disease,virostatic disposition,0.65
Infectious_Disease,fungicidal disposition,0.65
Infectious_Disease,disorder,0.6038461538461539
Infectious_Disease,virus penetration stage,0.6939024390243902
Infectious_Disease,virus translation stage,0.6695121951219513
Infectious_Disease,adhesion disposition,0.6605263157894737
Infectious_Disease,drug susceptibility of infectious agent,0.6780701754385965
Infectious_Disease,parasiticidal disposition,0.636046511627907
Infectious_Disease,neurotoxin disposition,0.675
Infectious_Disease,virus,0.5804347826086956
Infectious_Disease,intracellular infection,0.6451219512195122
Infectious_Disease,disease transmission model,0.6318181818181818
Infectious_Disease,respiratory system disease,0.7227272727272727
Infectious_Disease,latency end process boundary,0.6021739130434782
Infectious_Disease,infection incidence proportion profile,0.6642857142857143
Infectious_Disease,infection incidence,0.7743243243243243
Infectious_Disease,passive immunization against infectious agent,0.6563492063492063
Infectious_Disease,systematic infection,0.6605263157894737
Infectious_Disease,infection incidence profile,0.7166666666666667
Infectious_Disease,source of infection site,0.7119047619047619
Infectious_Disease,local infection,0.6924242424242425
Infectious_Disease,TRANS_0000008,0.5467741935483871
Infectious_Disease,acute infection,0.6924242424242425
Infectious_Disease,secondary infection role,0.6880952380952381
Infectious_Disease,enterotoxin disposition,0.6695121951219513
Infectious_Disease,coronavirus disease,0.7743243243243243
Infectious_Disease,infectious disease control strategy,0.789622641509434
Infectious_Disease,infectious disease lifetime prevalence,0.7714285714285714
Infectious_Disease,viral disease epidemic,0.675
Infectious_Disease,primary infectious disposition,0.7625
Infectious_Disease,symptomatic infectious structure carrier,0.7086206896551723
Infectious_Disease,lower respiratory tract disease,0.6744897959183673
Infectious_Disease,infectious disease prevalence,0.8329787234042553
Infectious_Disease,subclinical SARS-CoV-2 infection,0.61
Infectious_Disease,static agent disposition,0.6404761904761905
Infectious_Disease,pathogenic disposition,0.625
Infectious_Disease,immunization against infectious agent,0.6863636363636364
Infectious_Disease,single-stranded DNA virus,0.636046511627907
Infectious_Disease,virulence factor disposition,0.6891304347826087
Infectious_Disease,establishment of a clinically abnormal colony,0.5611111111111111
Infectious_Disease,coronavirus disease course,0.7227272727272727
Infectious_Disease,disposition,0.5879310344827586
Infectious_Disease,chronic infectious disease course,0.8029411764705883
Infectious_Disease,leukocyte-mediated immunity to infectious agent,0.65
Infectious_Disease,acute infectious disease course,0.8173469387755102
Infectious_Disease,cidal agent disposition,0.6451219512195122
Infectious_Disease,ERO_0001362,0.553448275862069
Infectious_Disease,incubation end process boundary,0.6540816326530612
Infectious_Disease,coronavirus disorder,0.6868421052631578
Infectious_Disease,asymptomatic infectious structure carrier,0.7042372881355932
Infectious_Disease,invasion disposition,0.6868421052631578
Infectious_Disease,endotoxin disposition,0.6551282051282051
Infectious_Disease,infected population,0.6932432432432433
Infectious_Disease,primary infection role,0.7
Infectious_Disease,collective resistance disposition,0.6460784313725491
Infectious_Disease,disease course,0.66875
Infectious_Disease,latency end temporal region,0.6055555555555556
Infectious_Disease,TRANS_0000002,0.5467741935483871
Infectious_Disease,virus host,0.6285714285714286
Infectious_Disease,viral adhesion disposition,0.6545454545454545
Infectious_Disease,infectious agent generative stage,0.7441176470588234
Infectious_Disease,transmissibility disposition,0.6239130434782608
Infectious_Disease,infection end temporal region,0.7265957446808511
Infectious_Disease,community-acquired infection,0.6239130434782608
Infectious_Disease,secondary infection,0.6662162162162162
Infectious_Disease,viricidal disposition,0.6551282051282051
Infectious_Disease,infectious structure host role,0.7625
Infectious_Disease,infection,0.7462962962962962
Infectious_Disease,double-stranded RNA virus,0.6127906976744186
Infectious_Disease,infectious structure host,0.7755813953488372
Infectious_Disease,subclinical infection,0.6551282051282051
Infectious_Disease,opportunistic infectious disposition,0.7277777777777777
Infectious_Disease,SARS-CoV-2 disorder,0.6391891891891892
Infectious_Disease,infectious agent host role,0.7681818181818181
Infectious_Disease,ERO_0000671,0.553448275862069
Infectious_Disease,parasitostatic disposition,0.6545454545454545
Infectious_Disease,active immunization against infectious agent,0.6596774193548387
Infectious_Disease,fungistatic disposition,0.6451219512195122
Infectious_Disease,communicability end process boundary,0.5981481481481481
Infectious_Disease,site of infection,0.6785714285714286
Infectious_Disease,vaccination against infectious agent,0.6907407407407408
Infectious_Disease,viral disease course,0.6868421052631578
Infectious_Disease,infectious disease sporadicity,0.825
Infectious_Disease,infectious agent host,0.7833333333333333
Infectious_Disease,virus transcription stage,0.6825581395348838
Infectious_Disease,infection start temporal region,0.7153061224489795
Infectious_Disease,infection incidence proportion,0.7
Infectious_Disease,cytotoxin disposition,0.6551282051282051
Infectious_Disease,infectious disease pandemic,0.85
Infectious_Disease,infectious disorder,0.8554054054054054
Infectious_Disease,extracellular infection,0.6451219512195122
Infectious_Disease,ERO_0000006,0.553448275862069
Infectious_Disease,communicability end temporal region,0.6009433962264151
Infectious_Disease,infectious disease incidence proportion,0.7657894736842106
Infectious_Disease,symptomatic infectious agent carrier,0.7092592592592593
Infectious_Disease,nursing-home acquired infection,0.6132653061224489
Infectious_Disease,TRANS_0000000,0.5467741935483871
Infectious_Disease,negative-sense single-stranded RNA virus,0.6396551724137931
Infectious_Disease,asymptomatic infectious agent carrier,0.7045454545454546
Infectious_Disease,infection start process boundary,0.69
Infectious_Disease,establishment of localization in virus host,0.630327868852459
Infectious_Disease,reverse zoonotic disposition,0.6239130434782608
Infectious_Disease,TRANS_0000007,0.5467741935483871
Infectious_Disease,T cell receptor complex,0.5963414634146341
Infectious_Disease,appearance of disorder,0.65
Infectious_Disease,ERO_0000337,0.553448275862069
Infectious_Disease,subclinical coronavirus infection,0.6264705882352941
Infectious_Disease,infectious disease control objective specification,0.7147058823529412
Infectious_Disease,infection incidence rate profile,0.71
Infectious_Disease,infectious agent reservoir,0.7681818181818181
Infectious_Disease,herd immunity to infectious organism,0.6907407407407408
Infectious_Disease,complex infection,0.6785714285714286
Infectious_Disease,viral disease pandemic,0.675
Infectious_Disease,process of establishing viral infection,0.6078947368421053
Infectious_Disease,virus disorder,0.7
Infectious_Disease,infectious disease incidence rate,0.8029411764705883
Infectious_Disease,collective disposition,0.675
Infectious_Disease,toxin disposition,0.65
Infectious_Disease,long-term non-progressing infectious disease course,0.7108695652173913
Infectious_Disease,bactericidal disposition,0.6404761904761905
Infectious_Disease,COVID-19 epidemic,0.5928571428571429
Infectious_Disease,sterilizing immunity to infectious agent,0.6741379310344828
Infectious_Disease,bacteriostatic disposition,0.6772727272727272
Infectious_Disease,double-stranded DNA virus,0.6127906976744186
Infectious_Disease,infectious disposition,0.825
Infectious_Disease,acute respiratory distress syndrome,0.6575471698113208
Infectious_Disease,viral disease,0.7403225806451613
Infectious_Disease,infectious disease epidemic,0.85
Infectious_Disease,infectious disease incidence,0.8413043478260869
Infectious_Disease,virus attachment stage,0.625
Infectious_Disease,virus replication,0.6214285714285714
Infectious_Disease,infectious pathogen transmissibility,0.7092592592592593
Infectious_Disease,infectious structure generative stage,0.740909090909091
Infectious_Disease,collective pathogenic disposition,0.6460784313725491
Infectious_Disease,hospital-acquired infection,0.6277777777777778
Infectious_Disease,simple infection,0.6852941176470588
Infectious_Disease,virus generative stage,0.675
Infectious_Disease,immunosuppressive disposition,0.6627659574468084
Infectious_Disease,infectious structure,0.7921052631578948
Infectious_Disease,primary infection,0.6785714285714286
Infectious_Disease,acquired immunity to infectious agent,0.6863636363636364
Infectious_Disease,SARS-COV-2 adhesion disposition,0.6132653061224489
Infectious_Disease,virus release stage,0.6662162162162162
Infectious_Disease,infectious agent colony,0.7670731707317073
Infectious_Disease,infectious human pathogen,0.7523255813953489
Infectious_Disease,COVID-19 disease course,0.6939024390243902
Infectious_Disease,humoral immunity to infectious agent,0.6907407407407408
Govt_Schemes,B cell receptor complex,0.5928571428571429
Govt_Schemes,COVID-19 mortality rate,0.5928571428571429
Govt_Schemes,GO_0019814,0.5863636363636363
Govt_Schemes,exotoxin disposition,0.60625
Govt_Schemes,GO_0051093,0.5863636363636363
Govt_Schemes,invasive disposition,0.575
Govt_Schemes,GO_0019061,0.5863636363636363
Govt_Schemes,zoonotic disposition,0.60625
Govt_Schemes,infection incidence rate,0.5888888888888889
Govt_Schemes,infectious disease mortality rate,0.5833333333333334
Govt_Schemes,GO_0048525,0.5863636363636363
Govt_Schemes,GO_0019081,0.5863636363636363
Govt_Schemes,GO_0008150,0.5863636363636363
Govt_Schemes,virostatic disposition,0.5970588235294118
Govt_Schemes,fungicidal disposition,0.5676470588235294
Govt_Schemes,adhesion disposition,0.575
Govt_Schemes,parasiticidal disposition,0.5581081081081081
Govt_Schemes,neurotoxin disposition,0.5970588235294118
Govt_Schemes,GO_0019083,0.5863636363636363
Govt_Schemes,respiratory system disease,0.6342105263157894
Govt_Schemes,GO_0050777,0.5863636363636363
Govt_Schemes,GO_0065007,0.5863636363636363
Govt_Schemes,enterotoxin disposition,0.5928571428571429
Govt_Schemes,infectious disease control strategy,0.5776595744680851
Govt_Schemes,primary infectious disposition,0.5452380952380953
Govt_Schemes,static agent disposition,0.5888888888888889
Govt_Schemes,pathogenic disposition,0.5676470588235294
Govt_Schemes,action specification,0.575
Govt_Schemes,virulence factor disposition,0.575
Govt_Schemes,establishment of a clinically abnormal colony,0.537719298245614
Govt_Schemes,disposition,0.5369565217391304
Govt_Schemes,GO_0006959,0.5863636363636363
Govt_Schemes,cidal agent disposition,0.5928571428571429
Govt_Schemes,GO_0006955,0.5863636363636363
Govt_Schemes,GO_0044409,0.5863636363636363
Govt_Schemes,invasion disposition,0.575
Govt_Schemes,GO_0002443,0.5863636363636363
Govt_Schemes,endotoxin disposition,0.6015151515151516
Govt_Schemes,GO_0032502,0.5863636363636363
Govt_Schemes,collective resistance disposition,0.6055555555555556
Govt_Schemes,GO_0019062,0.5863636363636363
Govt_Schemes,GO_0032991,0.5863636363636363
Govt_Schemes,viral adhesion disposition,0.581578947368421
Govt_Schemes,GO_0045087,0.5863636363636363
Govt_Schemes,plan specification,0.55
Govt_Schemes,transmissibility disposition,0.55
Govt_Schemes,GO_19076,0.6
Govt_Schemes,viricidal disposition,0.5712121212121213
Govt_Schemes,quarantine control strategy,0.5782051282051281
Govt_Schemes,GO_0019028,0.5863636363636363
Govt_Schemes,GO_0046718,0.5863636363636363
Govt_Schemes,GO_0019031,0.5863636363636363
Govt_Schemes,GO_0048519,0.5863636363636363
Govt_Schemes,opportunistic infectious disposition,0.575
Govt_Schemes,GO_0046727,0.5863636363636363
Govt_Schemes,place closure control strategy,0.569047619047619
Govt_Schemes,SARS-CoV-2 incidence rate,0.6121621621621621
Govt_Schemes,parasitostatic disposition,0.581578947368421
Govt_Schemes,GO_0044403,0.5863636363636363
Govt_Schemes,fungistatic disposition,0.5928571428571429
Govt_Schemes,GO_0051234,0.5863636363636363
Govt_Schemes,vector control strategy,0.5928571428571429
Govt_Schemes,cytotoxin disposition,0.6015151515151516
Govt_Schemes,GO_0002250,0.5863636363636363
Govt_Schemes,case isolation control strategy,0.5662790697674418
Govt_Schemes,reverse zoonotic disposition,0.575
Govt_Schemes,T cell receptor complex,0.6214285714285714
Govt_Schemes,GO_0019068,0.5863636363636363
Govt_Schemes,infection incidence rate profile,0.5636363636363636
Govt_Schemes,COVID-19 incidence rate,0.6214285714285714
Govt_Schemes,GO_0042101,0.5863636363636363
Govt_Schemes,infectious disease incidence rate,0.5833333333333334
Govt_Schemes,collective disposition,0.5970588235294118
Govt_Schemes,toxin disposition,0.5879310344827586
Govt_Schemes,bactericidal disposition,0.5611111111111111
Govt_Schemes,bacteriostatic disposition,0.581578947368421
Govt_Schemes,infectious disposition,0.5676470588235294
Govt_Schemes,GO_0044411,0.5863636363636363
Govt_Schemes,collective pathogenic disposition,0.5833333333333334
Govt_Schemes,GO_0019815,0.5863636363636363
Govt_Schemes,immunosuppressive disposition,0.5719512195121951
Govt_Schemes,SARS-COV-2 adhesion disposition,0.5895348837209302
Govt_Schemes,GO_0044406,0.5863636363636363
Public_Sector,B cell receptor complex,0.6722222222222223
Public_Sector,COVID-19 mortality rate,0.5611111111111111
Public_Sector,three-dimensional spatial region,0.5611111111111111
Public_Sector,communicability start temporal region,0.63
Public_Sector,incubation end temporal region,0.636046511627907
Public_Sector,virus adhesion susceptible cell,0.5863636363636363
Public_Sector,normal resident microbiota population,0.59
Public_Sector,infection incidence rate,0.6121621621621621
Public_Sector,diseased population,0.60625
Public_Sector,PR_000003622,0.53
Public_Sector,infectious agent population,0.6
Public_Sector,infectious disease mortality rate,0.6021739130434782
Public_Sector,division of geopolitical entity,0.609090909090909
Public_Sector,one-dimensional spatial region,0.5662790697674418
Public_Sector,susceptible organism,0.6318181818181818
Public_Sector,local infection,0.7
Public_Sector,lower respiratory tract disease,0.5863636363636363
Public_Sector,establishment of a clinically abnormal colony,0.5879310344827586
Public_Sector,temporal region,0.6285714285714286
Public_Sector,geospatial region,0.6166666666666667
Public_Sector,susceptible population,0.6214285714285714
Public_Sector,infected population,0.60625
Public_Sector,latency end temporal region,0.625
Public_Sector,Country,0.6
Public_Sector,infection end temporal region,0.6166666666666667
Public_Sector,two-dimensional spatial region,0.5662790697674418
Public_Sector,zero-dimensional spatial region,0.5636363636363636
Public_Sector,place closure control strategy,0.6825581395348838
Public_Sector,SARS-CoV-2 incidence rate,0.581578947368421
Public_Sector,infection start temporal region,0.609090909090909
Public_Sector,immune population,0.6166666666666667
Public_Sector,pathogen birth temporal region,0.6127906976744186
Public_Sector,communicability end temporal region,0.6375
Public_Sector,T cell receptor complex,0.6444444444444444
Public_Sector,CL_0000000,0.5369565217391304
Public_Sector,pathogen death temporal region,0.5895348837209302
Public_Sector,zero-dimensional temporal region,0.5611111111111111
Public_Sector,country,0.6
Public_Sector,infection incidence rate profile,0.6055555555555556
Public_Sector,COVID-19 incidence rate,0.5888888888888889
Public_Sector,infectious disease incidence rate,0.6021739130434782
Public_Sector,organism population,0.60625
Public_Sector,SARS-COV-2 adhesion susceptible cell,0.5520408163265306
Public_Sector,geographical region,0.6375
Public_Sector,spatial region,0.6351851851851852
Public_Sector,one-dimensional temporal region,0.5636363636363636
Public_Sector,spatiotemporal region,0.5970588235294118
Political,B cell receptor complex,0.575
Political,positive-sense single-stranded RNA virus,0.5724489795918367
Political,GO_0019814,0.5026315789473684
Political,GO_0051093,0.5026315789473684
Political,GO_0019061,0.5026315789473684
Political,GO_0048525,0.5026315789473684
Political,GO_0019081,0.5026315789473684
Political,GO_0008150,0.5026315789473684
Political,GO_0019083,0.5026315789473684
Political,GO_0050777,0.5026315789473684
Political,GO_0065007,0.5026315789473684
Political,local infection,0.6583333333333334
Political,establishment of a clinically abnormal colony,0.5796296296296296
Political,GO_0006959,0.5026315789473684
Political,GO_0006955,0.5026315789473684
Political,GO_0044409,0.5026315789473684
Political,GO_0002443,0.5026315789473684
Political,GO_0032502,0.5026315789473684
Political,GO_0019062,0.5026315789473684
Political,GO_0032991,0.5026315789473684
Political,Country,0.575
Political,GO_0045087,0.5026315789473684
Political,GO_19076,0.5088235294117647
Political,double-stranded RNA virus,0.5676470588235294
Political,GO_0019028,0.5026315789473684
Political,GO_0046718,0.5026315789473684
Political,GO_0019031,0.5026315789473684
Political,GO_0048519,0.5026315789473684
Political,GO_0046727,0.5026315789473684
Political,GO_0044403,0.5026315789473684
Political,GO_0051234,0.5026315789473684
Political,single-stranded RNA retrovirus,0.5269230769230769
Political,GO_0002250,0.5026315789473684
Political,negative-sense single-stranded RNA virus,0.5112244897959184
Political,T cell receptor complex,0.575
Political,country,0.575
Political,GO_0019068,0.5026315789473684
Political,GO_0042101,0.5026315789473684
Political,GO_0044411,0.5026315789473684
Political,GO_0019815,0.5026315789473684
Political,GO_0044406,0.5026315789473684
International,B cell receptor complex,0.5888888888888889
International,positive-sense single-stranded RNA virus,0.6009433962264151
International,COVID-19 pandemic,0.5833333333333334
International,establishment of a clinically abnormal colony,0.5879310344827586
International,plan specification,0.6758064516129032
International,double-stranded RNA virus,0.6078947368421053
International,single-stranded RNA retrovirus,0.6593023255813953
International,infectious disease pandemic,0.625
International,negative-sense single-stranded RNA virus,0.6009433962264151
International,T cell receptor complex,0.6166666666666667
International,viral disease pandemic,0.5928571428571429
State_Bank_of_India,B cell receptor complex,0.5452380952380953
State_Bank_of_India,COVID-19 mortality rate,0.569047619047619
State_Bank_of_India,GO_0019814,0.5189655172413793
State_Bank_of_India,GO_0051093,0.5189655172413793
State_Bank_of_India,GO_0019061,0.5189655172413793
State_Bank_of_India,incubation end temporal region,0.6336734693877552
State_Bank_of_India,epitope site,0.5790322580645162
State_Bank_of_India,infection incidence rate,0.6127906976744186
State_Bank_of_India,infectious disease mortality rate,0.5846153846153846
State_Bank_of_India,GO_0048525,0.5189655172413793
State_Bank_of_India,GO_0019081,0.5189655172413793
State_Bank_of_India,pathogen portal of entry site,0.6791666666666666
State_Bank_of_India,GO_0008150,0.5189655172413793
State_Bank_of_India,GO_0019083,0.5189655172413793
State_Bank_of_India,GO_0050777,0.5189655172413793
State_Bank_of_India,latency end process boundary,0.6840425531914894
State_Bank_of_India,GO_0065007,0.5189655172413793
State_Bank_of_India,source of infection site,0.6593023255813953
State_Bank_of_India,site,0.5804347826086956
State_Bank_of_India,establishment of a clinically abnormal colony,0.653125
State_Bank_of_India,GO_0006959,0.5189655172413793
State_Bank_of_India,reservoir of pathogen role,0.6055555555555556
State_Bank_of_India,GO_0006955,0.5189655172413793
State_Bank_of_India,incubation end process boundary,0.65
State_Bank_of_India,GO_0044409,0.5189655172413793
State_Bank_of_India,GO_0002443,0.5189655172413793
State_Bank_of_India,GO_0032502,0.5189655172413793
State_Bank_of_India,GO_0019062,0.5189655172413793
State_Bank_of_India,pathogen portal of exit site,0.6840425531914894
State_Bank_of_India,GO_0032991,0.5189655172413793
State_Bank_of_India,latency end temporal region,0.6673913043478261
State_Bank_of_India,GO_0045087,0.5189655172413793
State_Bank_of_India,infection end temporal region,0.6166666666666667
State_Bank_of_India,GO_19076,0.524074074074074
State_Bank_of_India,GO_0019028,0.5189655172413793
State_Bank_of_India,GO_0046718,0.5189655172413793
State_Bank_of_India,GO_0019031,0.5189655172413793
State_Bank_of_India,GO_0048519,0.5189655172413793
State_Bank_of_India,GO_0046727,0.5189655172413793
State_Bank_of_India,SARS-CoV-2 incidence rate,0.6318181818181818
State_Bank_of_India,GO_0044403,0.5189655172413793
State_Bank_of_India,GO_0051234,0.5189655172413793
State_Bank_of_India,communicability end process boundary,0.6318181818181818
State_Bank_of_India,site of infection,0.7277777777777777
State_Bank_of_India,GO_0002250,0.5189655172413793
State_Bank_of_India,communicability end temporal region,0.6166666666666667
State_Bank_of_India,case isolation control strategy,0.63
State_Bank_of_India,T cell receptor complex,0.569047619047619
State_Bank_of_India,GO_0019068,0.5189655172413793
State_Bank_of_India,infection incidence rate profile,0.6068627450980393
State_Bank_of_India,infectious agent reservoir,0.6055555555555556
State_Bank_of_India,COVID-19 incidence rate,0.5928571428571429
State_Bank_of_India,GO_0042101,0.5189655172413793
State_Bank_of_India,infectious disease incidence rate,0.6038461538461539
State_Bank_of_India,GO_0044411,0.5189655172413793
State_Bank_of_India,GO_0019815,0.5189655172413793
State_Bank_of_India,GO_0044406,0.5189655172413793
Dedicated Covid Hospital,B cell receptor complex,0.6414893617021277
Dedicated Covid Hospital,COVID-19 mortality rate,0.6627659574468084
Dedicated Covid Hospital,hospital facility,0.6451219512195122
Dedicated Covid Hospital,GO_0019814,0.5088235294117647
Dedicated Covid Hospital,GO_0051093,0.5088235294117647
Dedicated Covid Hospital,GO_0019061,0.5088235294117647
Dedicated Covid Hospital,incubation end temporal region,0.6351851851851852
Dedicated Covid Hospital,establishment of localization in human host,0.6291044776119403
Dedicated Covid Hospital,infection incidence rate,0.6375
Dedicated Covid Hospital,infectious disease mortality rate,0.6254385964912281
Dedicated Covid Hospital,GO_0048525,0.5088235294117647
Dedicated Covid Hospital,GO_0019081,0.5088235294117647
Dedicated Covid Hospital,GO_0008150,0.5088235294117647
Dedicated Covid Hospital,GO_0019083,0.5088235294117647
Dedicated Covid Hospital,respiratory system disease,0.63
Dedicated Covid Hospital,GO_0050777,0.5088235294117647
Dedicated Covid Hospital,latency end process boundary,0.6230769230769231
Dedicated Covid Hospital,GO_0065007,0.5088235294117647
Dedicated Covid Hospital,negative regulation of establishment of localization,0.6210526315789474
Dedicated Covid Hospital,establishment of a clinically abnormal colony,0.5949275362318841
Dedicated Covid Hospital,GO_0006959,0.5088235294117647
Dedicated Covid Hospital,GO_0006955,0.5088235294117647
Dedicated Covid Hospital,incubation end process boundary,0.65
Dedicated Covid Hospital,GO_0044409,0.5088235294117647
Dedicated Covid Hospital,GO_0002443,0.5088235294117647
Dedicated Covid Hospital,GO_0032502,0.5088235294117647
Dedicated Covid Hospital,GO_0019062,0.5088235294117647
Dedicated Covid Hospital,GO_0032991,0.5088235294117647
Dedicated Covid Hospital,latency end temporal region,0.6264705882352941
Dedicated Covid Hospital,GO_0045087,0.5088235294117647
Dedicated Covid Hospital,infection end temporal region,0.619811320754717
Dedicated Covid Hospital,GO_19076,0.5125
Dedicated Covid Hospital,GO_0019028,0.5088235294117647
Dedicated Covid Hospital,GO_0046718,0.5088235294117647
Dedicated Covid Hospital,GO_0019031,0.5088235294117647
Dedicated Covid Hospital,GO_0048519,0.5088235294117647
Dedicated Covid Hospital,GO_0046727,0.5088235294117647
Dedicated Covid Hospital,place closure control strategy,0.6351851851851852
Dedicated Covid Hospital,SARS-CoV-2 incidence rate,0.6132653061224489
Dedicated Covid Hospital,GO_0044403,0.5088235294117647
Dedicated Covid Hospital,active immunization against infectious agent,0.5970588235294118
Dedicated Covid Hospital,GO_0051234,0.5088235294117647
Dedicated Covid Hospital,communicability end process boundary,0.6333333333333333
Dedicated Covid Hospital,establishment of localization in host,0.6467213114754098
Dedicated Covid Hospital,GO_0002250,0.5088235294117647
Dedicated Covid Hospital,communicability end temporal region,0.6194915254237288
Dedicated Covid Hospital,establishment of localization,0.619811320754717
Dedicated Covid Hospital,establishment of localization in virus host,0.6440298507462687
Dedicated Covid Hospital,T cell receptor complex,0.6414893617021277
Dedicated Covid Hospital,CL_0000000,0.5088235294117647
Dedicated Covid Hospital,GO_0019068,0.5088235294117647
Dedicated Covid Hospital,infection incidence rate profile,0.6464285714285714
Dedicated Covid Hospital,COVID-19 incidence rate,0.6202127659574468
Dedicated Covid Hospital,GO_0042101,0.5088235294117647
Dedicated Covid Hospital,infectious disease incidence rate,0.6429824561403508
Dedicated Covid Hospital,GO_0044411,0.5088235294117647
Dedicated Covid Hospital,GO_0019815,0.5088235294117647
Dedicated Covid Hospital,GO_0044406,0.5088235294117647
Police_Person,B cell receptor complex,0.6166666666666667
Police_Person,GO_0019814,0.5369565217391304
Police_Person,GO_0051093,0.5369565217391304
Police_Person,information content entity,0.6294871794871795
Police_Person,GO_0019061,0.5369565217391304
Police_Person,incubation end temporal region,0.636046511627907
Police_Person,establishment of localization in human host,0.5571428571428572
Police_Person,drug-based immunosuppressed organism,0.5928571428571429
Police_Person,PR_000003622,0.53
Police_Person,GO_0048525,0.5369565217391304
Police_Person,GO_0019081,0.5369565217391304
Police_Person,descriptive information content entity,0.6068627450980393
Police_Person,colonization of human,0.6264705882352941
Police_Person,division of geopolitical entity,0.6318181818181818
Police_Person,GO_0008150,0.5369565217391304
Police_Person,GO_0019083,0.5369565217391304
Police_Person,respiratory system disease,0.6038461538461539
Police_Person,GO_0050777,0.5369565217391304
Police_Person,latency end process boundary,0.6695121951219513
Police_Person,GO_0065007,0.5369565217391304
Police_Person,extended organism,0.5833333333333334
Police_Person,geopolitical entity,0.7
Police_Person,susceptible organism,0.6318181818181818
Police_Person,immunosuppressed organism,0.6078947368421053
Police_Person,resistant entity,0.5879310344827586
Police_Person,designative information content entity,0.5872549019607843
Police_Person,lower respiratory tract disease,0.5863636363636363
Police_Person,establishment of a clinically abnormal colony,0.5879310344827586
Police_Person,GO_0006959,0.5369565217391304
Police_Person,GO_0006955,0.5369565217391304
Police_Person,incubation end process boundary,0.6545454545454545
Police_Person,GO_0044409,0.5369565217391304
Police_Person,GO_0002443,0.5369565217391304
Police_Person,GO_0032502,0.5369565217391304
Police_Person,immaterial entity,0.6166666666666667
Police_Person,GO_0019062,0.5369565217391304
Police_Person,material entity,0.5928571428571429
Police_Person,GO_0032991,0.5369565217391304
Police_Person,immunocompetent organism,0.6121621621621621
Police_Person,latency end temporal region,0.65
Police_Person,GO_0045087,0.5369565217391304
Police_Person,infection end temporal region,0.6404761904761905
Police_Person,GO_19076,0.5452380952380953
Police_Person,GO_0019028,0.5369565217391304
Police_Person,GO_0046718,0.5369565217391304
Police_Person,organism,0.5928571428571429
Police_Person,immunodeficient organism,0.6391891891891892
Police_Person,entity,0.5552631578947369
Police_Person,GO_0019031,0.5369565217391304
Police_Person,GO_0048519,0.5369565217391304
Police_Person,realizable entity,0.65
Police_Person,GO_0046727,0.5369565217391304
Police_Person,GO_0044403,0.5369565217391304
Police_Person,GO_0051234,0.5369565217391304
Police_Person,communicability end process boundary,0.6540816326530612
Police_Person,organism substance,0.6112903225806451
Police_Person,anatomical entity,0.65
Police_Person,geographical entity,0.6375
Police_Person,pathologically immunosuppressed organism,0.6575471698113208
Police_Person,GO_0002250,0.5369565217391304
Police_Person,communicability end temporal region,0.6375
Police_Person,T cell receptor complex,0.6166666666666667
Police_Person,CL_0000000,0.5369565217391304
Police_Person,GO_0019068,0.5369565217391304
Police_Person,molecular entity,0.656896551724138
Police_Person,herd immunity to infectious organism,0.5724489795918367
Police_Person,GO_0042101,0.5369565217391304
Police_Person,organism population,0.6375
Police_Person,GO_0044411,0.5369565217391304
Police_Person,GO_0019815,0.5369565217391304
Police_Person,directive information content entity,0.5928571428571429
Police_Person,infectious human pathogen,0.6078947368421053
Police_Person,GO_0044406,0.5369565217391304
R97lAZPeb77i5ddeTaGSShN,B cell receptor complex,0.5369565217391304
R97lAZPeb77i5ddeTaGSShN,establishment of a clinically abnormal colony,0.5529411764705883
R97lAZPeb77i5ddeTaGSShN,T cell receptor complex,0.5369565217391304
Nationalized_Bank,B cell receptor complex,0.55
Nationalized_Bank,COVID-19 mortality rate,0.625
Nationalized_Bank,GO_0019814,0.524074074074074
Nationalized_Bank,GO_0051093,0.524074074074074
Nationalized_Bank,GO_0019061,0.524074074074074
Nationalized_Bank,incubation end temporal region,0.6840425531914894
Nationalized_Bank,infection incidence rate,0.6695121951219513
Nationalized_Bank,infectious disease mortality rate,0.63
Nationalized_Bank,GO_0048525,0.524074074074074
Nationalized_Bank,GO_0019081,0.524074074074074
Nationalized_Bank,GO_0008150,0.524074074074074
Nationalized_Bank,GO_0019083,0.524074074074074
Nationalized_Bank,GO_0050777,0.524074074074074
Nationalized_Bank,latency end process boundary,0.6277777777777778
Nationalized_Bank,GO_0065007,0.524074074074074
Nationalized_Bank,establishment of a clinically abnormal colony,0.6112903225806451
Nationalized_Bank,GO_0006959,0.524074074074074
Nationalized_Bank,reservoir of pathogen role,0.5895348837209302
Nationalized_Bank,GO_0006955,0.524074074074074
Nationalized_Bank,incubation end process boundary,0.6791666666666666
Nationalized_Bank,GO_0044409,0.524074074074074
Nationalized_Bank,GO_0002443,0.524074074074074
Nationalized_Bank,GO_0032502,0.524074074074074
Nationalized_Bank,GO_0019062,0.524074074074074
Nationalized_Bank,GO_0032991,0.524074074074074
Nationalized_Bank,latency end temporal region,0.6318181818181818
Nationalized_Bank,GO_0045087,0.524074074074074
Nationalized_Bank,infection end temporal region,0.6673913043478261
Nationalized_Bank,GO_19076,0.53
Nationalized_Bank,GO_0019028,0.524074074074074
Nationalized_Bank,GO_0046718,0.524074074074074
Nationalized_Bank,GO_0019031,0.524074074074074
Nationalized_Bank,GO_0048519,0.524074074074074
Nationalized_Bank,GO_0046727,0.524074074074074
Nationalized_Bank,SARS-CoV-2 incidence rate,0.6166666666666667
Nationalized_Bank,GO_0044403,0.524074074074074
Nationalized_Bank,GO_0051234,0.524074074074074
Nationalized_Bank,communicability end process boundary,0.6386792452830189
Nationalized_Bank,GO_0002250,0.524074074074074
Nationalized_Bank,communicability end temporal region,0.6423076923076922
Nationalized_Bank,T cell receptor complex,0.55
Nationalized_Bank,CL_0000000,0.524074074074074
Nationalized_Bank,GO_0019068,0.524074074074074
Nationalized_Bank,infection incidence rate profile,0.6336734693877552
Nationalized_Bank,infectious agent reservoir,0.6127906976744186
Nationalized_Bank,COVID-19 incidence rate,0.6
Nationalized_Bank,GO_0042101,0.524074074074074
Nationalized_Bank,infectious disease incidence rate,0.63
Nationalized_Bank,GO_0044411,0.524074074074074
Nationalized_Bank,GO_0019815,0.524074074074074
Nationalized_Bank,GO_0044406,0.524074074074074
RBUgwiGgH0Fl8jjSQKhOvty,B cell receptor complex,0.5152173913043478
MUDRA,establishment of a clinically abnormal colony,0.51
R9bxGJQY5fRwxzfzJMOy6u1,B cell receptor complex,0.5152173913043478
OverDraft,B cell receptor complex,0.54375
OverDraft,establishment of a clinically abnormal colony,0.5055555555555555
OverDraft,T cell receptor complex,0.54375
City,B cell receptor complex,0.524074074074074
City,infectious disease course,0.5189655172413793
City,division of geopolitical entity,0.5642857142857143
City,local infection,0.6078947368421053
City,lower respiratory tract disease,0.5357142857142857
City,establishment of a clinically abnormal colony,0.5112244897959184
City,coronavirus disease course,0.5166666666666666
City,chronic infectious disease course,0.5310810810810811
City,acute infectious disease course,0.5357142857142857
City,disease course,0.5055555555555555
City,place closure control strategy,0.5382352941176471
City,T cell receptor complex,0.524074074074074
City,CL_0000000,0.5214285714285714
City,complex infection,0.5928571428571429
City,COVID-19 disease course,0.524074074074074
R9JTwNa02wDiCbgJvuPv7Ui,B cell receptor complex,0.5369565217391304
R9JTwNa02wDiCbgJvuPv7Ui,NCBITaxon_2,0.5676470588235294
R9JTwNa02wDiCbgJvuPv7Ui,establishment of a clinically abnormal colony,0.5382352941176471
R9JTwNa02wDiCbgJvuPv7Ui,T cell receptor complex,0.5369565217391304
R9JTwNa02wDiCbgJvuPv7Ui,angiotensin-converting enzyme 2,0.5611111111111111
ExchangeRate,COVID-19 mortality rate,0.6214285714285714
ExchangeRate,infection incidence rate,0.6722222222222223
ExchangeRate,infectious disease mortality rate,0.6277777777777778
ExchangeRate,establishment of a clinically abnormal colony,0.5552631578947369
ExchangeRate,SARS-CoV-2 incidence rate,0.6391891891891892
ExchangeRate,T cell receptor complex,0.5928571428571429
ExchangeRate,infection incidence rate profile,0.6318181818181818
ExchangeRate,COVID-19 incidence rate,0.65
ExchangeRate,infectious disease incidence rate,0.65
InfectedSpouse,infected population,0.7833333333333333
InfectedSpouse,T cell receptor complex,0.6121621621621621
Nurse,B cell receptor complex,0.5214285714285714
Nurse,ERO_0000347,0.5125
Nurse,incubation end temporal region,0.5642857142857143
Nurse,PR_000003622,0.5088235294117647
Nurse,ERO_0000008,0.5125
Nurse,latency end process boundary,0.5409090909090909
Nurse,lower respiratory tract disease,0.5333333333333333
Nurse,ERO_0001362,0.5125
Nurse,incubation end process boundary,0.5611111111111111
Nurse,latency end temporal region,0.54375
Nurse,infection end temporal region,0.5382352941176471
Nurse,ERO_0000671,0.5125
Nurse,communicability end process boundary,0.523170731707317
Nurse,ERO_0000006,0.5125
Nurse,communicability end temporal region,0.525
Nurse,T cell receptor complex,0.5214285714285714
Nurse,ERO_0000337,0.5125
ThridParty,establishment of a clinically abnormal colony,0.5590909090909091
ThridParty,T cell receptor complex,0.5712121212121213
COVID-19_Diagnosis,B cell receptor complex,0.5475609756097561
COVID-19_Diagnosis,COVID-19 disease incidence proportion,0.7227272727272727
COVID-19_Diagnosis,COVID-19 mortality rate,0.7182926829268292
COVID-19_Diagnosis,GO_0019814,0.5571428571428572
COVID-19_Diagnosis,GO_0051093,0.5571428571428572
COVID-19_Diagnosis,GO_0019061,0.5571428571428572
COVID-19_Diagnosis,incubation end temporal region,0.5958333333333333
COVID-19_Diagnosis,COVID-19 pandemic,0.7928571428571428
COVID-19_Diagnosis,geospatial location,0.5851351351351352
COVID-19_Diagnosis,GO_0048525,0.5214285714285714
COVID-19_Diagnosis,GO_0019081,0.5571428571428572
COVID-19_Diagnosis,COVID-19,0.7576923076923078
COVID-19_Diagnosis,COVID-19 incidence,0.7833333333333333
COVID-19_Diagnosis,division of geopolitical entity,0.5928571428571429
COVID-19_Diagnosis,GO_0008150,0.5214285714285714
COVID-19_Diagnosis,virus penetration stage,0.5963414634146341
COVID-19_Diagnosis,virus translation stage,0.6451219512195122
COVID-19_Diagnosis,GO_0019083,0.5571428571428572
COVID-19_Diagnosis,GO_0050777,0.5214285714285714
COVID-19_Diagnosis,latency end process boundary,0.5804347826086956
COVID-19_Diagnosis,COVID-19 sporadicity,0.7657894736842106
COVID-19_Diagnosis,GO_0065007,0.5214285714285714
COVID-19_Diagnosis,COVID-19 endemicity,0.7743243243243243
COVID-19_Diagnosis,TRANS_0000008,0.5467741935483871
COVID-19_Diagnosis,acute infection,0.6015151515151516
COVID-19_Diagnosis,establishment of a clinically abnormal colony,0.5452380952380953
COVID-19_Diagnosis,GO_0006959,0.5214285714285714
COVID-19_Diagnosis,acute infectious disease course,0.6132653061224489
COVID-19_Diagnosis,GO_0006955,0.5214285714285714
COVID-19_Diagnosis,incubation end process boundary,0.5928571428571429
COVID-19_Diagnosis,GO_0044409,0.5214285714285714
COVID-19_Diagnosis,GO_0002443,0.5214285714285714
COVID-19_Diagnosis,GO_0032502,0.5214285714285714
COVID-19_Diagnosis,GO_0019062,0.5571428571428572
COVID-19_Diagnosis,GO_0032991,0.5214285714285714
COVID-19_Diagnosis,latency end temporal region,0.5833333333333334
COVID-19_Diagnosis,TRANS_0000002,0.5467741935483871
COVID-19_Diagnosis,GO_0045087,0.5214285714285714
COVID-19_Diagnosis,plan specification,0.5888888888888889
COVID-19_Diagnosis,infection end temporal region,0.598936170212766
COVID-19_Diagnosis,SARS-CoV-2 penetration stage,0.6239130434782608
COVID-19_Diagnosis,GO_19076,0.5653846153846154
COVID-19_Diagnosis,genetic resistance to pathogen,0.575
COVID-19_Diagnosis,GO_0019028,0.5571428571428572
COVID-19_Diagnosis,GO_0046718,0.5214285714285714
COVID-19_Diagnosis,GO_0019031,0.5571428571428572
COVID-19_Diagnosis,GO_0048519,0.5571428571428572
COVID-19_Diagnosis,GO_0046727,0.5214285714285714
COVID-19_Diagnosis,place closure control strategy,0.575
COVID-19_Diagnosis,quality,0.53
COVID-19_Diagnosis,GO_0044403,0.5214285714285714
COVID-19_Diagnosis,GO_0051234,0.5214285714285714
COVID-19_Diagnosis,communicability end process boundary,0.5981481481481481
COVID-19_Diagnosis,COVID-19 prevalence,0.7472972972972972
COVID-19_Diagnosis,COVID-19 lifetime prevalence,0.7108695652173913
COVID-19_Diagnosis,GO_0002250,0.5214285714285714
COVID-19_Diagnosis,communicability end temporal region,0.6009433962264151
COVID-19_Diagnosis,TRANS_0000000,0.5467741935483871
COVID-19_Diagnosis,TRANS_0000007,0.5467741935483871
COVID-19_Diagnosis,T cell receptor complex,0.5475609756097561
COVID-19_Diagnosis,CL_0000000,0.5214285714285714
COVID-19_Diagnosis,GO_0019068,0.5571428571428572
COVID-19_Diagnosis,COVID-19 incidence rate,0.7426829268292683
COVID-19_Diagnosis,GO_0042101,0.5214285714285714
COVID-19_Diagnosis,COVID-19 epidemic,0.7642857142857143
COVID-19_Diagnosis,acute respiratory distress syndrome,0.5820754716981132
COVID-19_Diagnosis,GO_0044411,0.5214285714285714
COVID-19_Diagnosis,GO_0019815,0.5571428571428572
COVID-19_Diagnosis,COVID-19 disease course,0.7914634146341464
COVID-19_Diagnosis,GO_0044406,0.5214285714285714
Place,B cell receptor complex,0.5571428571428572
Place,ERO_0000347,0.5125
Place,three-dimensional spatial region,0.5310810810810811
Place,communicability start temporal region,0.5214285714285714
Place,incubation end temporal region,0.5357142857142857
Place,epitope site,0.5676470588235294
Place,PR_000003622,0.5088235294117647
Place,pathogen portal of entry site,0.5382352941176471
Place,ERO_0000008,0.5125
Place,one-dimensional spatial region,0.5357142857142857
Place,latency end process boundary,0.5712121212121213
Place,source of infection site,0.5189655172413793
Place,local infection,0.6
Place,site,0.5611111111111111
Place,establishment of a clinically abnormal colony,0.51
Place,temporal region,0.6
Place,geospatial region,0.5863636363636363
Place,ERO_0001362,0.5125
Place,incubation end process boundary,0.5333333333333333
Place,pathogen portal of exit site,0.5409090909090909
Place,latency end temporal region,0.575
Place,Country,0.5333333333333333
Place,plan specification,0.6239130434782608
Place,infection end temporal region,0.5382352941176471
Place,function,0.5269230769230769
Place,two-dimensional spatial region,0.5357142857142857
Place,zero-dimensional spatial region,0.5333333333333333
Place,place closure control strategy,0.5928571428571429
Place,ERO_0000671,0.5125
Place,quality,0.5333333333333333
Place,communicability end process boundary,0.523170731707317
Place,cell space,0.7166666666666667
Place,infection start temporal region,0.5333333333333333
Place,ERO_0000006,0.5125
Place,pathogen birth temporal region,0.5357142857142857
Place,communicability end temporal region,0.525
Place,T cell receptor complex,0.5571428571428572
Place,CL_0000000,0.5166666666666666
Place,ERO_0000337,0.5125
Place,pathogen death temporal region,0.5357142857142857
Place,zero-dimensional temporal region,0.5310810810810811
Place,country,0.5333333333333333
Place,geographical region,0.575
Place,anatomical space,0.6404761904761905
Place,spatial region,0.6078947368421053
Place,one-dimensional temporal region,0.5333333333333333
Place,spatiotemporal region,0.5653846153846154
RCraHWfkJdLn81eSUZBYdL1,B cell receptor complex,0.558695652173913
RCraHWfkJdLn81eSUZBYdL1,establishment of a clinically abnormal colony,0.5529411764705883
Statistics,B cell receptor complex,0.5106060606060606
Statistics,information content entity,0.5888888888888889
Statistics,incubation end temporal region,0.575
Statistics,normal resident microbiota population,0.5563829787234043
Statistics,diseased population,0.6224137931034482
Statistics,infectious agent population,0.5851351351351352
Statistics,descriptive information content entity,0.5958333333333333
Statistics,processed material,0.5928571428571429
Statistics,latency end process boundary,0.5552631578947369
Statistics,process that results in death,0.6294871794871795
Statistics,designative information content entity,0.5958333333333333
Statistics,lower respiratory tract disease,0.6207317073170732
Statistics,establishment of a clinically abnormal colony,0.5954545454545455
Statistics,susceptible population,0.60625
Statistics,incubation end process boundary,0.5719512195121951
Statistics,infected population,0.5879310344827586
Statistics,material entity,0.65
Statistics,latency end temporal region,0.5581081081081081
Statistics,plan specification,0.5928571428571429
Statistics,infection end temporal region,0.5525641025641026
Statistics,material processing,0.6224137931034482
Statistics,communicability end process boundary,0.558695652173913
Statistics,immune population,0.5611111111111111
Statistics,communicability end temporal region,0.5388888888888889
Statistics,T cell receptor complex,0.5409090909090909
Statistics,CL_0000000,0.5
Statistics,organism population,0.6224137931034482
Statistics,directive information content entity,0.5804347826086956
RC9UzdECKKuvX9tfnIA2ht5,NCBITaxon_2,0.5676470588235294
RC9UzdECKKuvX9tfnIA2ht5,establishment of a clinically abnormal colony,0.5382352941176471
RC9UzdECKKuvX9tfnIA2ht5,T cell receptor complex,0.558695652173913
RC9UzdECKKuvX9tfnIA2ht5,angiotensin-converting enzyme 2,0.5611111111111111
Moderate_COVID-19,B cell receptor complex,0.6
Moderate_COVID-19,COVID-19 disease incidence proportion,0.6166666666666667
Moderate_COVID-19,COVID-19 mortality rate,0.65
Moderate_COVID-19,GO_0019814,0.5981481481481481
Moderate_COVID-19,object aggregate,0.6318181818181818
Moderate_COVID-19,GO_0051093,0.5981481481481481
Moderate_COVID-19,GO_0019061,0.5981481481481481
Moderate_COVID-19,incubation end temporal region,0.598936170212766
Moderate_COVID-19,COVID-19 pandemic,0.6852941176470588
Moderate_COVID-19,infection incidence rate,0.6207317073170732
Moderate_COVID-19,PR_000003622,0.5189655172413793
Moderate_COVID-19,infectious disease mortality rate,0.61
Moderate_COVID-19,GO_0048525,0.524074074074074
Moderate_COVID-19,GO_0019081,0.5981481481481481
Moderate_COVID-19,COVID-19,0.77
Moderate_COVID-19,COVID-19 incidence,0.6785714285714286
Moderate_COVID-19,GO_0008150,0.5611111111111111
Moderate_COVID-19,GO_0019083,0.5981481481481481
Moderate_COVID-19,GO_0050777,0.524074074074074
Moderate_COVID-19,latency end process boundary,0.6055555555555556
Moderate_COVID-19,COVID-19 sporadicity,0.6662162162162162
Moderate_COVID-19,GO_0065007,0.524074074074074
Moderate_COVID-19,COVID-19 endemicity,0.6722222222222223
Moderate_COVID-19,infectious disease control strategy,0.6038461538461539
Moderate_COVID-19,adhesion factor,0.60625
Moderate_COVID-19,virulence factor disposition,0.5833333333333334
Moderate_COVID-19,establishment of a clinically abnormal colony,0.5629032258064516
Moderate_COVID-19,GO_0006959,0.5611111111111111
Moderate_COVID-19,GO_0006955,0.5611111111111111
Moderate_COVID-19,incubation end process boundary,0.5958333333333333
Moderate_COVID-19,GO_0044409,0.5611111111111111
Moderate_COVID-19,GO_0002443,0.524074074074074
Moderate_COVID-19,GO_0032502,0.524074074074074
Moderate_COVID-19,GO_0019062,0.5981481481481481
Moderate_COVID-19,GO_0032991,0.5611111111111111
Moderate_COVID-19,latency end temporal region,0.5863636363636363
Moderate_COVID-19,GO_0045087,0.524074074074074
Moderate_COVID-19,infection end temporal region,0.6021739130434782
Moderate_COVID-19,invasion factor,0.575
Moderate_COVID-19,GO_19076,0.61
Moderate_COVID-19,intermediate host role,0.6294871794871795
Moderate_COVID-19,quarantine control strategy,0.609090909090909
Moderate_COVID-19,GO_0019028,0.5981481481481481
Moderate_COVID-19,GO_0046718,0.5611111111111111
Moderate_COVID-19,GO_0019031,0.5981481481481481
Moderate_COVID-19,GO_0048519,0.5981481481481481
Moderate_COVID-19,GO_0046727,0.524074074074074
Moderate_COVID-19,place closure control strategy,0.5776595744680851
Moderate_COVID-19,SARS-CoV-2 incidence rate,0.6166666666666667
Moderate_COVID-19,GO_0044403,0.524074074074074
Moderate_COVID-19,GO_0051234,0.5611111111111111
Moderate_COVID-19,communicability end process boundary,0.6009433962264151
Moderate_COVID-19,COVID-19 prevalence,0.6722222222222223
Moderate_COVID-19,vector control strategy,0.575
Moderate_COVID-19,COVID-19 lifetime prevalence,0.6277777777777778
Moderate_COVID-19,GO_0002250,0.524074074074074
Moderate_COVID-19,communicability end temporal region,0.5846153846153846
Moderate_COVID-19,case isolation control strategy,0.575
Moderate_COVID-19,virulence factor,0.6015151515151516
Moderate_COVID-19,T cell receptor complex,0.6
Moderate_COVID-19,intermediate host,0.6558823529411765
Moderate_COVID-19,infectious disease control objective specification,0.5992537313432835
Moderate_COVID-19,GO_0019068,0.5981481481481481
Moderate_COVID-19,infection incidence rate profile,0.6540816326530612
Moderate_COVID-19,COVID-19 incidence rate,0.65
Moderate_COVID-19,GO_0042101,0.5611111111111111
Moderate_COVID-19,infectious disease incidence rate,0.63
Moderate_COVID-19,object,0.5804347826086956
Moderate_COVID-19,COVID-19 epidemic,0.6852941176470588
Moderate_COVID-19,GO_0044411,0.5611111111111111
Moderate_COVID-19,GO_0019815,0.5981481481481481
Moderate_COVID-19,COVID-19 disease course,0.65
Moderate_COVID-19,GO_0044406,0.524074074074074
CorporateCurrentAccount,COVID-19 mortality rate,0.6456521739130434
CorporateCurrentAccount,infection incidence rate,0.598936170212766
CorporateCurrentAccount,infectious disease mortality rate,0.6107142857142857
CorporateCurrentAccount,establishment of a clinically abnormal colony,0.5823529411764706
CorporateCurrentAccount,SARS-CoV-2 incidence rate,0.5958333333333333
CorporateCurrentAccount,T cell receptor complex,0.6239130434782608
CorporateCurrentAccount,infection incidence rate profile,0.5954545454545455
CorporateCurrentAccount,COVID-19 incidence rate,0.6021739130434782
CorporateCurrentAccount,infectious disease incidence rate,0.6107142857142857
LAP,B cell receptor complex,0.5269230769230769
LAP,three-dimensional spatial region,0.5071428571428571
LAP,communicability start temporal region,0.525
LAP,incubation end temporal region,0.5106060606060606
LAP,one-dimensional spatial region,0.5106060606060606
LAP,latency end process boundary,0.5467741935483871
LAP,lower respiratory tract disease,0.5088235294117647
LAP,temporal region,0.5055555555555555
LAP,geospatial region,0.5
LAP,incubation end process boundary,0.5088235294117647
LAP,disease course,0.5088235294117647
LAP,latency end temporal region,0.55
LAP,polymerase chain reaction,0.5214285714285714
LAP,two-dimensional spatial region,0.5106060606060606
LAP,zero-dimensional spatial region,0.5088235294117647
LAP,place closure control strategy,0.5106060606060606
LAP,communicability end process boundary,0.5012820512820513
LAP,viral disease course,0.5369565217391304
LAP,infection start temporal region,0.5088235294117647
LAP,pathogen birth temporal region,0.5106060606060606
LAP,communicability end temporal region,0.5026315789473684
LAP,case isolation control strategy,0.5088235294117647
LAP,T cell receptor complex,0.5269230769230769
LAP,CL_0000000,0.5269230769230769
LAP,pathogen death temporal region,0.5106060606060606
LAP,zero-dimensional temporal region,0.5071428571428571
LAP,geographical region,0.5409090909090909
LAP,spatial region,0.5088235294117647
LAP,one-dimensional temporal region,0.5088235294117647
LAP,spatiotemporal region,0.5333333333333333
InfectedNiece,infected population,0.73125
InfectedNiece,T cell receptor complex,0.5888888888888889
InfectedSon,infected population,0.7833333333333333
InfectedSon,T cell receptor complex,0.5676470588235294
Indian_Bank,incubation end temporal region,0.6207317073170732
Indian_Bank,latency end process boundary,0.5782051282051281
Indian_Bank,establishment of a clinically abnormal colony,0.5928571428571429
Indian_Bank,reservoir of pathogen role,0.5581081081081081
Indian_Bank,incubation end process boundary,0.6166666666666667
Indian_Bank,latency end temporal region,0.581578947368421
Indian_Bank,infection end temporal region,0.625
Indian_Bank,communicability end process boundary,0.598936170212766
Indian_Bank,communicability end temporal region,0.6021739130434782
Indian_Bank,infectious agent reservoir,0.6121621621621621
RZ2UJHbWgJHsKvyMtjEX6W,B cell receptor complex,0.5388888888888889
RZ2UJHbWgJHsKvyMtjEX6W,NCBITaxon_2,0.5409090909090909
RZ2UJHbWgJHsKvyMtjEX6W,T cell receptor complex,0.5388888888888889
RZ2UJHbWgJHsKvyMtjEX6W,angiotensin-converting enzyme 2,0.5632075471698114
KishanCreditCard,establishment of a clinically abnormal colony,0.5975409836065574
KishanCreditCard,T cell receptor complex,0.5782051282051281
Account,IDO_0000486,0.5055555555555555
Account,B cell receptor complex,0.55
Account,IDO_0000489,0.5055555555555555
Account,IDO_0000525,0.5055555555555555
Account,IDO_0000655,0.5055555555555555
Account,IDO_0001029,0.5055555555555555
Account,IDO_0000593,0.5055555555555555
Account,IDO_0000568,0.5055555555555555
Account,IDO_0000407,0.5055555555555555
Account,IDO_0000454,0.5055555555555555
Account,positive-sense single-stranded RNA virus,0.5138297872340426
Account,IDO_0000659,0.5055555555555555
Account,IDO_0000578,0.5055555555555555
Account,IDO_0000552,0.5055555555555555
Account,IDO_0000657,0.5055555555555555
Account,IDO_0001164,0.5055555555555555
Account,IDO_0000467,0.5055555555555555
Account,IDO_0000526,0.5055555555555555
Account,IDO_0000488,0.5055555555555555
Account,IDO_0001353,0.5055555555555555
Account,IDO_0001093,0.5055555555555555
Account,IDO_0000621,0.5055555555555555
Account,IDO_0000464,0.5055555555555555
Account,IDO_0000522,0.5055555555555555
Account,IDO_0000626,0.5055555555555555
Account,IDO_0001350,0.5055555555555555
Account,IDO_0000408,0.5055555555555555
Account,IDO_0000403,0.5055555555555555
Account,IDO_0000617,0.5055555555555555
Account,IDO_0000469,0.5055555555555555
Account,IDO_0000470,0.5055555555555555
Account,IDO_0000431,0.5055555555555555
Account,IDO_0001011,0.5055555555555555
Account,IDO_0000446,0.5055555555555555
Account,IDO_0000427,0.5055555555555555
Account,IDO_0000611,0.5055555555555555
Account,IDO_0001028,0.5055555555555555
Account,IDO_0000437,0.5055555555555555
Account,IDO_0000585,0.5055555555555555
Account,IDO_0000496,0.5055555555555555
Account,IDO_0000451,0.5055555555555555
Account,IDO_0000482,0.5055555555555555
Account,IDO_0000566,0.5055555555555555
Account,IDO_0000495,0.5055555555555555
Account,IDO_0000615,0.5055555555555555
Account,IDO_0000665,0.5055555555555555
Account,IDO_0001007,0.5055555555555555
Account,IDO_0001107,0.5055555555555555
Account,IDO_0000543,0.5055555555555555
Account,IDO_0001072,0.5055555555555555
Account,IDO_0000435,0.5055555555555555
Account,chronic infection,0.6166666666666667
Account,IDO_0000629,0.5055555555555555
Account,IDO_0001352,0.5055555555555555
Account,IDO_0000554,0.5055555555555555
Account,IDO_0000468,0.5055555555555555
Account,IDO_0000584,0.5055555555555555
Account,IDO_0000456,0.5055555555555555
Account,IDO_0000410,0.5055555555555555
Account,IDO_0001083,0.5055555555555555
Account,IDO_0001167,0.5055555555555555
Account,IDO_0000457,0.5055555555555555
Account,IDO_0000509,0.5055555555555555
Account,IDO_0000480,0.5055555555555555
Account,IDO_0001356,0.5055555555555555
Account,IDO_0000425,0.5055555555555555
Account,IDO_0000424,0.5055555555555555
Account,IDO_0000524,0.5055555555555555
Account,IDO_0001000,0.5055555555555555
Account,IDO_0000471,0.5055555555555555
Account,IDO_0001163,0.5055555555555555
Account,IDO_0000532,0.5055555555555555
Account,IDO_0001090,0.5055555555555555
Account,IDO_0001030,0.5055555555555555
Account,IDO_0000420,0.5055555555555555
Account,IDO_0000409,0.5055555555555555
Account,IDO_0001197,0.5055555555555555
Account,IDO_0001127,0.5055555555555555
Account,IDO_0001025,0.5055555555555555
Account,IDO_0000619,0.5055555555555555
Account,IDO_0000632,0.5055555555555555
Account,IDO_0000618,0.5055555555555555
Account,IDO_0001157,0.5055555555555555
Account,IDO_0000553,0.5055555555555555
Account,IDO_0000607,0.5055555555555555
Account,IDO_0001355,0.5055555555555555
Account,IDO_0000426,0.5055555555555555
Account,IDO_0000463,0.5055555555555555
Account,IDO_0000642,0.5055555555555555
Account,IDO_0000545,0.5055555555555555
Account,IDO_0000520,0.5055555555555555
Account,IDO_0001009,0.5055555555555555
Account,IDO_0000466,0.5055555555555555
Account,IDO_0000436,0.5055555555555555
Account,IDO_0000547,0.5055555555555555
Account,IDO_0000588,0.5055555555555555
Account,IDO_0000434,0.5055555555555555
Account,IDO_0001088,0.5055555555555555
Account,IDO_0000653,0.5055555555555555
Account,IDO_0000481,0.5055555555555555
Account,IDO_0000630,0.5055555555555555
Account,IDO_0000551,0.5055555555555555
Account,IDO_0000586,0.5055555555555555
Account,IDO_0001134,0.5055555555555555
Account,IDO_0001126,0.5055555555555555
Account,IDO_0000533,0.5055555555555555
Account,IDO_0000419,0.5055555555555555
Account,IDO_0000535,0.5055555555555555
Account,IDO_0000608,0.5055555555555555
Account,IDO_0000485,0.5055555555555555
Account,IDO_0001168,0.5055555555555555
Account,IDO_0000458,0.5055555555555555
Account,IDO_0000499,0.5055555555555555
Account,IDO_0000445,0.5055555555555555
Account,IDO_0000638,0.5055555555555555
Account,IDO_0000539,0.5055555555555555
Account,IDO_0000604,0.5055555555555555
Account,establishment of a clinically abnormal colony,0.5461538461538461
Account,IDO_0000643,0.5055555555555555
Account,IDO_0000450,0.5055555555555555
Account,IDO_0000656,0.5055555555555555
Account,IDO_0000583,0.5055555555555555
Account,chronic infectious disease course,0.55
Account,history,0.5214285714285714
Account,IDO_0000487,0.5055555555555555
Account,IDO_0000455,0.5055555555555555
Account,IDO_0001010,0.5055555555555555
Account,IDO_0000500,0.5055555555555555
Account,IDO_0001345,0.5055555555555555
Account,IDO_0001096,0.5055555555555555
Account,IDO_0000502,0.5055555555555555
Account,IDO_0000483,0.5055555555555555
Account,IDO_0000400,0.5055555555555555
Account,IDO_0000531,0.5055555555555555
Account,IDO_0000497,0.5055555555555555
Account,IDO_0001196,0.5055555555555555
Account,IDO_0000494,0.5055555555555555
Account,IDO_0001130,0.5055555555555555
Account,IDO_0000663,0.5055555555555555
Account,IDO_0001040,0.5055555555555555
Account,IDO_0000633,0.5055555555555555
Account,IDO_0000515,0.5055555555555555
Account,IDO_0001089,0.5055555555555555
Account,IDO_0000506,0.5055555555555555
Account,IDO_0001092,0.5055555555555555
Account,IDO_0001378,0.5055555555555555
Account,plan specification,0.65
Account,IDO_0000576,0.5055555555555555
Account,IDO_0000415,0.5055555555555555
Account,IDO_0001374,0.5055555555555555
Account,IDO_0000530,0.5055555555555555
Account,IDO_0000640,0.5055555555555555
Account,IDO_0000473,0.5055555555555555
Account,IDO_0001346,0.5055555555555555
Account,IDO_0000650,0.5055555555555555
Account,IDO_0000406,0.5055555555555555
Account,IDO_0001198,0.5055555555555555
Account,IDO_0000581,0.5055555555555555
Account,IDO_0000567,0.5055555555555555
Account,double-stranded RNA virus,0.54375
Account,IDO_0000453,0.5055555555555555
Account,IDO_0000472,0.5055555555555555
Account,IDO_0001172,0.5055555555555555
Account,IDO_0000627,0.5055555555555555
Account,IDO_0000511,0.5055555555555555
Account,IDO_0000412,0.5055555555555555
Account,IDO_0000587,0.5055555555555555
Account,IDO_0000592,0.5055555555555555
Account,IDO_0000651,0.5055555555555555
Account,IDO_0000579,0.5055555555555555
Account,IDO_0000475,0.5055555555555555
Account,IDO_0000448,0.5055555555555555
Account,IDO_0000444,0.5055555555555555
Account,IDO_0000490,0.5055555555555555
Account,IDO_0001091,0.5055555555555555
Account,IDO_0001008,0.5055555555555555
Account,IDO_0000631,0.5055555555555555
Account,IDO_0000571,0.5055555555555555
Account,IDO_0000402,0.5055555555555555
Account,IDO_0001110,0.5055555555555555
Account,IDO_0000557,0.5055555555555555
Account,IDO_0001085,0.5055555555555555
Account,IDO_0000512,0.5055555555555555
Account,IDO_0000498,0.5055555555555555
Account,IDO_0000606,0.5055555555555555
Account,IDO_0000523,0.5055555555555555
Account,IDO_0001343,0.5055555555555555
Account,IDO_0000537,0.5055555555555555
Account,IDO_0000596,0.5055555555555555
Account,IDO_0000430,0.5055555555555555
Account,IDO_0000625,0.5055555555555555
Account,IDO_0000550,0.5055555555555555
Account,IDO_0001005,0.5055555555555555
Account,single-stranded RNA retrovirus,0.5310810810810811
Account,IDO_0001166,0.5055555555555555
Account,IDO_0000504,0.5055555555555555
Account,IDO_0001109,0.5055555555555555
Account,case isolation control strategy,0.581578947368421
Account,IDO_0001377,0.5055555555555555
Account,IDO_0000422,0.5055555555555555
Account,IDO_0001026,0.5055555555555555
Account,negative-sense single-stranded RNA virus,0.5138297872340426
Account,IDO_0000513,0.5055555555555555
Account,IDO_0001348,0.5055555555555555
Account,IDO_0000623,0.5055555555555555
Account,T cell receptor complex,0.55
Account,IDO_0000501,0.5055555555555555
Account,CL_0000000,0.5088235294117647
Account,IDO_0000603,0.5055555555555555
Account,IDO_0000401,0.5055555555555555
Account,IDO_0001027,0.5055555555555555
Account,IDO_0001335,0.5055555555555555
Account,IDO_0000612,0.5055555555555555
Account,IDO_0001351,0.5055555555555555
Account,IDO_0000421,0.5055555555555555
Account,IDO_0001199,0.5055555555555555
Account,IDO_0000449,0.5055555555555555
Account,IDO_0000639,0.5055555555555555
Account,IDO_0001354,0.5055555555555555
Account,IDO_0001001,0.5055555555555555
Account,IDO_0000514,0.5055555555555555
Account,IDO_0000580,0.5055555555555555
Account,IDO_0000528,0.5055555555555555
Account,IDO_0001094,0.5055555555555555
Account,IDO_0001041,0.5055555555555555
Account,IDO_0000616,0.5055555555555555
Account,IDO_0001037,0.5055555555555555
Account,IDO_0001349,0.5055555555555555
Account,IDO_0000484,0.5055555555555555
Account,IDO_0000459,0.5055555555555555
Account,IDO_0001002,0.5055555555555555
Account,IDO_0000447,0.5055555555555555
Account,IDO_0001133,0.5055555555555555
Account,IDO_0000570,0.5055555555555555
Account,IDO_0000610,0.5055555555555555
Account,IDO_0000628,0.5055555555555555
Account,IDO_0001065,0.5055555555555555
Account,IDO_0001124,0.5055555555555555
Account,IDO_0000544,0.5055555555555555
Account,IDO_0000549,0.5055555555555555
Account,IDO_0001111,0.5055555555555555
Account,IDO_0000423,0.5055555555555555
Account,IDO_0001036,0.5055555555555555
Account,IDO_0001165,0.5055555555555555
Account,IDO_0000654,0.5055555555555555
Account,IDO_0000479,0.5055555555555555
Account,IDO_0000538,0.5055555555555555
Account,IDO_0000589,0.5055555555555555
Account,IDO_0001095,0.5055555555555555
Account,IDO_0000477,0.5055555555555555
Account,IDO_0000635,0.5055555555555555
Account,IDO_0001357,0.5055555555555555
Account,IDO_0000548,0.5055555555555555
Account,IDO_0001054,0.5055555555555555
Account,IDO_0000414,0.5055555555555555
Account,IDO_0000474,0.5055555555555555
Account,IDO_0000519,0.5055555555555555
Account,IDO_0000438,0.5055555555555555
Account,IDO_0001344,0.5055555555555555
Account,IDO_0000590,0.5055555555555555
Account,IDO_0000503,0.5055555555555555
SubStandard,B cell receptor complex,0.5382352941176471
SubStandard,COVID-19 mortality rate,0.5382352941176471
SubStandard,infection incidence rate,0.5642857142857143
SubStandard,infectious disease mortality rate,0.5636363636363636
SubStandard,adhesion factor,0.6038461538461539
SubStandard,virulence factor disposition,0.5782051282051281
SubStandard,establishment of a clinically abnormal colony,0.5928571428571429
SubStandard,invasion factor,0.6038461538461539
SubStandard,SARS-CoV-2 incidence rate,0.5888888888888889
SubStandard,virulence factor,0.5981481481481481
SubStandard,T cell receptor complex,0.5088235294117647
SubStandard,infection incidence rate profile,0.5662790697674418
SubStandard,COVID-19 incidence rate,0.5382352941176471
SubStandard,infectious disease incidence rate,0.5863636363636363
Financial,B cell receptor complex,0.5125
Financial,establishment of a clinically abnormal colony,0.5796296296296296
Financial,T cell receptor complex,0.5125
Commercial_Banks,B cell receptor complex,0.5782051282051281
Commercial_Banks,GO_0019814,0.5269230769230769
Commercial_Banks,GO_0051093,0.5269230769230769
Commercial_Banks,GO_0019061,0.5269230769230769
Commercial_Banks,incubation end temporal region,0.6239130434782608
Commercial_Banks,PR_000003622,0.5214285714285714
Commercial_Banks,GO_0048525,0.5269230769230769
Commercial_Banks,GO_0019081,0.5269230769230769
Commercial_Banks,GO_0008150,0.5269230769230769
Commercial_Banks,processed material,0.6558823529411765
Commercial_Banks,GO_0019083,0.5269230769230769
Commercial_Banks,GO_0050777,0.5269230769230769
Commercial_Banks,latency end process boundary,0.609090909090909
Commercial_Banks,GO_0065007,0.5269230769230769
Commercial_Banks,establishment of a clinically abnormal colony,0.6139344262295081
Commercial_Banks,GO_0006959,0.5269230769230769
Commercial_Banks,reservoir of pathogen role,0.5928571428571429
Commercial_Banks,GO_0006955,0.5269230769230769
Commercial_Banks,incubation end process boundary,0.6202127659574468
Commercial_Banks,GO_0044409,0.5269230769230769
Commercial_Banks,GO_0002443,0.5269230769230769
Commercial_Banks,GO_0032502,0.5269230769230769
Commercial_Banks,GO_0019062,0.5269230769230769
Commercial_Banks,material entity,0.7080645161290323
Commercial_Banks,PCR product,0.5611111111111111
Commercial_Banks,GO_0032991,0.5269230769230769
Commercial_Banks,latency end temporal region,0.6127906976744186
Commercial_Banks,GO_0045087,0.5269230769230769
Commercial_Banks,infection end temporal region,0.6277777777777778
Commercial_Banks,material processing,0.6785714285714286
Commercial_Banks,GO_19076,0.5333333333333333
Commercial_Banks,GO_0019028,0.5269230769230769
Commercial_Banks,GO_0046718,0.5269230769230769
Commercial_Banks,GO_0019031,0.5269230769230769
Commercial_Banks,GO_0048519,0.5269230769230769
Commercial_Banks,GO_0046727,0.5269230769230769
Commercial_Banks,GO_0044403,0.5269230769230769
Commercial_Banks,GO_0051234,0.5269230769230769
Commercial_Banks,communicability end process boundary,0.6423076923076922
Commercial_Banks,GO_0002250,0.5269230769230769
Commercial_Banks,communicability end temporal region,0.6460784313725491
Commercial_Banks,T cell receptor complex,0.5782051282051281
Commercial_Banks,CL_0000000,0.5653846153846154
Commercial_Banks,GO_0019068,0.5269230769230769
Commercial_Banks,infectious agent reservoir,0.6166666666666667
Commercial_Banks,GO_0042101,0.5269230769230769
Commercial_Banks,GO_0044411,0.5269230769230769
Commercial_Banks,GO_0019815,0.5269230769230769
Commercial_Banks,GO_0044406,0.5269230769230769
Covid-19_Impacted,B cell receptor complex,0.6
Covid-19_Impacted,COVID-19 disease incidence proportion,0.6907407407407408
Covid-19_Impacted,COVID-19 mortality rate,0.775
Covid-19_Impacted,COVID-19 pandemic,0.8029411764705883
Covid-19_Impacted,COVID-19,0.77
Covid-19_Impacted,COVID-19 incidence,0.7928571428571428
Covid-19_Impacted,COVID-19 sporadicity,0.8013513513513513
Covid-19_Impacted,COVID-19 endemicity,0.7833333333333333
Covid-19_Impacted,establishment of a clinically abnormal colony,0.5467741935483871
Covid-19_Impacted,plan specification,0.5928571428571429
Covid-19_Impacted,COVID-19 prevalence,0.8111111111111111
Covid-19_Impacted,COVID-19 lifetime prevalence,0.7833333333333333
Covid-19_Impacted,T cell receptor complex,0.6
Covid-19_Impacted,CL_0000000,0.524074074074074
Covid-19_Impacted,COVID-19 incidence rate,0.775
Covid-19_Impacted,COVID-19 epidemic,0.8029411764705883
Covid-19_Impacted,COVID-19 disease course,0.775
InfectedDaughter,establishment of a clinically abnormal colony,0.5483606557377049
InfectedDaughter,infected population,0.7357142857142857
InfectedDaughter,T cell receptor complex,0.5782051282051281
Covid-19_not_Impacted,B cell receptor complex,0.609090909090909
Covid-19_not_Impacted,COVID-19 disease incidence proportion,0.6741379310344828
Covid-19_not_Impacted,COVID-19 mortality rate,0.7909090909090909
Covid-19_not_Impacted,COVID-19 pandemic,0.7657894736842106
Covid-19_not_Impacted,COVID-19,0.7258620689655172
Covid-19_not_Impacted,COVID-19 incidence,0.7833333333333333
Covid-19_not_Impacted,COVID-19 sporadicity,0.7670731707317073
Covid-19_not_Impacted,COVID-19 endemicity,0.775
Covid-19_not_Impacted,establishment of a clinically abnormal colony,0.5712121212121213
Covid-19_not_Impacted,plan specification,0.5782051282051281
Covid-19_not_Impacted,COVID-19 prevalence,0.775
Covid-19_not_Impacted,COVID-19 lifetime prevalence,0.7765306122448979
Covid-19_not_Impacted,T cell receptor complex,0.609090909090909
Covid-19_not_Impacted,CL_0000000,0.5145161290322581
Covid-19_not_Impacted,COVID-19 incidence rate,0.7681818181818181
Covid-19_not_Impacted,COVID-19 epidemic,0.7657894736842106
Covid-19_not_Impacted,COVID-19 disease course,0.7454545454545455
Viral_Disease,B cell receptor complex,0.5611111111111111
Viral_Disease,COVID-19 disease incidence proportion,0.65
Viral_Disease,respiratory droplet virus fomite,0.6277777777777778
Viral_Disease,positive-sense single-stranded RNA virus,0.6009433962264151
Viral_Disease,exotoxin disposition,0.6318181818181818
Viral_Disease,source of infection role,0.5851351351351352
Viral_Disease,viral pathogenesis,0.7080645161290323
Viral_Disease,invasive disposition,0.6621212121212122
Viral_Disease,infectious disease endemicity,0.6642857142857143
Viral_Disease,incubation end temporal region,0.6127906976744186
Viral_Disease,infectious disease course,0.6868421052631578
Viral_Disease,zoonotic disposition,0.6318181818181818
Viral_Disease,metastatic infection,0.5712121212121213
Viral_Disease,virus adhesion susceptible cell,0.6545454545454545
Viral_Disease,source of infection,0.575
Viral_Disease,disordered virus,0.6224137931034482
Viral_Disease,infectious disease,0.7403225806451613
Viral_Disease,process of establishing an infection,0.5928571428571429
Viral_Disease,disease,0.8
Viral_Disease,infection incidence rate,0.6121621621621621
Viral_Disease,subclinical virus infection,0.625
Viral_Disease,disease surveillance objective specification,0.5903508771929825
Viral_Disease,PR_000003622,0.53
Viral_Disease,negative regulation of viral process,0.6132653061224489
Viral_Disease,infectious disease mortality rate,0.6456521739130434
Viral_Disease,virus synthesis stage,0.6852941176470588
Viral_Disease,chronic infection,0.5833333333333334
Viral_Disease,virus aggregate,0.7
Viral_Disease,infection prevalence,0.6318181818181818
Viral_Disease,virus uncoating stage,0.6852941176470588
Viral_Disease,virostatic disposition,0.7071428571428571
Viral_Disease,fungicidal disposition,0.6785714285714286
Viral_Disease,viral load,0.7543478260869566
Viral_Disease,disorder,0.6404761904761905
Viral_Disease,virus penetration stage,0.6722222222222223
Viral_Disease,virus translation stage,0.7
Viral_Disease,adhesion disposition,0.6318181818181818
Viral_Disease,parasiticidal disposition,0.6605263157894737
Viral_Disease,neurotoxin disposition,0.6214285714285714
Viral_Disease,virus,0.6722222222222223
Viral_Disease,intracellular infection,0.6444444444444444
Viral_Disease,disease transmission model,0.6294871794871795
Viral_Disease,respiratory system disease,0.732051282051282
Viral_Disease,latency end process boundary,0.5719512195121951
Viral_Disease,infection incidence proportion profile,0.5480392156862746
Viral_Disease,infection incidence,0.60625
Viral_Disease,systematic infection,0.5712121212121213
Viral_Disease,infection incidence profile,0.575
Viral_Disease,source of infection site,0.6121621621621621
Viral_Disease,local infection,0.6285714285714286
Viral_Disease,acute infection,0.5928571428571429
Viral_Disease,secondary infection role,0.5851351351351352
Viral_Disease,enterotoxin disposition,0.6166666666666667
Viral_Disease,coronavirus disease,0.79375
Viral_Disease,viral plaque assay,0.7403225806451613
Viral_Disease,infectious disease control strategy,0.6375
Viral_Disease,infectious disease lifetime prevalence,0.6264705882352941
Viral_Disease,viral disease epidemic,0.8214285714285714
Viral_Disease,primary infectious disposition,0.6127906976744186
Viral_Disease,lower respiratory tract disease,0.7
Viral_Disease,infectious disease prevalence,0.6642857142857143
Viral_Disease,subclinical SARS-CoV-2 infection,0.6277777777777778
Viral_Disease,static agent disposition,0.6391891891891892
Viral_Disease,pathogenic disposition,0.6214285714285714
Viral_Disease,single-stranded DNA virus,0.6342105263157894
Viral_Disease,virulence factor disposition,0.6695121951219513
Viral_Disease,establishment of a clinically abnormal colony,0.553448275862069
Viral_Disease,coronavirus disease course,0.732051282051282
Viral_Disease,disposition,0.6166666666666667
Viral_Disease,chronic infectious disease course,0.6456521739130434
Viral_Disease,acute infectious disease course,0.6545454545454545
Viral_Disease,cidal agent disposition,0.6722222222222223
Viral_Disease,incubation end process boundary,0.5863636363636363
Viral_Disease,coronavirus disorder,0.6924242424242425
Viral_Disease,invasion disposition,0.6621212121212122
Viral_Disease,endotoxin disposition,0.6264705882352941
Viral_Disease,primary infection role,0.6214285714285714
Viral_Disease,collective resistance disposition,0.6239130434782608
Viral_Disease,disease course,0.7092592592592593
Viral_Disease,latency end temporal region,0.6
Viral_Disease,virus host,0.6673913043478261
Viral_Disease,viral adhesion disposition,0.7064102564102563
Viral_Disease,transmissibility disposition,0.6451219512195122
Viral_Disease,infection end temporal region,0.5928571428571429
Viral_Disease,community-acquired infection,0.5719512195121951
Viral_Disease,secondary infection,0.575
Viral_Disease,viricidal disposition,0.7441176470588234
Viral_Disease,infection,0.5409090909090909
Viral_Disease,double-stranded RNA virus,0.6078947368421053
Viral_Disease,subclinical infection,0.6264705882352941
Viral_Disease,opportunistic infectious disposition,0.5724489795918367
Viral_Disease,SARS-CoV-2 disorder,0.6375
Viral_Disease,parasitostatic disposition,0.6294871794871795
Viral_Disease,fungistatic disposition,0.6444444444444444
Viral_Disease,communicability end process boundary,0.5928571428571429
Viral_Disease,site of infection,0.5833333333333334
Viral_Disease,viral disease course,0.8439393939393939
Viral_Disease,infectious disease sporadicity,0.6593023255813953
Viral_Disease,virus transcription stage,0.6605263157894737
Viral_Disease,infection start temporal region,0.5863636363636363
Viral_Disease,infection incidence proportion,0.5662790697674418
Viral_Disease,cytotoxin disposition,0.6264705882352941
Viral_Disease,infectious disease pandemic,0.675
Viral_Disease,infectious disorder,0.6375
Viral_Disease,extracellular infection,0.6166666666666667
Viral_Disease,communicability end temporal region,0.6166666666666667
Viral_Disease,infectious disease incidence proportion,0.6230769230769231
Viral_Disease,nursing-home acquired infection,0.5636363636363636
Viral_Disease,negative-sense single-stranded RNA virus,0.6009433962264151
Viral_Disease,infection start process boundary,0.5611111111111111
Viral_Disease,establishment of localization in virus host,0.575
Viral_Disease,reverse zoonotic disposition,0.6207317073170732
Viral_Disease,T cell receptor complex,0.5611111111111111
Viral_Disease,appearance of disorder,0.65
Viral_Disease,subclinical coronavirus infection,0.6021739130434782
Viral_Disease,infectious disease control objective specification,0.5928571428571429
Viral_Disease,infection incidence rate profile,0.5833333333333334
Viral_Disease,viral envelope,0.7462962962962962
Viral_Disease,complex infection,0.5833333333333334
Viral_Disease,viral disease pandemic,0.8214285714285714
Viral_Disease,process of establishing viral infection,0.6038461538461539
Viral_Disease,virus disorder,0.7462962962962962
Viral_Disease,infectious disease incidence rate,0.6456521739130434
Viral_Disease,collective disposition,0.6214285714285714
Viral_Disease,toxin disposition,0.65
Viral_Disease,long-term non-progressing infectious disease course,0.590625
Viral_Disease,bactericidal disposition,0.6662162162162162
Viral_Disease,COVID-19 epidemic,0.6166666666666667
Viral_Disease,bacteriostatic disposition,0.6294871794871795
Viral_Disease,double-stranded DNA virus,0.6078947368421053
Viral_Disease,viral capsid,0.77
Viral_Disease,infectious disposition,0.6214285714285714
Viral_Disease,acute respiratory distress syndrome,0.6583333333333334
Viral_Disease,viral disease,0.95
Viral_Disease,infectious disease epidemic,0.675
Viral_Disease,infectious disease incidence,0.6695121951219513
Viral_Disease,virus attachment stage,0.6785714285714286
Viral_Disease,virus replication,0.65
Viral_Disease,collective pathogenic disposition,0.6021739130434782
Viral_Disease,hospital-acquired infection,0.6
Viral_Disease,simple infection,0.6224137931034482
Viral_Disease,virus generative stage,0.6785714285714286
Viral_Disease,immunosuppressive disposition,0.6166666666666667
Viral_Disease,primary infection,0.6166666666666667
Viral_Disease,SARS-COV-2 adhesion disposition,0.609090909090909
Viral_Disease,virus release stage,0.7
Viral_Disease,COVID-19 disease course,0.7277777777777777
Regional_Rural_Banks,B cell receptor complex,0.5895348837209302
Regional_Rural_Banks,COVID-19 mortality rate,0.6127906976744186
Regional_Rural_Banks,positive-sense single-stranded RNA virus,0.6
Regional_Rural_Banks,GO_0019814,0.55
Regional_Rural_Banks,GO_0051093,0.55
Regional_Rural_Banks,three-dimensional spatial region,0.6807692307692308
Regional_Rural_Banks,communicability start temporal region,0.6429824561403508
Regional_Rural_Banks,GO_0019061,0.55
Regional_Rural_Banks,incubation end temporal region,0.63
Regional_Rural_Banks,infection incidence rate,0.609090909090909
Regional_Rural_Banks,PR_000003622,0.5125
Regional_Rural_Banks,infectious disease mortality rate,0.6386792452830189
Regional_Rural_Banks,GO_0048525,0.55
Regional_Rural_Banks,GO_0019081,0.55
Regional_Rural_Banks,division of geopolitical entity,0.6068627450980393
Regional_Rural_Banks,primary immunodeficiency,0.5863636363636363
Regional_Rural_Banks,GO_0008150,0.55
Regional_Rural_Banks,one-dimensional spatial region,0.67
Regional_Rural_Banks,GO_0019083,0.55
Regional_Rural_Banks,GEO_000000371,0.5409090909090909
Regional_Rural_Banks,GO_0050777,0.55
Regional_Rural_Banks,latency end process boundary,0.5958333333333333
Regional_Rural_Banks,GO_0065007,0.55
Regional_Rural_Banks,local infection,0.5928571428571429
Regional_Rural_Banks,primary infectious disposition,0.59
Regional_Rural_Banks,action specification,0.6
Regional_Rural_Banks,establishment of a clinically abnormal colony,0.6346153846153847
Regional_Rural_Banks,temporal region,0.65
Regional_Rural_Banks,GO_0006959,0.55
Regional_Rural_Banks,reservoir of pathogen role,0.6239130434782608
Regional_Rural_Banks,geospatial region,0.6391891891891892
Regional_Rural_Banks,ribonucleic acid,0.6722222222222223
Regional_Rural_Banks,GO_0006955,0.55
Regional_Rural_Banks,incubation end process boundary,0.6068627450980393
Regional_Rural_Banks,GO_0044409,0.55
Regional_Rural_Banks,GO_0002443,0.55
Regional_Rural_Banks,GO_0032502,0.55
Regional_Rural_Banks,primary infection role,0.6404761904761905
Regional_Rural_Banks,GO_0019062,0.55
Regional_Rural_Banks,GO_0032991,0.55
Regional_Rural_Banks,latency end temporal region,0.6202127659574468
Regional_Rural_Banks,Country,0.5611111111111111
Regional_Rural_Banks,GO_0045087,0.55
Regional_Rural_Banks,infection end temporal region,0.6540816326530612
Regional_Rural_Banks,GO_19076,0.5571428571428572
Regional_Rural_Banks,nucleic acid,0.60625
Regional_Rural_Banks,double-stranded RNA virus,0.6277777777777778
Regional_Rural_Banks,GO_0019028,0.55
Regional_Rural_Banks,GO_0046718,0.55
Regional_Rural_Banks,GO_0019031,0.55
Regional_Rural_Banks,two-dimensional spatial region,0.67
Regional_Rural_Banks,zero-dimensional spatial region,0.6852941176470588
Regional_Rural_Banks,GO_0048519,0.55
Regional_Rural_Banks,GO_0046727,0.55
Regional_Rural_Banks,SARS-CoV-2 incidence rate,0.5833333333333334
Regional_Rural_Banks,GO_0044403,0.55
Regional_Rural_Banks,active immunization against infectious agent,0.60625
Regional_Rural_Banks,GO_0051234,0.55
Regional_Rural_Banks,communicability end process boundary,0.6107142857142857
Regional_Rural_Banks,geographical entity,0.6294871794871795
Regional_Rural_Banks,infection start temporal region,0.6656862745098039
Regional_Rural_Banks,single-stranded RNA retrovirus,0.61
Regional_Rural_Banks,pathogen birth temporal region,0.63
Regional_Rural_Banks,GO_0002250,0.55
Regional_Rural_Banks,communicability end temporal region,0.6318181818181818
Regional_Rural_Banks,negative-sense single-stranded RNA virus,0.6166666666666667
Regional_Rural_Banks,T cell receptor complex,0.5895348837209302
Regional_Rural_Banks,GEO_000000370,0.5409090909090909
Regional_Rural_Banks,CL_0000000,0.5166666666666666
Regional_Rural_Banks,pathogen death temporal region,0.63
Regional_Rural_Banks,zero-dimensional temporal region,0.7
Regional_Rural_Banks,country,0.5611111111111111
Regional_Rural_Banks,GO_0019068,0.55
Regional_Rural_Banks,infection incidence rate profile,0.6038461538461539
Regional_Rural_Banks,infectious agent reservoir,0.6239130434782608
Regional_Rural_Banks,deoxyribonucleic acid,0.6451219512195122
Regional_Rural_Banks,COVID-19 incidence rate,0.5662790697674418
Regional_Rural_Banks,geographical feature,0.65
Regional_Rural_Banks,GO_0042101,0.55
Regional_Rural_Banks,infectious disease incidence rate,0.5820754716981132
Regional_Rural_Banks,geographical region,0.6551282051282051
Regional_Rural_Banks,GEO_000000372,0.5409090909090909
Regional_Rural_Banks,GO_0044411,0.55
Regional_Rural_Banks,spatial region,0.6264705882352941
Regional_Rural_Banks,primary pathogen,0.6444444444444444
Regional_Rural_Banks,simple infection,0.5611111111111111
Regional_Rural_Banks,GO_0019815,0.55
Regional_Rural_Banks,primary infection,0.6121621621621621
Regional_Rural_Banks,GO_0044406,0.55
Regional_Rural_Banks,one-dimensional temporal region,0.6852941176470588
Regional_Rural_Banks,spatiotemporal region,0.6207317073170732
SalaryAccount,establishment of a clinically abnormal colony,0.6051724137931035
SalaryAccount,T cell receptor complex,0.5888888888888889
Close_Contact,B cell receptor complex,0.6166666666666667
Close_Contact,ERO_0000347,0.5333333333333333
Close_Contact,GO_0019814,0.5369565217391304
Close_Contact,GO_0051093,0.5369565217391304
Close_Contact,GO_0019061,0.5369565217391304
Close_Contact,incubation end temporal region,0.5895348837209302
Close_Contact,infectious disease course,0.6342105263157894
Close_Contact,pathogen portal of entry role,0.6166666666666667
Close_Contact,GO_0048525,0.5369565217391304
Close_Contact,GO_0019081,0.5369565217391304
Close_Contact,pathogen portal of entry site,0.6166666666666667
Close_Contact,contact pathogen transmission process,0.61
Close_Contact,ERO_0000008,0.5333333333333333
Close_Contact,GO_0008150,0.5369565217391304
Close_Contact,GO_0019083,0.5369565217391304
Close_Contact,respiratory system disease,0.5782051282051281
Close_Contact,GEO_000000371,0.5269230769230769
Close_Contact,GO_0050777,0.5369565217391304
Close_Contact,latency end process boundary,0.6207317073170732
Close_Contact,GO_0065007,0.5369565217391304
Close_Contact,systematic infection,0.6318181818181818
Close_Contact,action specification,0.6621212121212122
Close_Contact,establishment of a clinically abnormal colony,0.5879310344827586
Close_Contact,coronavirus disease course,0.6294871794871795
Close_Contact,GO_0006959,0.5369565217391304
Close_Contact,chronic infectious disease course,0.6021739130434782
Close_Contact,acute infectious disease course,0.609090909090909
Close_Contact,GO_0006955,0.5369565217391304
Close_Contact,ERO_0001362,0.5333333333333333
Close_Contact,incubation end process boundary,0.6318181818181818
Close_Contact,GO_0044409,0.5369565217391304
Close_Contact,GO_0002443,0.5369565217391304
Close_Contact,GO_0032502,0.5369565217391304
Close_Contact,GO_0019062,0.5369565217391304
Close_Contact,GO_0032991,0.5369565217391304
Close_Contact,disease course,0.6351851851851852
Close_Contact,latency end temporal region,0.6
Close_Contact,GO_0045087,0.5369565217391304
Close_Contact,infection end temporal region,0.5928571428571429
Close_Contact,GO_19076,0.5452380952380953
Close_Contact,polymerase chain reaction,0.6868421052631578
Close_Contact,GO_0019028,0.5369565217391304
Close_Contact,GO_0046718,0.5369565217391304
Close_Contact,entry into host through host barriers,0.57
Close_Contact,GO_0019031,0.5369565217391304
Close_Contact,GO_0048519,0.5369565217391304
Close_Contact,GO_0046727,0.5369565217391304
Close_Contact,ERO_0000671,0.5333333333333333
Close_Contact,GO_0044403,0.5369565217391304
Close_Contact,GO_0051234,0.5369565217391304
Close_Contact,communicability end process boundary,0.6132653061224489
Close_Contact,viral disease course,0.6318181818181818
Close_Contact,pathogen portal of entry,0.6391891891891892
Close_Contact,ERO_0000006,0.5333333333333333
Close_Contact,GO_0002250,0.5369565217391304
Close_Contact,communicability end temporal region,0.575
Close_Contact,T cell receptor complex,0.6166666666666667
Close_Contact,GEO_000000370,0.5269230769230769
Close_Contact,CL_0000000,0.5804347826086956
Close_Contact,ERO_0000337,0.5333333333333333
Close_Contact,contact tracing,0.7
Close_Contact,GO_0019068,0.5369565217391304
Close_Contact,GO_0042101,0.5369565217391304
Close_Contact,long-term non-progressing infectious disease course,0.590625
Close_Contact,GEO_000000372,0.5269230769230769
Close_Contact,GO_0044411,0.5369565217391304
Close_Contact,GO_0019815,0.5369565217391304
Close_Contact,entry into host,0.6285714285714286
Close_Contact,COVID-19 disease course,0.6444444444444444
Close_Contact,GO_0044406,0.5369565217391304
PartnershipCurrentAccount,establishment of a clinically abnormal colony,0.6071428571428572
PartnershipCurrentAccount,T cell receptor complex,0.6166666666666667
R8SnIhN7DlXnUHHZGIRbFe4,B cell receptor complex,0.5152173913043478
Severe_COVID-19,B cell receptor complex,0.6078947368421053
Severe_COVID-19,COVID-19 disease incidence proportion,0.6038461538461539
Severe_COVID-19,COVID-19 mortality rate,0.6605263157894737
Severe_COVID-19,ERO_0000347,0.5653846153846154
Severe_COVID-19,GO_0019814,0.57
Severe_COVID-19,GO_0051093,0.57
Severe_COVID-19,GO_0019061,0.57
Severe_COVID-19,incubation end temporal region,0.5611111111111111
Severe_COVID-19,epitope site,0.5981481481481481
Severe_COVID-19,COVID-19 pandemic,0.7
Severe_COVID-19,infection incidence rate,0.5782051282051281
Severe_COVID-19,PR_000003622,0.524074074074074
Severe_COVID-19,infectious disease mortality rate,0.575
Severe_COVID-19,GO_0019081,0.57
Severe_COVID-19,pathogen portal of entry site,0.5636363636363636
Severe_COVID-19,COVID-19,0.7978260869565217
Severe_COVID-19,COVID-19 incidence,0.6924242424242425
Severe_COVID-19,ERO_0000008,0.5653846153846154
Severe_COVID-19,GO_0008150,0.53
Severe_COVID-19,GO_0019083,0.57
Severe_COVID-19,respiratory system disease,0.5719512195121951
Severe_COVID-19,latency end process boundary,0.6127906976744186
Severe_COVID-19,COVID-19 sporadicity,0.6785714285714286
Severe_COVID-19,COVID-19 endemicity,0.6852941176470588
Severe_COVID-19,systematic infection,0.5928571428571429
Severe_COVID-19,source of infection site,0.6294871794871795
Severe_COVID-19,acute infection,0.5833333333333334
Severe_COVID-19,site,0.5552631578947369
Severe_COVID-19,establishment of a clinically abnormal colony,0.55
Severe_COVID-19,GO_0006959,0.53
Severe_COVID-19,acute infectious disease course,0.5804347826086956
Severe_COVID-19,GO_0006955,0.53
Severe_COVID-19,ERO_0001362,0.6038461538461539
Severe_COVID-19,incubation end process boundary,0.5804347826086956
Severe_COVID-19,GO_0044409,0.53
Severe_COVID-19,GO_0019062,0.57
Severe_COVID-19,pathogen portal of exit site,0.5662790697674418
Severe_COVID-19,GO_0032991,0.53
Severe_COVID-19,latency end temporal region,0.569047619047619
Severe_COVID-19,infection end temporal region,0.5636363636363636
Severe_COVID-19,GO_19076,0.5804347826086956
Severe_COVID-19,GO_0019028,0.57
Severe_COVID-19,GO_0046718,0.53
Severe_COVID-19,GO_0019031,0.57
Severe_COVID-19,GO_0048519,0.57
Severe_COVID-19,ERO_0000671,0.6038461538461539
Severe_COVID-19,SARS-CoV-2 incidence rate,0.625
Severe_COVID-19,GO_0051234,0.53
Severe_COVID-19,communicability end process boundary,0.5676470588235294
Severe_COVID-19,site of infection,0.60625
Severe_COVID-19,COVID-19 prevalence,0.6852941176470588
Severe_COVID-19,COVID-19 lifetime prevalence,0.636046511627907
Severe_COVID-19,ERO_0000006,0.5653846153846154
Severe_COVID-19,communicability end temporal region,0.55
Severe_COVID-19,T cell receptor complex,0.6078947368421053
Severe_COVID-19,ERO_0000337,0.5653846153846154
Severe_COVID-19,GO_0019068,0.57
Severe_COVID-19,infection incidence rate profile,0.598936170212766
Severe_COVID-19,COVID-19 incidence rate,0.6605263157894737
Severe_COVID-19,GO_0042101,0.53
Severe_COVID-19,infectious disease incidence rate,0.5958333333333333
Severe_COVID-19,COVID-19 epidemic,0.7
Severe_COVID-19,acute respiratory distress syndrome,0.57
Severe_COVID-19,GO_0044411,0.53
Severe_COVID-19,simple infection,0.6112903225806451
Severe_COVID-19,GO_0019815,0.57
Severe_COVID-19,COVID-19 disease course,0.6605263157894737
Profit,B cell receptor complex,0.553448275862069
Profit,COVID-19 mortality rate,0.553448275862069
Profit,GO_0019814,0.5125
Profit,object aggregate,0.5409090909090909
Profit,GO_0051093,0.5125
Profit,coronavirus aggregate,0.5981481481481481
Profit,GO_0019061,0.5125
Profit,incubation end temporal region,0.5333333333333333
Profit,infection incidence rate,0.55
Profit,PR_000003622,0.5611111111111111
Profit,infectious structure aggregate,0.5333333333333333
Profit,infectious disease mortality rate,0.5269230769230769
Profit,GO_0048525,0.5125
Profit,GO_0019081,0.5125
Profit,virus aggregate,0.5452380952380953
Profit,GO_0008150,0.5125
Profit,viral load,0.575
Profit,GO_0019083,0.5125
Profit,GO_0050777,0.5125
Profit,latency end process boundary,0.5382352941176471
Profit,GO_0065007,0.5125
Profit,SARS-CoV-2 aggregate,0.5653846153846154
Profit,acellular structure aggregate,0.5071428571428571
Profit,establishment of a clinically abnormal colony,0.5088235294117647
Profit,GO_0006959,0.5125
Profit,GO_0006955,0.5125
Profit,incubation end process boundary,0.5310810810810811
Profit,GO_0044409,0.5125
Profit,GO_0002443,0.5125
Profit,GO_0032502,0.5125
Profit,GO_0019062,0.5125
Profit,PCR product,0.6852941176470588
Profit,GO_0032991,0.5125
Profit,latency end temporal region,0.5409090909090909
Profit,GO_0045087,0.5125
Profit,infection end temporal region,0.5357142857142857
Profit,GO_19076,0.5214285714285714
Profit,GO_0019028,0.5125
Profit,GO_0046718,0.5125
Profit,GO_0019031,0.5125
Profit,production,0.7
Profit,GO_0048519,0.5125
Profit,GO_0046727,0.5125
Profit,SARS-CoV-2 incidence rate,0.5790322580645162
Profit,GO_0044403,0.5125
Profit,GO_0051234,0.5125
Profit,communicability end process boundary,0.5214285714285714
Profit,viroid aggregate,0.6318181818181818
Profit,GO_0002250,0.5125
Profit,communicability end temporal region,0.523170731707317
Profit,T cell receptor complex,0.553448275862069
Profit,GO_0019068,0.5125
Profit,infection incidence rate profile,0.581578947368421
Profit,COVID-19 incidence rate,0.553448275862069
Profit,GO_0042101,0.5125
Profit,infectious disease incidence rate,0.5269230769230769
Profit,prion aggregate,0.6404761904761905
Profit,GO_0044411,0.5125
Profit,GO_0019815,0.5125
Profit,GO_0044406,0.5125
Profit,negative regulation of production,0.5525641025641026
COVID-19 dedicated facility,B cell receptor complex,0.61
COVID-19 dedicated facility,COVID-19 disease incidence proportion,0.715625
COVID-19 dedicated facility,COVID-19 mortality rate,0.75
COVID-19 dedicated facility,hospital facility,0.7227272727272727
COVID-19 dedicated facility,GO_0019814,0.5310810810810811
COVID-19 dedicated facility,GO_0051093,0.5310810810810811
COVID-19 dedicated facility,source of infection role,0.6068627450980393
COVID-19 dedicated facility,GO_0019061,0.5310810810810811
COVID-19 dedicated facility,incubation end temporal region,0.6254385964912281
COVID-19 dedicated facility,COVID-19 pandemic,0.7454545454545455
COVID-19 dedicated facility,virus adhesion susceptible cell,0.656896551724138
COVID-19 dedicated facility,source of infection,0.6021739130434782
COVID-19 dedicated facility,infection incidence rate,0.6460784313725491
COVID-19 dedicated facility,infectious disease mortality rate,0.6666666666666667
COVID-19 dedicated facility,GO_0048525,0.504054054054054
COVID-19 dedicated facility,GO_0019081,0.5310810810810811
COVID-19 dedicated facility,facility,0.6785714285714286
COVID-19 dedicated facility,COVID-19,0.6785714285714286
COVID-19 dedicated facility,COVID-19 incidence,0.7388888888888888
COVID-19 dedicated facility,GO_0008150,0.504054054054054
COVID-19 dedicated facility,processed material,0.6277777777777778
COVID-19 dedicated facility,GO_0019083,0.5310810810810811
COVID-19 dedicated facility,GO_0050777,0.504054054054054
COVID-19 dedicated facility,latency end process boundary,0.6136363636363636
COVID-19 dedicated facility,COVID-19 sporadicity,0.7691489361702127
COVID-19 dedicated facility,GO_0065007,0.504054054054054
COVID-19 dedicated facility,COVID-19 endemicity,0.7978260869565217
COVID-19 dedicated facility,source of infection site,0.6264705882352941
COVID-19 dedicated facility,establishment of a clinically abnormal colony,0.5888888888888889
COVID-19 dedicated facility,GO_0006959,0.504054054054054
COVID-19 dedicated facility,cell,0.5467741935483871
COVID-19 dedicated facility,GO_0006955,0.504054054054054
COVID-19 dedicated facility,incubation end process boundary,0.6224137931034482
COVID-19 dedicated facility,GO_0044409,0.504054054054054
COVID-19 dedicated facility,GO_0002443,0.504054054054054
COVID-19 dedicated facility,GO_0032502,0.504054054054054
COVID-19 dedicated facility,GO_0019062,0.5310810810810811
COVID-19 dedicated facility,material entity,0.6404761904761905
COVID-19 dedicated facility,GO_0032991,0.504054054054054
COVID-19 dedicated facility,latency end temporal region,0.6166666666666667
COVID-19 dedicated facility,GO_0045087,0.504054054054054
COVID-19 dedicated facility,infection end temporal region,0.6285714285714286
COVID-19 dedicated facility,material processing,0.5804347826086956
COVID-19 dedicated facility,GO_19076,0.5357142857142857
COVID-19 dedicated facility,GO_0019028,0.5310810810810811
COVID-19 dedicated facility,GO_0046718,0.504054054054054
COVID-19 dedicated facility,GO_0019031,0.5310810810810811
COVID-19 dedicated facility,GO_0048519,0.5310810810810811
COVID-19 dedicated facility,GO_0046727,0.504054054054054
COVID-19 dedicated facility,SARS-CoV-2 incidence rate,0.6807692307692308
COVID-19 dedicated facility,quality,0.5970588235294118
COVID-19 dedicated facility,GO_0044403,0.504054054054054
COVID-19 dedicated facility,active immunization against infectious agent,0.6049295774647887
COVID-19 dedicated facility,GO_0051234,0.504054054054054
COVID-19 dedicated facility,communicability end process boundary,0.6246031746031746
COVID-19 dedicated facility,cell space,0.5851351351351352
COVID-19 dedicated facility,COVID-19 prevalence,0.7326086956521739
COVID-19 dedicated facility,COVID-19 lifetime prevalence,0.7227272727272727
COVID-19 dedicated facility,GO_0002250,0.504054054054054
COVID-19 dedicated facility,communicability end temporal region,0.6435483870967742
COVID-19 dedicated facility,T cell receptor complex,0.61
COVID-19 dedicated facility,CL_0000000,0.504054054054054
COVID-19 dedicated facility,GO_0019068,0.5310810810810811
COVID-19 dedicated facility,infection incidence rate profile,0.6703389830508475
COVID-19 dedicated facility,COVID-19 incidence rate,0.77
COVID-19 dedicated facility,GO_0042101,0.504054054054054
COVID-19 dedicated facility,infectious disease incidence rate,0.6333333333333333
COVID-19 dedicated facility,SARS-COV-2 adhesion susceptible cell,0.6722222222222223
COVID-19 dedicated facility,COVID-19 epidemic,0.7454545454545455
COVID-19 dedicated facility,GO_0044411,0.504054054054054
COVID-19 dedicated facility,GO_0019815,0.5310810810810811
COVID-19 dedicated facility,healthcare facility,0.7326086956521739
COVID-19 dedicated facility,COVID-19 disease course,0.75
COVID-19 dedicated facility,GO_0044406,0.504054054054054
R7XBnVsDnaC0Py9h4dBPM13,B cell receptor complex,0.5369565217391304
R7XBnVsDnaC0Py9h4dBPM13,double-stranded DNA,0.569047619047619
R7XBnVsDnaC0Py9h4dBPM13,single-stranded DNA virus,0.5541666666666667
R7XBnVsDnaC0Py9h4dBPM13,establishment of a clinically abnormal colony,0.5676470588235294
R7XBnVsDnaC0Py9h4dBPM13,double-stranded DNA retrovirus,0.5443396226415094
R7XBnVsDnaC0Py9h4dBPM13,double-stranded DNA virus,0.5541666666666667
Security_Guard,B cell receptor complex,0.5581081081081081
Security_Guard,ERO_0000347,0.57
Security_Guard,innate immunity to infectious agent,0.6132653061224489
Security_Guard,OBI_0000237,0.53
Security_Guard,incubation end temporal region,0.5863636363636363
Security_Guard,OBI_0000406,0.53
Security_Guard,OBI_0000094,0.53
Security_Guard,pathogen portal of entry role,0.5895348837209302
Security_Guard,disease surveillance objective specification,0.5879310344827586
Security_Guard,PR_000003622,0.5269230769230769
Security_Guard,passive immunity to infectious agent,0.63
Security_Guard,pathogen portal of entry site,0.5662790697674418
Security_Guard,ERO_0000008,0.57
Security_Guard,viral load,0.6166666666666667
Security_Guard,double-stranded DNA,0.5712121212121213
Security_Guard,surveillance process,0.6264705882352941
Security_Guard,processed material,0.60625
Security_Guard,latency end process boundary,0.6166666666666667
Security_Guard,OBI_1110034,0.53
Security_Guard,OBI_0000552,0.53
Security_Guard,OBI_1110001,0.53
Security_Guard,lower respiratory tract disease,0.6277777777777778
Security_Guard,single-stranded DNA virus,0.6038461538461539
Security_Guard,establishment of a clinically abnormal colony,0.5855932203389831
Security_Guard,leukocyte-mediated immunity to infectious agent,0.5975409836065574
Security_Guard,OBI_0000415,0.53
Security_Guard,ERO_0001362,0.57
Security_Guard,incubation end process boundary,0.6055555555555556
Security_Guard,material entity,0.6224137931034482
Security_Guard,pathogen surveillance,0.5928571428571429
Security_Guard,immunity to pathogen,0.6264705882352941
Security_Guard,leukocyte mediated immunity,0.5963414634146341
Security_Guard,latency end temporal region,0.5963414634146341
Security_Guard,infection end temporal region,0.5895348837209302
Security_Guard,material processing,0.6015151515151516
Security_Guard,entry into host through host barriers,0.6068627450980393
Security_Guard,OBI_0000011,0.53
Security_Guard,ERO_0000671,0.57
Security_Guard,communicability end process boundary,0.63
Security_Guard,OBI_0000070,0.53
Security_Guard,OBI_0100026,0.53
Security_Guard,pathogen portal of entry,0.581578947368421
Security_Guard,OBI_0600058,0.53
Security_Guard,ERO_0000006,0.57
Security_Guard,communicability end temporal region,0.6132653061224489
Security_Guard,T cell receptor complex,0.5581081081081081
Security_Guard,OBI_0000047,0.53
Security_Guard,ERO_0000337,0.57
Security_Guard,vector surveillance,0.6318181818181818
Security_Guard,double-stranded DNA retrovirus,0.5636363636363636
Security_Guard,herd immunity to infectious organism,0.61
Security_Guard,sterilizing immunity to infectious agent,0.6166666666666667
Security_Guard,double-stranded DNA virus,0.5782051282051281
Security_Guard,OBI_0000086,0.53
Security_Guard,entry into host,0.6224137931034482
Security_Guard,acquired immunity to infectious agent,0.6264705882352941
Security_Guard,humoral immunity to infectious agent,0.61
Education,B cell receptor complex,0.575
Education,GO_0019814,0.5026315789473684
Education,GO_0051093,0.5026315789473684
Education,biological regulation,0.6833333333333332
Education,information content entity,0.5928571428571429
Education,GO_0019061,0.5026315789473684
Education,negative regulation of viral process,0.6055555555555556
Education,GO_0048525,0.5026315789473684
Education,GO_0019081,0.5026315789473684
Education,descriptive information content entity,0.598936170212766
Education,GO_0008150,0.5026315789473684
Education,negative regulation of biological process,0.59
Education,GO_0019083,0.5026315789473684
Education,GO_0050777,0.5026315789473684
Education,GO_0065007,0.5026315789473684
Education,negative regulation of life-sustaining process,0.5772727272727273
Education,infectious disease control strategy,0.5863636363636363
Education,designative information content entity,0.5776595744680851
Education,negative regulation of developmental process,0.5820754716981132
Education,negative regulation of establishment of localization,0.5811475409836065
Education,action specification,0.6913793103448276
Education,establishment of a clinically abnormal colony,0.5611111111111111
Education,GO_0006959,0.5026315789473684
Education,history,0.575
Education,GO_0006955,0.5026315789473684
Education,GO_0044409,0.5026315789473684
Education,GO_0002443,0.5026315789473684
Education,GO_0032502,0.5026315789473684
Education,GO_0019062,0.5026315789473684
Education,GO_0032991,0.5026315789473684
Education,GO_0045087,0.5026315789473684
Education,GO_19076,0.5088235294117647
Education,negative regulation of replication,0.636046511627907
Education,quarantine control strategy,0.6166666666666667
Education,GO_0019028,0.5026315789473684
Education,GO_0046718,0.5026315789473684
Education,GO_0019031,0.5026315789473684
Education,GO_0048519,0.5026315789473684
Education,GO_0046727,0.5026315789473684
Education,place closure control strategy,0.5782051282051281
Education,GO_0044403,0.5026315789473684
Education,GO_0051234,0.5026315789473684
Education,negative regulation of immune response,0.598936170212766
Education,vector control strategy,0.60625
Education,GO_0002250,0.5026315789473684
Education,case isolation control strategy,0.6
Education,T cell receptor complex,0.575
Education,infectious disease control objective specification,0.5855932203389831
Education,GO_0019068,0.5026315789473684
Education,GO_0042101,0.5026315789473684
Education,GO_0044411,0.5026315789473684
Education,GO_0019815,0.5026315789473684
Education,directive information content entity,0.6055555555555556
Education,GO_0044406,0.5026315789473684
Education,negative regulation of production,0.6404761904761905
Anniversary,B cell receptor complex,0.5382352941176471
Anniversary,positive-sense single-stranded RNA virus,0.5676470588235294
Anniversary,incubation end temporal region,0.6207317073170732
Anniversary,latency end process boundary,0.6551282051282051
Anniversary,pathogen birth process boundary,0.6404761904761905
Anniversary,establishment of a clinically abnormal colony,0.575
Anniversary,CARO_0000062,0.5369565217391304
Anniversary,incubation end process boundary,0.6404761904761905
Anniversary,CARO_0000000,0.5369565217391304
Anniversary,latency end temporal region,0.6342105263157894
Anniversary,infection end temporal region,0.6
Anniversary,double-stranded RNA virus,0.6166666666666667
Anniversary,communicability end process boundary,0.6202127659574468
Anniversary,single-stranded RNA retrovirus,0.5963414634146341
Anniversary,CARO_0000005,0.5369565217391304
Anniversary,pathogen birth temporal region,0.6207317073170732
Anniversary,communicability end temporal region,0.5804347826086956
Anniversary,negative-sense single-stranded RNA virus,0.5872549019607843
Anniversary,T cell receptor complex,0.5382352941176471
Recurring,B cell receptor complex,0.575
Recurring,COVID-19 mortality rate,0.54375
Recurring,ERO_0000347,0.55
Recurring,positive-sense single-stranded RNA virus,0.5316326530612244
Recurring,GO_0019814,0.5026315789473684
Recurring,GO_0051093,0.5026315789473684
Recurring,GO_0019061,0.5026315789473684
Recurring,incubation end temporal region,0.6038461538461539
Recurring,infection incidence rate,0.5712121212121213
Recurring,infectious disease mortality rate,0.569047619047619
Recurring,GO_0048525,0.5026315789473684
Recurring,GO_0019081,0.5026315789473684
Recurring,ERO_0000008,0.55
Recurring,GO_0008150,0.5026315789473684
Recurring,GO_0019083,0.5026315789473684
Recurring,GO_0050777,0.5026315789473684
Recurring,latency end process boundary,0.5581081081081081
Recurring,GO_0065007,0.5026315789473684
Recurring,lower respiratory tract disease,0.575
Recurring,establishment of a clinically abnormal colony,0.524074074074074
Recurring,GO_0006959,0.5026315789473684
Recurring,GO_0006955,0.5026315789473684
Recurring,ERO_0001362,0.55
Recurring,incubation end process boundary,0.55
Recurring,GO_0044409,0.5026315789473684
Recurring,GO_0002443,0.5026315789473684
Recurring,GO_0032502,0.5026315789473684
Recurring,GO_0019062,0.5026315789473684
Recurring,GO_0032991,0.5026315789473684
Recurring,latency end temporal region,0.6166666666666667
Recurring,GO_0045087,0.5026315789473684
Recurring,infection end temporal region,0.6078947368421053
Recurring,GO_19076,0.5088235294117647
Recurring,polymerase chain reaction,0.6264705882352941
Recurring,double-stranded RNA virus,0.5676470588235294
Recurring,GO_0019028,0.5026315789473684
Recurring,GO_0046718,0.5026315789473684
Recurring,GO_0019031,0.5026315789473684
Recurring,GO_0048519,0.5026315789473684
Recurring,GO_0046727,0.5026315789473684
Recurring,place closure control strategy,0.6038461538461539
Recurring,ERO_0000671,0.55
Recurring,SARS-CoV-2 incidence rate,0.5676470588235294
Recurring,GO_0044403,0.5026315789473684
Recurring,GO_0051234,0.5026315789473684
Recurring,communicability end process boundary,0.5388888888888889
Recurring,single-stranded RNA retrovirus,0.5782051282051281
Recurring,ERO_0000006,0.55
Recurring,GO_0002250,0.5026315789473684
Recurring,communicability end temporal region,0.5863636363636363
Recurring,negative-sense single-stranded RNA virus,0.5316326530612244
Recurring,T cell receptor complex,0.575
Recurring,CL_0000000,0.5026315789473684
Recurring,ERO_0000337,0.55
Recurring,GO_0019068,0.5026315789473684
Recurring,infection incidence rate profile,0.5719512195121951
Recurring,COVID-19 incidence rate,0.54375
Recurring,GO_0042101,0.5026315789473684
Recurring,infectious disease incidence rate,0.569047619047619
Recurring,GO_0044411,0.5026315789473684
Recurring,GO_0019815,0.5026315789473684
Recurring,GO_0044406,0.5026315789473684
ETB,B cell receptor complex,0.5269230769230769
ETB,T cell receptor complex,0.5269230769230769
Exposure_to_Covid_-19,B cell receptor complex,0.6318181818181818
Exposure_to_Covid_-19,incubation end temporal region,0.5872549019607843
Exposure_to_Covid_-19,susceptibility to infectious agent,0.6318181818181818
Exposure_to_Covid_-19,PR_000003622,0.5409090909090909
Exposure_to_Covid_-19,drug susceptibility of infectious agent,0.6
Exposure_to_Covid_-19,latency end process boundary,0.5928571428571429
Exposure_to_Covid_-19,susceptibility,0.5928571428571429
Exposure_to_Covid_-19,establishment of a clinically abnormal colony,0.5863636363636363
Exposure_to_Covid_-19,incubation end process boundary,0.5846153846153846
Exposure_to_Covid_-19,latency end temporal region,0.5958333333333333
Exposure_to_Covid_-19,infection end temporal region,0.61
Exposure_to_Covid_-19,drug susceptibility,0.575
Exposure_to_Covid_-19,place closure control strategy,0.6460784313725491
Exposure_to_Covid_-19,communicability end process boundary,0.5903508771929825
Exposure_to_Covid_-19,communicability end temporal region,0.5928571428571429
Exposure_to_Covid_-19,T cell receptor complex,0.6318181818181818
Exposure_to_Covid_-19,CL_0000000,0.5145161290322581
Non_Scheduled_Banks,B cell receptor complex,0.5928571428571429
Non_Scheduled_Banks,GO_0019814,0.5189655172413793
Non_Scheduled_Banks,GO_0051093,0.5189655172413793
Non_Scheduled_Banks,GO_0019061,0.5189655172413793
Non_Scheduled_Banks,incubation end temporal region,0.6336734693877552
Non_Scheduled_Banks,infectious disease course,0.6318181818181818
Non_Scheduled_Banks,obligatory symbiont,0.581578947368421
Non_Scheduled_Banks,epitope site,0.5790322580645162
Non_Scheduled_Banks,GO_0048525,0.5189655172413793
Non_Scheduled_Banks,GO_0019081,0.5189655172413793
Non_Scheduled_Banks,pathogen portal of entry site,0.5958333333333333
Non_Scheduled_Banks,GO_0008150,0.5189655172413793
Non_Scheduled_Banks,GO_0019083,0.5189655172413793
Non_Scheduled_Banks,GO_0050777,0.5189655172413793
Non_Scheduled_Banks,latency end process boundary,0.6202127659574468
Non_Scheduled_Banks,GO_0065007,0.5189655172413793
Non_Scheduled_Banks,source of infection site,0.5895348837209302
Non_Scheduled_Banks,site,0.5369565217391304
Non_Scheduled_Banks,establishment of a clinically abnormal colony,0.590625
Non_Scheduled_Banks,coronavirus disease course,0.6277777777777778
Non_Scheduled_Banks,GO_0006959,0.5189655172413793
Non_Scheduled_Banks,chronic infectious disease course,0.6038461538461539
Non_Scheduled_Banks,reservoir of pathogen role,0.5833333333333334
Non_Scheduled_Banks,planned process,0.6264705882352941
Non_Scheduled_Banks,acute infectious disease course,0.61
Non_Scheduled_Banks,GO_0006955,0.5189655172413793
Non_Scheduled_Banks,incubation end process boundary,0.65
Non_Scheduled_Banks,GO_0044409,0.5189655172413793
Non_Scheduled_Banks,GO_0002443,0.5189655172413793
Non_Scheduled_Banks,GO_0032502,0.5189655172413793
Non_Scheduled_Banks,GO_0019062,0.5189655172413793
Non_Scheduled_Banks,pathogen portal of exit site,0.598936170212766
Non_Scheduled_Banks,GO_0032991,0.5189655172413793
Non_Scheduled_Banks,disease course,0.6015151515151516
Non_Scheduled_Banks,latency end temporal region,0.6021739130434782
Non_Scheduled_Banks,GO_0045087,0.5189655172413793
Non_Scheduled_Banks,plan specification,0.6121621621621621
Non_Scheduled_Banks,infection end temporal region,0.6375
Non_Scheduled_Banks,GO_19076,0.524074074074074
Non_Scheduled_Banks,GO_0019028,0.5189655172413793
Non_Scheduled_Banks,GO_0046718,0.5189655172413793
Non_Scheduled_Banks,GO_0019031,0.5189655172413793
Non_Scheduled_Banks,GO_0048519,0.5189655172413793
Non_Scheduled_Banks,GO_0046727,0.5189655172413793
Non_Scheduled_Banks,GO_0044403,0.5189655172413793
Non_Scheduled_Banks,GO_0051234,0.5189655172413793
Non_Scheduled_Banks,communicability end process boundary,0.6136363636363636
Non_Scheduled_Banks,site of infection,0.5611111111111111
Non_Scheduled_Banks,viral disease course,0.6038461538461539
Non_Scheduled_Banks,GO_0002250,0.5189655172413793
Non_Scheduled_Banks,communicability end temporal region,0.6166666666666667
Non_Scheduled_Banks,T cell receptor complex,0.5928571428571429
Non_Scheduled_Banks,CL_0000000,0.553448275862069
Non_Scheduled_Banks,GO_0019068,0.5189655172413793
Non_Scheduled_Banks,infectious agent reservoir,0.6055555555555556
Non_Scheduled_Banks,GO_0042101,0.5189655172413793
Non_Scheduled_Banks,long-term non-progressing infectious disease course,0.5785714285714285
Non_Scheduled_Banks,GO_0044411,0.5189655172413793
Non_Scheduled_Banks,GO_0019815,0.5189655172413793
Non_Scheduled_Banks,COVID-19 disease course,0.6166666666666667
Non_Scheduled_Banks,GO_0044406,0.5189655172413793
Zone,B cell receptor complex,0.524074074074074
Zone,three-dimensional spatial region,0.5333333333333333
Zone,communicability start temporal region,0.523170731707317
Zone,incubation end temporal region,0.5382352941176471
Zone,infectious disease course,0.5189655172413793
Zone,virus adhesion susceptible cell,0.5357142857142857
Zone,division of geopolitical entity,0.5357142857142857
Zone,one-dimensional spatial region,0.5382352941176471
Zone,GEO_000000371,0.5088235294117647
Zone,local infection,0.6078947368421053
Zone,lower respiratory tract disease,0.5071428571428571
Zone,coronavirus disease course,0.55
Zone,temporal region,0.5552631578947369
Zone,chronic infectious disease course,0.5310810810810811
Zone,cell,0.575
Zone,geospatial region,0.5452380952380953
Zone,acute infectious disease course,0.5071428571428571
Zone,disease course,0.5611111111111111
Zone,latency end temporal region,0.5145161290322581
Zone,infection end temporal region,0.5409090909090909
Zone,two-dimensional spatial region,0.5382352941176471
Zone,zero-dimensional spatial region,0.5642857142857143
Zone,place closure control strategy,0.5382352941176471
Zone,cell space,0.5214285714285714
Zone,viral disease course,0.5333333333333333
Zone,infection start temporal region,0.5357142857142857
Zone,pathogen birth temporal region,0.5382352941176471
Zone,communicability end temporal region,0.5269230769230769
Zone,T cell receptor complex,0.524074074074074
Zone,GEO_000000370,0.5088235294117647
Zone,pathogen death temporal region,0.5382352941176471
Zone,zero-dimensional temporal region,0.5611111111111111
Zone,long-term non-progressing infectious disease course,0.5045454545454545
Zone,SARS-COV-2 adhesion susceptible cell,0.525
Zone,geographical region,0.5369565217391304
Zone,GEO_000000372,0.5088235294117647
Zone,spatial region,0.5611111111111111
Zone,COVID-19 disease course,0.524074074074074
Zone,one-dimensional temporal region,0.5357142857142857
Zone,spatiotemporal region,0.53
State,B cell receptor complex,0.5214285714285714
State,COVID-19 mortality rate,0.5928571428571429
State,incubation end temporal region,0.5357142857142857
State,epitope site,0.6264705882352941
State,infection incidence rate,0.5879310344827586
State,infectious disease mortality rate,0.581578947368421
State,pathogen portal of entry site,0.5676470588235294
State,latency end process boundary,0.5409090909090909
State,source of infection site,0.5879310344827586
State,site,0.7833333333333333
State,establishment of a clinically abnormal colony,0.53
State,incubation end process boundary,0.5333333333333333
State,pathogen portal of exit site,0.5712121212121213
State,latency end temporal region,0.54375
State,infection end temporal region,0.5382352941176471
State,SARS-CoV-2 incidence rate,0.5833333333333334
State,communicability end process boundary,0.523170731707317
State,site of infection,0.5863636363636363
State,communicability end temporal region,0.525
State,case isolation control strategy,0.5888888888888889
State,T cell receptor complex,0.5571428571428572
State,infection incidence rate profile,0.5581081081081081
State,COVID-19 incidence rate,0.5571428571428572
State,infectious disease incidence rate,0.5552631578947369
Gathering,B cell receptor complex,0.5125
Gathering,object aggregate,0.61
Gathering,coronavirus aggregate,0.5833333333333334
Gathering,infectious disease course,0.5382352941176471
Gathering,infectious structure aggregate,0.5525641025641026
Gathering,virus aggregate,0.6166666666666667
Gathering,SARS-CoV-2 aggregate,0.5879310344827586
Gathering,acellular structure aggregate,0.581578947368421
Gathering,action specification,0.6224137931034482
Gathering,establishment of a clinically abnormal colony,0.5425925925925926
Gathering,coronavirus disease course,0.5357142857142857
Gathering,chronic infectious disease course,0.5452380952380953
Gathering,acute infectious disease course,0.575
Gathering,disease course,0.5804347826086956
Gathering,function,0.6264705882352941
Gathering,viroid aggregate,0.61
Gathering,viral disease course,0.553448275862069
Gathering,T cell receptor complex,0.54375
Gathering,herd immunity to infectious organism,0.5833333333333334
Gathering,prion aggregate,0.6166666666666667
Gathering,long-term non-progressing infectious disease course,0.5666666666666667
Gathering,COVID-19 disease course,0.54375
Home,B cell receptor complex,0.5611111111111111
Home,hospital facility,0.5452380952380953
Home,GO_0019814,0.5214285714285714
Home,GO_0051093,0.5214285714285714
Home,communicability start temporal region,0.523170731707317
Home,GO_0019061,0.5214285714285714
Home,epitope site,0.575
Home,latency start process boundary,0.5088235294117647
Home,infectious structure aggregate,0.5088235294117647
Home,GO_0048525,0.5214285714285714
Home,GO_0019081,0.5214285714285714
Home,pathogen portal of entry site,0.5409090909090909
Home,GO_0008150,0.5214285714285714
Home,GO_0019083,0.5214285714285714
Home,GO_0050777,0.5214285714285714
Home,GO_0065007,0.5214285714285714
Home,source of infection site,0.5214285714285714
Home,local infection,0.5552631578947369
Home,communicability start process boundary,0.5214285714285714
Home,site,0.575
Home,symptomatic infectious structure carrier,0.5181818181818182
Home,architectual structure,0.5269230769230769
Home,establishment of a clinically abnormal colony,0.5112244897959184
Home,GO_0006959,0.5214285714285714
Home,GO_0006955,0.5214285714285714
Home,GO_0044409,0.5214285714285714
Home,asymptomatic infectious structure carrier,0.5166666666666666
Home,GO_0002443,0.5214285714285714
Home,GO_0032502,0.5214285714285714
Home,GO_0019062,0.5214285714285714
Home,pathogen portal of exit site,0.54375
Home,GO_0032991,0.5214285714285714
Home,Country,0.5409090909090909
Home,GO_0045087,0.5214285714285714
Home,incubation start process boundary,0.504054054054054
Home,GO_19076,0.5333333333333333
Home,infectious structure host role,0.5382352941176471
Home,double-stranded RNA virus,0.5189655172413793
Home,GO_0019028,0.5214285714285714
Home,GO_0046718,0.5214285714285714
Home,GO_0019031,0.5214285714285714
Home,infectious structure host,0.5189655172413793
Home,GO_0048519,0.5214285714285714
Home,GO_0046727,0.5214285714285714
Home,place closure control strategy,0.5088235294117647
Home,GO_0044403,0.5214285714285714
Home,GO_0051234,0.5214285714285714
Home,site of infection,0.5452380952380953
Home,infection start temporal region,0.5357142857142857
Home,GO_0002250,0.5214285714285714
Home,infection start process boundary,0.5055555555555555
Home,T cell receptor complex,0.5611111111111111
Home,country,0.5409090909090909
Home,GO_0019068,0.5214285714285714
Home,GO_0042101,0.5214285714285714
Home,GO_0044411,0.5214285714285714
Home,GO_0019815,0.5214285714285714
Home,infectious structure,0.5333333333333333
Home,GO_0044406,0.5214285714285714
Personal,B cell receptor complex,0.5790322580645162
Personal,COVID-19 mortality rate,0.5467741935483871
Personal,ERO_0000347,0.6078947368421053
Personal,positive-sense single-stranded RNA virus,0.5541666666666667
Personal,GO_0019814,0.5055555555555555
Personal,GO_0051093,0.5055555555555555
Personal,innate immunity to infectious agent,0.5430232558139535
Personal,GO_0019061,0.5055555555555555
Personal,incubation end temporal region,0.5552631578947369
Personal,normal resident microbiota population,0.5611111111111111
Personal,establishment of localization in human host,0.5480392156862746
Personal,innate immune response,0.6166666666666667
Personal,infection incidence rate,0.575
Personal,PR_000003622,0.55
Personal,infectious disease mortality rate,0.5719512195121951
Personal,GO_0048525,0.5055555555555555
Personal,symptomatic carrier,0.5611111111111111
Personal,GO_0019081,0.5055555555555555
Personal,colonization of human,0.553448275862069
Personal,ERO_0000008,0.6078947368421053
Personal,primary immunodeficiency,0.575
Personal,GO_0008150,0.5055555555555555
Personal,GO_0019083,0.5055555555555555
Personal,GO_0050777,0.5055555555555555
Personal,latency end process boundary,0.6166666666666667
Personal,GO_0065007,0.5055555555555555
Personal,local infection,0.5804347826086956
Personal,primary infectious disposition,0.581578947368421
Personal,symptomatic infectious structure carrier,0.5333333333333333
Personal,establishment of a clinically abnormal colony,0.5632075471698114
Personal,GO_0006959,0.5055555555555555
Personal,GO_0006955,0.5055555555555555
Personal,ERO_0001362,0.6078947368421053
Personal,incubation end process boundary,0.6038461538461539
Personal,GO_0044409,0.5055555555555555
Personal,GO_0002443,0.5055555555555555
Personal,GO_0032502,0.5055555555555555
Personal,primary infection role,0.6166666666666667
Personal,GO_0019062,0.5055555555555555
Personal,GO_0032991,0.5055555555555555
Personal,latency end temporal region,0.5642857142857143
Personal,GO_0045087,0.5055555555555555
Personal,infection end temporal region,0.5851351351351352
Personal,GO_19076,0.5125
Personal,double-stranded RNA virus,0.5712121212121213
Personal,GO_0019028,0.5055555555555555
Personal,GO_0046718,0.5055555555555555
Personal,GO_0019031,0.5055555555555555
Personal,GO_0048519,0.5055555555555555
Personal,symptomatic carrier role,0.60625
Personal,GO_0046727,0.5055555555555555
Personal,ERO_0000671,0.6078947368421053
Personal,SARS-CoV-2 incidence rate,0.6015151515151516
Personal,GO_0044403,0.5055555555555555
Personal,GO_0051234,0.5055555555555555
Personal,communicability end process boundary,0.5863636363636363
Personal,symptom,0.5833333333333334
Personal,single-stranded RNA retrovirus,0.5552631578947369
Personal,ERO_0000006,0.6078947368421053
Personal,GO_0002250,0.5055555555555555
Personal,communicability end temporal region,0.5430232558139535
Personal,symptomatic infectious agent carrier,0.5636363636363636
Personal,negative-sense single-stranded RNA virus,0.5333333333333333
Personal,T cell receptor complex,0.5790322580645162
Personal,CL_0000000,0.5055555555555555
Personal,ERO_0000337,0.6078947368421053
Personal,GO_0019068,0.5055555555555555
Personal,infection incidence rate profile,0.575
Personal,COVID-19 incidence rate,0.5467741935483871
Personal,GO_0042101,0.5055555555555555
Personal,infectious disease incidence rate,0.5475609756097561
Personal,GO_0044411,0.5055555555555555
Personal,primary pathogen,0.6166666666666667
Personal,GO_0019815,0.5055555555555555
Personal,primary infection,0.61
Personal,infectious human pathogen,0.5712121212121213
Personal,GO_0044406,0.5055555555555555
Car,droplet pathogen transmission process,0.5
Car,B cell receptor complex,0.5269230769230769
Car,contact pathogen transmission process,0.525
Car,virus uncoating stage,0.5333333333333333
Car,disease transmission model,0.5189655172413793
Car,pathogen vehicle,0.5026315789473684
Car,generative stage,0.5026315789473684
Car,pathogen generative stage,0.5214285714285714
Car,TRANS_0000008,0.5125
Car,SARS-CoV-2 synthesis stage,0.5189655172413793
Car,SARS-CoV-2 genome replication stage,0.5026315789473684
Car,establishment of a clinically abnormal colony,0.5125
Car,pathogen transmission process,0.5125
Car,transmission interval,0.5333333333333333
Car,indirect pathogen transmission process,0.523170731707317
Car,TRANS_0000002,0.5125
Car,infectious agent generative stage,0.5333333333333333
Car,SARS-CoV-2 penetration stage,0.5145161290322581
Car,SARS-CoV-2 attachment stage,0.5166666666666666
Car,SARS-CoV-2 release stage,0.524074074074074
Car,biological vehicle,0.5452380952380953
Car,virus transcription stage,0.5214285714285714
Car,pathogen vehicle role,0.5333333333333333
Car,TRANS_0000000,0.5125
Car,TRANS_0000007,0.5125
Car,T cell receptor complex,0.5269230769230769
Car,CL_0000000,0.5269230769230769
Car,SARS-CoV-2 uncoating stage,0.5189655172413793
Car,virus attachment stage,0.53
Car,infectious structure generative stage,0.5
Car,biological vehicle role,0.5653846153846154
Car,SARS-CoV-2 transcription stage,0.5409090909090909
TermDeposit,T cell receptor complex,0.6264705882352941
Lending,B cell receptor complex,0.5166666666666666
Lending,incubation end temporal region,0.5851351351351352
Lending,latency end process boundary,0.5928571428571429
Lending,establishment of a clinically abnormal colony,0.5461538461538461
Lending,incubation end process boundary,0.5552631578947369
Lending,latency end temporal region,0.6264705882352941
Lending,infection end temporal region,0.5888888888888889
Lending,communicability end process boundary,0.5662790697674418
Lending,communicability end temporal region,0.5928571428571429
Lending,T cell receptor complex,0.5166666666666666
SecondaryContact,contact pathogen transmission process,0.6386792452830189
SecondaryContact,secondary infection role,0.75
SecondaryContact,establishment of a clinically abnormal colony,0.5975409836065574
SecondaryContact,secondary infection,0.7928571428571428
SecondaryContact,T cell receptor complex,0.6038461538461539
SecondaryContact,contact tracing,0.7080645161290323
Operational,droplet pathogen transmission process,0.6166666666666667
Operational,B cell receptor complex,0.5970588235294118
Operational,COVID-19 mortality rate,0.5970588235294118
Operational,pathogen death process boundary,0.6166666666666667
Operational,process profile,0.6423076923076922
Operational,latency start process boundary,0.5963414634146341
Operational,process of establishing an infection,0.598936170212766
Operational,infection incidence rate,0.6214285714285714
Operational,PR_000003622,0.5369565217391304
Operational,negative regulation of viral process,0.6414893617021277
Operational,infectious disease mortality rate,0.5863636363636363
Operational,contact pathogen transmission process,0.6166666666666667
Operational,surveillance process,0.5467741935483871
Operational,negative regulation of biological process,0.6230769230769231
Operational,latency end process boundary,0.5782051282051281
Operational,negative regulation of life-sustaining process,0.5903508771929825
Operational,process that results in death,0.625
Operational,communicability start process boundary,0.5724489795918367
Operational,pathogen birth process boundary,0.6166666666666667
Operational,negative regulation of developmental process,0.6136363636363636
Operational,establishment of a clinically abnormal colony,0.575
Operational,process boundary,0.6351851851851852
Operational,pathogen transmission process,0.625
Operational,planned process,0.6038461538461539
Operational,incubation end process boundary,0.5928571428571429
Operational,indirect pathogen transmission process,0.5928571428571429
Operational,biological process,0.5879310344827586
Operational,incubation start process boundary,0.5863636363636363
Operational,GO_19076,0.5026315789473684
Operational,function,0.6605263157894737
Operational,developmental process,0.6375
Operational,SARS-CoV-2 incidence rate,0.5888888888888889
Operational,communicability end process boundary,0.5776595744680851
Operational,horizontal pathogen transmission process,0.6068627450980393
Operational,infection start process boundary,0.5895348837209302
Operational,T cell receptor complex,0.5970588235294118
Operational,infection incidence rate profile,0.6127906976744186
Operational,COVID-19 incidence rate,0.5970588235294118
Operational,process,0.6166666666666667
Operational,process of establishing viral infection,0.61
Operational,infectious disease incidence rate,0.5863636363636363
Operational,symbiotic process,0.5928571428571429
PriorityAccount,PR_000003622,0.524074074074074
PriorityAccount,establishment of a clinically abnormal colony,0.5833333333333334
PriorityAccount,T cell receptor complex,0.581578947368421
Credit',T cell receptor complex,0.5833333333333334
InfectedNeighbor,B cell receptor complex,0.5782051282051281
InfectedNeighbor,infected population,0.7357142857142857
InfectedNeighbor,T cell receptor complex,0.5782051282051281
InfectedSister,infected population,0.7227272727272727
InfectedSister,T cell receptor complex,0.5851351351351352
Customer,B cell receptor complex,0.6112903225806451
Customer,incubation end temporal region,0.6078947368421053
Customer,PR_000003622,0.5
Customer,latency end process boundary,0.5611111111111111
Customer,establishment of a clinically abnormal colony,0.5443396226415094
Customer,incubation end process boundary,0.6038461538461539
Customer,latency end temporal region,0.5642857142857143
Customer,infection end temporal region,0.5851351351351352
Customer,communicability end process boundary,0.5863636363636363
Customer,communicability end temporal region,0.5662790697674418
Customer,case isolation control strategy,0.5782051282051281
Customer,T cell receptor complex,0.6112903225806451
Customer,CL_0000000,0.5055555555555555
OnHuman,establishment of localization in human host,0.59
OnHuman,colonization of human,0.7
OnHuman,establishment of a clinically abnormal colony,0.5461538461538461
OnHuman,infectious human pathogen,0.6375
InfectedMother,infected population,0.7530303030303032
InfectedMother,T cell receptor complex,0.5851351351351352
Coronavirus,respiratory droplet virus fomite,0.636046511627907
Coronavirus,positive-sense single-stranded RNA virus,0.6264705882352941
Coronavirus,coronavirus aggregate,0.79375
Coronavirus,virus adhesion susceptible cell,0.569047619047619
Coronavirus,disordered virus,0.7092592592592593
Coronavirus,subclinical virus infection,0.6605263157894737
Coronavirus,virus synthesis stage,0.60625
Coronavirus,virus aggregate,0.6423076923076922
Coronavirus,virus uncoating stage,0.60625
Coronavirus,virus penetration stage,0.5970588235294118
Coronavirus,virus translation stage,0.5970588235294118
Coronavirus,virus,0.7625
Coronavirus,coronavirus disease,0.8166666666666665
Coronavirus,single-stranded DNA virus,0.6722222222222223
Coronavirus,establishment of a clinically abnormal colony,0.5392857142857143
Coronavirus,coronavirus disease course,0.7472972972972972
Coronavirus,coronavirus disorder,0.8048387096774193
Coronavirus,virus host,0.6880952380952381
Coronavirus,double-stranded RNA virus,0.7
Coronavirus,virus transcription stage,0.5888888888888889
Coronavirus,coronavirus replication,0.7735294117647058
Coronavirus,negative-sense single-stranded RNA virus,0.6068627450980393
Coronavirus,establishment of localization in virus host,0.5981481481481481
Coronavirus,subclinical coronavirus infection,0.7
Coronavirus,virus disorder,0.65
Coronavirus,coronavirus,0.95
Coronavirus,coronavirus pathogenesis,0.7642857142857143
Coronavirus,double-stranded DNA virus,0.7
Coronavirus,respiratory droplet coronavirus fomite,0.6744897959183673
Coronavirus,virus attachment stage,0.6015151515151516
Coronavirus,virus replication,0.6285714285714286
Coronavirus,virus generative stage,0.6015151515151516
Coronavirus,virus release stage,0.6166666666666667
Loan,B cell receptor complex,0.524074074074074
Loan,incubation end temporal region,0.5382352941176471
Loan,latency end process boundary,0.54375
Loan,establishment of a clinically abnormal colony,0.5316326530612244
Loan,incubation end process boundary,0.5071428571428571
Loan,latency end temporal region,0.5790322580645162
Loan,plan specification,0.5863636363636363
Loan,infection end temporal region,0.5409090909090909
Loan,communicability end process boundary,0.525
Loan,communicability end temporal region,0.5525641025641026
Loan,T cell receptor complex,0.524074074074074
Private_Sector,B cell receptor complex,0.6391891891891892
Private_Sector,COVID-19 mortality rate,0.5851351351351352
Private_Sector,three-dimensional spatial region,0.6021739130434782
Private_Sector,innate immunity to infectious agent,0.6336734693877552
Private_Sector,communicability start temporal region,0.6068627450980393
Private_Sector,incubation end temporal region,0.6318181818181818
Private_Sector,normal resident microbiota population,0.6068627450980393
Private_Sector,establishment of localization in human host,0.5552631578947369
Private_Sector,innate immune response,0.6444444444444444
Private_Sector,infection incidence rate,0.6078947368421053
Private_Sector,PR_000003622,0.5653846153846154
Private_Sector,infectious disease mortality rate,0.598936170212766
Private_Sector,symptomatic carrier,0.6318181818181818
Private_Sector,host,0.5611111111111111
Private_Sector,division of geopolitical entity,0.5833333333333334
Private_Sector,generically dependent continuant,0.6021739130434782
Private_Sector,one-dimensional spatial region,0.5863636363636363
Private_Sector,latency end process boundary,0.6404761904761905
Private_Sector,definitive host,0.656896551724138
Private_Sector,local infection,0.656896551724138
Private_Sector,symptomatic infectious structure carrier,0.6166666666666667
Private_Sector,lower respiratory tract disease,0.6055555555555556
Private_Sector,dead-end host,0.6351851851851852
Private_Sector,establishment of a clinically abnormal colony,0.5516949152542373
Private_Sector,temporal region,0.656896551724138
Private_Sector,colonized host,0.6285714285714286
Private_Sector,pathogen host,0.7092592592592593
Private_Sector,geospatial region,0.6435483870967742
Private_Sector,incubation end process boundary,0.6277777777777778
Private_Sector,latency end temporal region,0.6451219512195122
Private_Sector,virus host,0.6166666666666667
Private_Sector,infection end temporal region,0.6127906976744186
Private_Sector,dead-end host role,0.6375
Private_Sector,intermediate host role,0.7
Private_Sector,infectious structure host role,0.6318181818181818
Private_Sector,entry into host through host barriers,0.6068627450980393
Private_Sector,infectious structure host,0.6294871794871795
Private_Sector,two-dimensional spatial region,0.5863636363636363
Private_Sector,zero-dimensional spatial region,0.6055555555555556
Private_Sector,symptomatic carrier role,0.6078947368421053
Private_Sector,specifically dependent continuant,0.598936170212766
Private_Sector,place closure control strategy,0.6772727272727272
Private_Sector,infectious agent host role,0.625
Private_Sector,SARS-CoV-2 incidence rate,0.6038461538461539
Private_Sector,communicability end process boundary,0.61
Private_Sector,symptom,0.5928571428571429
Private_Sector,infectious agent host,0.6214285714285714
Private_Sector,symbiont host role,0.6375
Private_Sector,infection start temporal region,0.6055555555555556
Private_Sector,establishment of localization in host,0.5676470588235294
Private_Sector,pathogen birth temporal region,0.6318181818181818
Private_Sector,host role,0.5804347826086956
Private_Sector,communicability end temporal region,0.6132653061224489
Private_Sector,symptomatic infectious agent carrier,0.63
Private_Sector,establishment of localization in virus host,0.5728070175438597
Private_Sector,colonization of host,0.6264705882352941
Private_Sector,T cell receptor complex,0.6662162162162162
Private_Sector,intermediate host,0.7080645161290323
Private_Sector,definitive host role,0.6558823529411765
Private_Sector,pathogen death temporal region,0.6545454545454545
Private_Sector,zero-dimensional temporal region,0.6239130434782608
Private_Sector,infection incidence rate profile,0.6021739130434782
Private_Sector,COVID-19 incidence rate,0.5851351351351352
Private_Sector,independent continuant,0.5888888888888889
Private_Sector,infectious disease incidence rate,0.598936170212766
Private_Sector,adhesion of symbiont to host,0.5928571428571429
Private_Sector,geographical region,0.6318181818181818
Private_Sector,pathogen host role,0.7
Private_Sector,spatial region,0.6642857142857143
Private_Sector,entry into host,0.656896551724138
Private_Sector,one-dimensional temporal region,0.6055555555555556
Private_Sector,spatiotemporal region,0.65
Mild_COVID-19,B cell receptor complex,0.5611111111111111
Mild_COVID-19,COVID-19 disease incidence proportion,0.61
Mild_COVID-19,COVID-19 mortality rate,0.6722222222222223
Mild_COVID-19,GO_0019814,0.5804347826086956
Mild_COVID-19,GO_0051093,0.5804347826086956
Mild_COVID-19,GO_0019061,0.5804347826086956
Mild_COVID-19,incubation end temporal region,0.5662790697674418
Mild_COVID-19,epitope site,0.57
Mild_COVID-19,COVID-19 pandemic,0.7166666666666667
Mild_COVID-19,establishment of localization in human host,0.5392857142857143
Mild_COVID-19,infection incidence rate,0.5851351351351352
Mild_COVID-19,infectious disease mortality rate,0.558695652173913
Mild_COVID-19,GO_0019081,0.5804347826086956
Mild_COVID-19,colonization of human,0.5382352941176471
Mild_COVID-19,pathogen portal of entry site,0.5452380952380953
Mild_COVID-19,COVID-19,0.830952380952381
Mild_COVID-19,COVID-19 incidence,0.7080645161290323
Mild_COVID-19,GO_0008150,0.5369565217391304
Mild_COVID-19,GO_0019083,0.5804347826086956
Mild_COVID-19,latency end process boundary,0.5963414634146341
Mild_COVID-19,COVID-19 sporadicity,0.6924242424242425
Mild_COVID-19,COVID-19 endemicity,0.7
Mild_COVID-19,source of infection site,0.5581081081081081
Mild_COVID-19,site,0.5088235294117647
Mild_COVID-19,lower respiratory tract disease,0.5409090909090909
Mild_COVID-19,establishment of a clinically abnormal colony,0.553448275862069
Mild_COVID-19,GO_0006959,0.5369565217391304
Mild_COVID-19,ribonucleic acid,0.656896551724138
Mild_COVID-19,GO_0006955,0.5369565217391304
Mild_COVID-19,ERO_0001362,0.5333333333333333
Mild_COVID-19,incubation end process boundary,0.5863636363636363
Mild_COVID-19,GO_0044409,0.5369565217391304
Mild_COVID-19,GO_0019062,0.5804347826086956
Mild_COVID-19,pathogen portal of exit site,0.5475609756097561
Mild_COVID-19,GO_0032991,0.5369565217391304
Mild_COVID-19,latency end temporal region,0.575
Mild_COVID-19,infection end temporal region,0.569047619047619
Mild_COVID-19,GO_19076,0.5928571428571429
Mild_COVID-19,nucleic acid,0.65
Mild_COVID-19,GO_0019028,0.5804347826086956
Mild_COVID-19,GO_0046718,0.5369565217391304
Mild_COVID-19,GO_0019031,0.5804347826086956
Mild_COVID-19,GO_0048519,0.5804347826086956
Mild_COVID-19,ERO_0000671,0.5333333333333333
Mild_COVID-19,SARS-CoV-2 incidence rate,0.581578947368421
Mild_COVID-19,active immunization against infectious agent,0.537719298245614
Mild_COVID-19,GO_0051234,0.5369565217391304
Mild_COVID-19,communicability end process boundary,0.6132653061224489
Mild_COVID-19,site of infection,0.5833333333333334
Mild_COVID-19,COVID-19 prevalence,0.7
Mild_COVID-19,COVID-19 lifetime prevalence,0.6451219512195122
Mild_COVID-19,communicability end temporal region,0.5958333333333333
Mild_COVID-19,T cell receptor complex,0.5611111111111111
Mild_COVID-19,CL_0000000,0.5369565217391304
Mild_COVID-19,GO_0019068,0.5804347826086956
Mild_COVID-19,infection incidence rate profile,0.5611111111111111
Mild_COVID-19,deoxyribonucleic acid,0.6264705882352941
Mild_COVID-19,COVID-19 incidence rate,0.6722222222222223
Mild_COVID-19,GO_0042101,0.5369565217391304
Mild_COVID-19,infectious disease incidence rate,0.5804347826086956
Mild_COVID-19,COVID-19 epidemic,0.7166666666666667
Mild_COVID-19,GO_0044411,0.5369565217391304
Mild_COVID-19,GO_0019815,0.5804347826086956
Mild_COVID-19,infectious human pathogen,0.5289473684210526
Mild_COVID-19,COVID-19 disease course,0.6722222222222223
InfectedFather,establishment of a clinically abnormal colony,0.5516949152542373
InfectedFather,infected population,0.7530303030303032
InfectedFather,T cell receptor complex,0.5851351351351352
IndividualCurrentAccount,establishment of a clinically abnormal colony,0.6094202898550725
IndividualCurrentAccount,T cell receptor complex,0.5776595744680851
RCiu13ZYAsGCD84ydSTDibs,B cell receptor complex,0.5152173913043478
RCiu13ZYAsGCD84ydSTDibs,establishment of a clinically abnormal colony,0.5382352941176471
RCiu13ZYAsGCD84ydSTDibs,T cell receptor complex,0.5152173913043478
